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ABSTRACT 
 
In this thesis technologies are developed to make integrated devices to study  neural 
activity in vitro: microelectrode arrays (MEAs), microfluidic modules and human neural 
stem cells (hNSCs). My aim was to develop novel in vitro models for neurodegenerative 
diseases such as multiple sclerosis (MS). As MS is a chronic neuroinflammatory disease 
that results in loss of myelin it evokes changes in neuronal conduction velocity  in the 
central nervous system (CNS). Therefore, developing a system that could electrically 
follow the progress of myelination through immunocytochemistry and via conduction 
velocity would be of great value in MS research. As a step towards this goal, I developed 
and fabricated functional custom MEAs on which the electrical activity of human 
dopaminergic neurons (differentiated from hNSCs) and mouse spinal cord cells was 
recorded. Microfluidic microchannels measuring 5 μm wide were successful in separating 
the cell bodies of human cerebral cortical neurons (hCCNs) from the axons in two 
different compartments. Mouse spinal cord cultures were electrically active from 2 days 
in vitro (DIV) and remained active up until 52 DIV. Nominal conduction velocity (NCV) 
measurements were recorded from these cultures on commercial MEAs from 6 to 24 DIV. 
NCV increased from 0.03 m/s at 2 DIV to 15.00 m/s at 24 DIV indicating increasing 
myelination. Combining this data with molecular methodologies promises new 
approaches in developing more human-relevant models for MS research and will provide 
a deeper understanding of the process of myelination and possible new treatments that 
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1.1 General Introduction 
 
The development of new technologies and in vitro models has been of paramount 
importance in understanding how human diseases progress and how to treat them. This 
has been strongly underpinned by the availability of powerful molecular and genetic 
techniques as well as improvements in live-imaging methodologies such as super-
resolution imaging. Perhaps less well recognised has been the quiet revolution that has 
occurred in microelectrode technology that has allowed the development of 
microelectrode arrays (MEAs) to detect the electrical activity of multiple excitable cells 
both in vivo and in vitro (Yi et al., 2015). The use of MEAs for in vivo and in vitro analysis 
grew from the development of single microelectrodes (Renshaw, Forbes and Morison, 
1940; Ward and Thomas, 1955). The first true arrays appeared in the early 1970s where 
extracellular activity was recorded from chick cardiomyocytes (Thomas et al., 1972). 
Since then, MEAs developed apace with the first electrical recordings from dissociated 
neurons in vitro on a 32 electrode array occurring a few years later (Pine, 1980). At 
present MEAs are available in different layouts consisting of hundreds of electrodes that 
are used in in vitro and in vivo studies as well as complementary metal oxide 
semiconductor technology (CMOS) arrays consisting of thousands of electrodes (Miccoli 
et al., 2019). 
 
Coupled with these developments, the discovery of human induced pluripotent stem cells 
(hiPSCs) (Takahashi and Yamanaka, 2006), have seen an increase in the use of human 
neuronal cultures to study neurological disorders in vitro (Logan et al., 2019). The use of 
hiPSCs allows the development of more relevant human models as well as avoiding 
problematic ethical issues raised when using human embryonic stem cells (hESCs). 
Furthermore, a focus on more relevant human tissues can lead to a reduction in the 
number of animals used for research.  
 
However, with all its advantages, in vitro cultures also have disadvantages, probably the 
most significant being a complete lack of normal neural architecture. Thus, the 
development of shaping technology to provide a more in vivo like environment can be 
seen as a critical technology in neuroscience. The simplest of these shaping technologies 
deploys chambers connected by microchannels. These techniques were first deployed in 
the late 1970s where a three-chamber compartment to spatially control neuronal 
development was reported (Campenot, 1977). Since then, chambers with regular 
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microchannels have been developed using soft lithography to study axonal growth by 
following their growth through microchannels measuring only a few microns in width 
(20 μm wide, 3 μm height and 10,000 μm in length) (Park et al., 2014). 
 
The research in this thesis focuses on developing and fabricating MEAs as well as 
microfluidics microchannels that will be combined with the cultures of hiPSCs and 
animal primary cultures to form integrated biochips to study neurons of the CNS. 
Ultimately such biochips can be used to study different neurodegenerative diseases like 
multiple sclerosis (MS) allowing for new in vitro models to be created. As MS occurs due 
to the breakdown of myelin and its failure to remyelinate (Gruchot et al., 2019), integrated 
biochips could be used to study neurodegeneration. Currently, most studies use MEAs 
and microfluidics separately to investigate myelination, demyelination and 
remyelination. Combining these three technologies will enable the study of diseases such 
as MS in unprecedented detail.  
 
This introduction (Chapter 1) will provide an overview of the literature in order to allow 
the reader to understand the background and aims of this research. Later, I will detail the 
process of manufacturing, developing and testing custom MEAs and microchannels 
followed by their fabrication (Chapter 2). Fabricated MEAs and microchannel 
functionality will be assessed with human neural stem cell (hNSC) cultures that were later 
differentiated into cortical and dopaminergic neurons (Chapter 3) as well mouse spinal 
cord cultures (Chapter 4). Electrical activity recorded over time will be detailed as well 
as the developmental progress and maturation of these cultures. The data obtained will 
allow a robust understanding at what stages of these cultures electrical maturation and 
synaptogenesis occurs. In the primary mouse cultures the process of myelination by 
measuring electrode-to-electrode conduction velocity is investigated (Chapter 4). Finally, 
the experimental results of these chapters allow us to draw near to answering the question 
posed in this introductory chapter: Are MEAs combined with microchannels suitable for 









1.2 Neurodegenerative Diseases 
 
1.2.1 Prevalence and Pathophysiology 
 
Neurodegeneration is a phenomenon that occurs in the central nervous system (CNS) 
which involves the dysfunction and destruction of neurons and glial cells (Dugger and 
Dickson, 2017). Examples of a few prominent neurological diseases caused by 
neurodegeneration include Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple 
sclerosis (MS) and motor neuron disease (MND). The pathologies caused by the 
degenerative processes are diverse in their pathophysiology with a variety of symptoms 
such as memory loss and cognitive impairment (AD) (Canter, Penney and Tsai, 2016) as 
well as affect mobility, speech and breathing (MND) (Taylor, Brown and Cleveland, 
2016).  
 
These disorders are a major and increasing threat to human health, and are becoming 
more prevalent globally due to the increase in the demographics of elderly populations 
(Przedborski, Vila and Jackson-Lewis, 2003). One way to understand the burden 
neurological disorders have on society is by looking at the disability-adjusted life-years 
(DALYs) which is a measurement obtained by the sum of years lived with disability and 
years of life lost. The DALY for neurological disorders is estimated to be one of the 
highest worldwide and measures at approximately 276 million, which attributes to 11.6% 
of global DALYs for all diseases. Neurological disorders were the cause of about 9 
million deaths worldwide in 2016, which equated to 16.5% of total global deaths, second 
behind cardiovascular diseases (Feigin et al., 2019).  
 
There are currently no cures for neurodegenerative diseases and the treatments available 
only serve to improve the patient’s quality of life by managing the symptoms or halting 
the progression of the disease (Durães, Pinto and Sousa, 2018). Therefore, it is important 
to find new treatment methods that may eventually lead to cures. In order to do this, we 
must better understand what causes them to progress and the underlying pathological 
mechanisms which due to obvious ethical constraints in humans are currently lacking. 
For example, it is known that certain neurodegenerative diseases occur due to the 
abnormal build-up of proteins in the brain or tissue, like β-amyloid accumulation in AD 
(Wisniewski et al., 1989),  α-synuclein accumulation in PD (Takeda et al., 1998) and β-
amyloid and Tau accumulation in MS (Gehrmann et al., 1995).  
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1.2.2 Parkinson’s Disease  
 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after 
AD and is characterised as a movement disorder. It was estimated that 6.1 million people 
suffered with PD worldwide in 2016, which was a substantial increase when compared to 
2.5 million recorded in 1990. PD is slightly more likely to occur in males than females as 
within those 6.1 million cases, 52.5% were men and 47.5% female. Prevalence of PD is 
uncommon before the age of 50, however, its prevalence increases with age and peaks 
between the ages of 85 and 89 (Ray Dorsey et al., 2018). There is currently no cure, 
however, available treatments help manage the disease and improve the quality of life of 
PD patients. These treatments include dopamine substitution and deep brain stimulation 
that help reduce motor and non-motor symptoms (Poewe et al., 2017).  
 
PD was first explained by James Parkinson more than two hundred years ago in his essay 
on ‘the shaking palsy’ (Parkinson, 1817). He studied 6 cases where he noted individuals 
expressing symptoms such as agitated extremities, interrupted speech, bowed body and 
total inability of walking. Most of his observations are valid until now. However, since 
then we have obtained a better understanding in what causes PD, but we still have a lot 
to understand as there is still no cure for it. PD is characterised by the death of 
dopaminergic neurons in the substantia nigra part of the brain and the accumulation of 
the presynaptic α-synuclein within neurons and glia (Poewe et al., 2017). Studies based 
on animal models show that the loss of dopamine producing neurons is triggered by the 
accumulation of α-synuclein (Dzamko, Geczy and Halliday, 2015). Therefore, it is known 
that cells with aggregated α-synuclein, known as Lewy’s bodies, play a significant role 
in PD.  
 
A model based on brains obtained at autopsy of patients clinically diagnosed with PD 
(Braak et al., 2003), showed that PD begins in the medulla and olfactory bulb (stages 1 
and 2) which associates with non-motor symptoms such as rapid eye movement sleep 
disorders and reduced sense of smell. As the disease pathology progresses, lesions are 
observed in the midbrain, specifically in the substantia nigra (stage 3 and 4). This is the 
stage at which PD is diagnosed and is the stage at which patients show motor symptoms 
such as tremors and bradykinesia. The final stages 5 and 6 of the pathology include the 
severe cases which show additional deterioration of the neocortex (Figure 1.1) (Braak et 
al., 2003). Another model used for pre-clinical testing of new treatments is based on the 
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in vivo study of neurotoxic lesions caused by dopaminergic neuron toxins. It involves the 
exposure of mice and primates to 6-Hydroxydopamine (6-OHDA) and 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) which produce PD like effects to be observed 
such as substantia nigra cell death and typical PD symptoms in the animals. However, the 
typical Lewy body formations observed in humans are not reproduced in these animal 
models. (Tieu, 2011). 
 










Figure 1.1: The progression of pathology in Parkinson’s disease. In the early stages of PD (stages 
1 and 2) α‐synuclein aggregations are present in the medulla oblongata and olfactory bulbs. Motor 
symptoms begin to present themselves at stages 3 and 4, where lesions are found in the midbrain, 
substantia nigra. The final and most severe cases of PD are stages 5 and 6 where lesions spread to the 
neocortex (from Poewe et al., 2017). 
 
 
1.2.3 Multiple Sclerosis  
 
1.2.3.1 Prevalence of MS  
 
Multiple sclerosis (MS) is the most common chronic neuroinflammatory disease that 
affects the CNS. Worldwide, the estimate of people living with MS is about 2.2 million 
(Wallin et al., 2019).  In the UK alone it is estimated that there are over 130,000 people 
living with MS, with Scotland having the highest prevalence and incidence rates (MS 
Society, 2020). Incidence and prevalence studies carried out over the last few decades 
indicate that women between the ages of 20 and 40 are more prone to be affected by MS 
when compared to men (Inglese, 2006). The ages at which people are most likely to be 
diagnosed with MS are between 40 and 50 years (Mackenzie et al., 2014). MS is not fatal 
but it dramatically reduces the quality of life of the people affected by it. The symptoms 
that arise from MS vary from person to person. The most common symptoms include 
 
7 
fatigue, loss of mobility, spasticity and cognitive decline (Feinstein, Freeman and Lo, 
2015). 
 
1.2.3.2 MS Subtypes 
 
MS has been categorised into four distinct clinical phenotypes and these terms have been 
used since their proposal in 1996. The four categories are: relapsing-remitting (RRMS), 
secondary-progressive (SPMS), primary progressive (PPMS) and progressive relapsing 
(PRMS) (Figure 1.2) (Lublin and Reingold, 1996). RRMS is the most common (85%) 
form of the disease and it is characterised by sudden onsets of symptoms that occur for a 
few days to months followed by periods of full recovery that are also variable in length. 
After roughly 25 years, RRMS patients often transition into the SPMS form of the disease 
where there is a steady decline of their symptoms and will no longer experience periods 
of remission (Weinshenker et al., 1989). Approximately 10% of patients fall in the PPMS 
course of the disease in which patients experience a steady decline and a worsening of 
their symptoms from the onset of the disease (Antel et al., 2012). The final and least 
common form is PRMS, which is characterised by a steady increase of symptoms from 
the onset but with exacerbation periods and no periods of recovery (Inglese, 2006). 
 
These classifications are useful from a theoretical standpoint. However, in clinical 
practice they are unable to capture the complexity of the disease as the transitions between 
RRMS and SPMS is unclear and also patients are placed in these categories based on their 
recollection and description of when their symptoms have occurred. Furthermore, all the 
MS phenotypes share common characteristics and there is currently no clinical or imaging 




























Figure 1.2: Four clinical phenotypes of multiple sclerosis. (A) Relapsing-remitting (RRMS) which 
is the most common. (B) Secondary-progressive (SPMS) is the form in which a RRMS patients will 
enter after about 25 years of having MS. (C) Primary progressive (PPMS) affects about 10% of MS 
patients. (D) Progressive relapsing (PRMS) is the least common form and the worst of the four 
(adapted from Jacobs, 2016). 
 
1.2.3.3 MS Pathophysiology 
 
In order to gain more knowledge about MS and its pathology, donated post-mortem brain 
tissue of patients have been studied. This pathology consists of plaques of inflammatory 
demyelination in the CNS in combination with inflammatory infiltrates, such as T cells 
and B cells, activated macrophages/microglia and axonal damage (Kutzelnigg and 
Lassmann, 2014). These plaques are not only observed in the white matter but are also 
present in the grey matter. MS lesions are highly variable from one patient to another with 
respect to axonal damage, inflammation and oligodendrocyte pathology (Lassmann, 
Brück and Lucchinetti, 2001). 
 
Neuroaxonal injury has not only been observed in acute and chronic plaques but also in 
normal appearing white matter (Trapp et al., 1998). Axonal loss is variable but may reach 
up to 70% when compared to healthy spinal cord and brain tissue (Lovas et al., 2000). 














is the process of anterograde degeneration of the distal part of the axon that is separated 
from the cell body (Dziedzic et al., 2010). 
 
The blood-brain barrier (BBB) restricts the transfer of cells, such as leukocytes, from the 
blood into the CNS. In MS, the BBB fails to restrict access to leukocytes and they 
therefore are able to enter and interact with other cells in the CNS. It is not clearly 
understood how the BBB changes to allow this but it is hypothesised that these changes 
in the vascular endothelium could be due to the presence pro- inflammatory cytokines 
such as tumor necrosis factor (TNF) (Wu and Alvarez, 2011). The presence of leukocytes, 
such a T cells and B cells, in the CNS trigger an inflammatory response, which alters the 
structure of the myelin sheath significantly and therefore leads to demyelination (Vassall, 




Myelin is an electrically insulating membrane of great importance whose dry mass 
consists of mostly lipids, at approximately 80%, with the remaining being proteins such 
as myelin basic protein (MBP) and proteolipid protein (PLP). Myelin forms a tightly 
packed multi-layered sheath around axons, which aids in the faster conduction of action 
potentials (Aggarwal et al., 2013). This myelin sheath was first observed about 300 years 
ago by Antonie van Leeuwenhoek (Schierbeek, 1953) but did not gain its current name 
for another 150 years since it was first observed. Rudolf Virchow first described this 
“medullary substance” that was found inside the hollow cavity of axons and hence gave 
it the name “myeline” as an analogy to bone marrow from the Greek ‘myelos’ (‘marrow’) 
(Virchow and Chance, 1860). Since then, the availability of new technologies and 
techniques such as electron microscopy, immunocytochemistry and electrophysiology 
has greatly improved our knowledge of the myelin sheath. 
 
We now know that the myelin sheath is dynamic and is formed from glial cells such as 
oligodendrocytes in the CNS and Schwann cells in the PNS. Oligodendrocytes arise from 
oligodendrocyte progenitor cells (OPCs) and are responsible for myelination of axons in 
the CNS. On the other hand, Schwann cells originate from the neural crest and produce 
the myelin that wraps around axons in the peripheral nervous system (PNS) (Monk, Feltri 
and Taveggia, 2015). OPCs account for approximately 5% of all the cells in the CNS of 
an adult (Gautier et al., 2015). Other types of glial cells are also found in the CNS and 
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these include astrocytes, which are the most abundant, and microglia (Zuchero and 
Barres, 2015). 
 
To myelinate axons, OPCs are able to proliferate and migrate to the required regions of 
the CNS. They will then differentiation into myelin-forming oligodendrocytes and begin 
to form a myelin sheath around the axon (Jagielska et al., 2012). They do this by two 
coordinated motions where the start of the innermost layer of growing myelin sheath 
wraps itself around the axon while the remaining myelin membrane forms layers along 
the axon (Snaidero et al., 2014). The process by which oligodendrocytes choose which 
axons to myelinate is not clearly understood as of yet but it is known that they are selective 
towards axons that are at least 0.2μm in diameter (Simons and Trajkovic, 2006). 
 
Recent studies have looked to identify factors that influence differentiation of OPCs and 
myelination. For example, an in vivo study by Azim and Butt, 2011 carried out on rats 
and mice, has identified that the enzyme glycogen synthase kinase 3β(GSK3β) has a 
regulatory effect on the proliferation and differentiation of OPCs. Inhibition of GSK3β 
enhanced the proliferation and survival of OPCs as well as their ability to differentiate 
into oligodendrocytes and thus promoted myelination via several different mechanisms. 
 
Oligodendrocytes not only form myelin to electrically insulate axons but also offer 
trophic and metabolic support as well as cause the cluster of sodium channels throughout 
an axon forming nodes of Ranvier. These nodes are very important as they allow saltatory 
conduction to occur and therefore facilitate the faster transport of electrical impulses 
(Bradl and Lassmann, 2010). Therefore, demyelinated axons or axons with partial myelin 
sheaths result in a reduction of axonal conduction velocity, which compromises the 
signalling function of the neuronal cells. The nodes of Ranvier not only increase the nerve 
conduction velocity by 20 to 100 fold when compared to non-myelinated axons but also 
reduce the energy consumption of neurons (Nave and Werner, 2014). This occurs because 
the requirement of ATP- dependent Na+/K+ exchange in maintaining the resting potential 




Demyelination in MS (Figure 1.3) is caused by the malfunction of myelin-producing 
oligodendrocytes, which once differentiated from OPCs, are unable to migrate to regions 
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that require remyelination. In order for remyelination to occur OPCs have to proliferate, 
migrate into regions of demyelination and differentiate into myelin-producing 
oligodendrocytes (mature oligodendrocytes) (Aharoni, 2015). Studies have shown that 
remyelination does occur in MS patients, however the extent at which the layers of 
compact myelin form are not the same as it was before demyelination occurred. The 
myelin sheath is thinner and more vulnerable to subsequent damage. This has been 
reported by calculating the g-ratio, which is the ratio between the diameter of the axon 
and the diameter of the myelin fibre. Remyelinated axons have a higher g-ratio when 
compared to their equivalent healthy myelinated axons (Bradl and Lassmann, 2010) 
 
Studies over the last few years have been looking at identifying factors that affect 
remyelination. One example of such factors is semaphorins which are secreted and trans- 
membrane proteins. More specifically, class 3 semaphorins have been shown to play a 
role in remyelination (Jongbloets and Pasterkamp, 2014). It has been identified that 
semaphorin 3A (Sema3A) blocked the recruitment of OPCs to demyelinated regions. 
Unlike Sema3A, semaphorin 3F (Sema3F) accelerated the recruitment of OPCs and also 


















Figure 1.3: Structural changes of neurons in multiple sclerosis. A healthy axon has compacted 
myelin sheath wrapped around its axon forming distinct nodes of Ranvier (blue arrows). Multiple 
sclerosis occurs due to demyelination of the axons which lead to the breakdown of the myelin sheath. 
(Adapted from Kalb, Giesser and Costello, 2012). 
 
 
Healthy Neuron Demyelinated Neuron 
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1.2.3.6 Animal vs Human Models of MS 
 
Experimental autoimmune encephalomyelitis (EAE) is the most commonly studied 
animal model for MS and it is thought to be the closest pathology model for MS (Franklin, 
2015). Over the years, it has helped us better understand the mechanisms of MS as well 
as test and develop drugs to treat MS patients (Farooqi, Gran and Constantinescu, 2010). 
During the past few years, several other animal models have been developed, however, 
their outcomes do not always reflect what would happen when compared to a human MS 
patient. This is due to the fact that there several differences between human and rodent 
oligodendrocytes.  
 
Some regions of rodent brains are underdeveloped when compared to human brains. For 
example, mice, unlike humans, totally lack the neocortical regions. Also, the opposite 
applies as the olfactory bulbs are much less developed in humans when compared to mice 
(Jakovcevski et al., 2009). Another difference is that the numbers of oligodendrocytes 
present in the human brain are greatly increased when compared to those found in mice. 
Also, gliogenesis occurs postnatally in mice whereas in humans it occurs during gestation 
(Craig et al., 2003). Finally, the time it takes for myelination to occur is another key 
difference. In humans it takes decades due to the complexity of the brain whereas in mice 
myelination only takes about 2 weeks (Semple et al., 2013). However, there are some 
similarities between humans and rodents, which include that both their OPCs show 
similar responses to growth factors, such as platelet-derived growth factor (PDGF) 
(Wilson, Onischke and Raine, 2003). 
 
The fact that there are so many differences between human and rodent models indicates 
the importance of developing human in vitro models that will be able to output more 
human relevant results. A possible solution to this is that since the discovery of human 
embryonic stem cells (hESCs) about two decades ago (Thomson et al., 1998) and more 
recently human induced pluripotent stem cells (hiPSCs) (Takahashi and Yamanaka, 
2006), together with their commercial availability, has allowed researchers to use human 
cells to develop novel models that will potentially improve our understanding of the 





1.2.4 Induced Pluripotent Stem Cells 
 
Rather than using complex and possibly divergent animal models for disease process 
studies, the availability of human tissues/cells could advance understanding by enabling 
relevant experiments in vitro. 
 
The discovery of hESCs, has generated great interest in developing new cell lines that 
would have a similar function to human primary cells such as neurons and glia. However, 
hESCs have associated ethical problems with their use relating to the destruction of 
human embryos (Di Ruscio et al., 2015). Takahashi and Yamanaka, 2006, were able to 
address this as they discovered a method to reprogramme adult fibroblasts into induced 
pluripotent stem cells (iPSCs) by introducing four transcription factors, Oct3/4, Sox2, c-
Myc and Klf4 to the cultures. 
 
Protocols are now available to differentiate human iPSCs into almost any cell type and 
therefore studies have utilized them to differentiate them into human neural stem cells 
(hNSCs). These hNSCs, also referred to as neural progenitor cells, can be further 
differentiated into any neuronal cell line, for example, dopaminergic neurons, cortical 
neurons, motor neurons and glial cells (Selvaraj et al., 2012). Therefore, iPSCs can be 
used for developing novel human in vitro models, as well as used in transplantation 
therapies of which they offer an  advantage over hESCs as they will not induce a post-
transplantation immune response because they are derived from the patients’ cells 
(Goldman and Kuypers, 2015). 
 
The time it takes to differentiate into each specific neuronal cell varies between each 
protocol. For example, differentiating into cerebral cortical neurons takes about 3 to 10 
days (Axolbio, 2016) and differentiating into dopaminergic neurons takes 14 days 
(STEMCELL Technologies). These differentiation protocols are fairly short in 
comparison to that of glial cells. A protocol published by Wang et al., 2013 described the 
process in which they differentiated human iPSCs into oligodendrocytes over a period of 
4 to 5 months. Since then a more recent protocol has been published that has halved the 





The availability of such protocols, even though time consuming and expensive, opens the 
possibility of further studies to utilise the use of human neurons and OPCs to investigate 
remyelination, which will directly relate to humans and not rodents. There have already 
been studies that have demonstrated in vivo myelination in the shiverer mouse following 
the transplantation of human OPCs differentiated from iPSCs (Douvaras et al., 2014).  
 
1.3 Microelectrode Array Technology 
 
Studying the function and connectivity of neurons in the brain involves interdisciplinary 
efforts and technological development which through the years have led to advances in 
genetic markers, immunostaining, electrophysiology and computational tools. These 
advances have allowed the identification of neuronal cell types and their functions in 
different regions of the CNS. At the core of this technology is the basic fact that the main 
functional substrate of the CNS is its wet bioelectricity which enables it to function as a 
massive parallel supercomputer. Thus, to get a better understanding of the brain’s 
complexity and pathology, innovative technologies require the measurement of electrical 
potentials over a wide field and in as much detail as possible. 
 
At the microscale, patch clamp can measure currents of single ion channels and carry out 
direct measurements of the intracellular voltage. While patch clamp is a powerful but 
exacting method (as not many neurons can be studied per experiment) (Wood, Williams 
and Waldron, 2004) it gives unprecedent detail with poor spatial resolution. At the 
macroscale, measurements can be obtained from large areas of the brain’s activity using 
techniques such as electroencephalography (EEG) which can detect electrical activity 
from the scalp with centimetre range spatial resolution (Obien et al., 2015) and can be 
equivalent to imaging large areas of the brain at high resolution. 
 
Microelectrode arrays (MEAs) offer a solution to the poor spatial resolution but as they 
only measure electrical potential a little detail is lost. They can be deployed to measure 
electrical activity in vivo and in vitro. The first MEA in vitro recordings were done on 
chick cardiomyocytes in 1972 (Thomas et al., 1972). The MEA was fabricated using 25 
mm glass coverslips and consisted of 30 platinum black electrodes, arranged in two rows 
50 μm apart and the interelectrode distance between rows was 100 μm (Figure 1.4A). 
For insulation a photopolymer layer was coated over the surface. A few years later, the 
first extracellular recordings from dissociated neuronal cultures were recorded on an 
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MEA. Dissociated cells from superior cervical ganglia of neonatal rats were cultured a 
glass coverslips that had 32 gold electrodes, in two horizontal groups of 16 at a 250 μm 
interelectrode distance with a silicon dioxide insulating layer (Pine, 1980). 
 
1.3.1 Types of MEAs for in vitro Applications 
 
Since those early arrays in the 1970s, MEAs have developed into having a variety of 
different features as well have thousands of electrodes. Most common MEAs have planar 
electrodes arranged uniformly with a set interelectrode distance and are used for in vitro 
cell culture analysis. An example includes the 60Standard MEA (Figure 1.4B) offered 
by Multichannel Systems (Reutlingen, Germany) which consists of 60 electrodes (59 
recording and 1 internal reference electrode) in an 8 x 8 layout grid with two options for 
electrode diameters (10 and 30 μm) and two options for interelectrode distances (100 and 
200 μm). The electrodes are made of titanium nitride (TiN) and the insulating layer is 
made of silicon nitride (Si3N4). Three dimensional MEAs are also commercially available 
that are ideal for studying brain slices as protruding electrodes can be fabricated that 
penetrate dead cell layers and therefore allow interfacing and recoding from healthy cells. 
A 60-3DMEA from Multichannel Systems (Figure 1.4C) consists of 60 TiN electrodes 
(59 recording and 1 internal reference electrode) arranged in an 8 x 8 grid with 
interelectrode distances of 100, 200 or 200 μm. The electrodes are 20 μm high, have a 
base diameter of 100 μm and a tip diameter of 12 μm. Another type of MEA offered by 
Multichannel Systems is a highly dense 256ThinMEA (Figure 1.4D) which contains 252 
TiN electrodes and four ground electrodes in a 16 x 16 grid. The versions available offer 
electrodes of diameter 10 or 30 μm and interelectrode distances ranging between 30 to 
200 μm. The electrodes are embedded in a 180 μm thick glass substrate making them 

































Figure 1.4: Different types of microelectrode arrays. (A) First MEA used for measuring electrical 
activity from dissociate cell cultures (Thomas et al., 1972). Right panel shows a magnified view of 
the electrode arrangement. (B) Standard 60MEA with 59 planar recording electrodes and one internal 
reference electrode. Right image shows a magnified view of the electrode layout in the centre of the 
MEA. (C) An example of an MEA with 3D electrodes (right image) arranged in the same way as those 
of the standard 60MEA. (D) High density MEA consisting of 256 electrodes of which 4 are the ground 
electrodes (visible as arrow heads in left image). (From Multichannel Systems, 2015). 
  









ARRAY CROSS SECTION C 
Fig. 1. The microelectrode array. (a), The completed array, plan view. A direct enlargement from array pattern 
masterplate; (b), the electrode tips covered with photopolymer insulation. The parallel troughs expose the 
underlying gold, which is eventually platinized; (c), diagrammatic cross-section of microelectrode array forming 
the floor of culture chamber. 
in a large patch, or ‘land’, which is left 
uninsulated, to allow convenient connection 
to associated electronic equipment. 
MATERIAL AND METHODS 
The arrays were fabricated in our laboratory by a 
procedure which, briefly, was as follows [lo]. Glass 
coverslips, 25 mm square, bearing vacuum-deposited 
nickel films (nominally 2 000 A thick) were coated 
with an acid-resistant, photosensitive polymer and 
exposed to light through a photographic negative of 
the desired pattern. The exposed polymer was then 
removed by ‘development’ and the metal thus un- 
covered was etched away in acid. This left a nickel 
image of the photographic negative on each cover- 
slip. The nickel was gold-plated and each slip was 
coated with a second photopolymer layer which 
served as insulation. The desired openings in this 
layer were formed by ‘developing’ the polymer after 
exposure through a second photographic negative of 
Exptl Cell Res 74 (1972) 
an appropriate pattern. A glass ring was then af- 
fixed to the insulated array with bees’ wax, thus 
creating a culture chamber whose floor contained 
the permanently-positioned microelectrode tips. In 
a final step, platinum black was deposited electro- 
chemically on the exposed tips. 
During culture incubation, the entire assembly was 
enclosed in a small Petri dish. For the electrophysio- 
logy experiments, the assembly was held in a circuit 
board that made contact with the e!ectrode lands via 
spring-loaded pins. In turn, the board was enclosed 
in a metal box which served as an electrical shield 
and contained switches permitting various sets of 4 
electrodes to be joined, via amplifiers, to a 4-trace 
oscilloscope. This box was mounted in the mechan- 
ical stage of an inverted microscope. Thus it was 
possible to observe the cell culture and the electrodes 
from which recordings were being made. A platinum- 
iridium wire inserted into the culture medium from 
above was used as the indifferent (or ‘reference’) 
electrode during recording. Temperature and atmos- 
phere composition could be controlled during re- 
cording, and medium could be changed by a perfu- 
sion arrangement. 
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4.6 Three dimensi nal MEA: 60-3DMEA 
60-3DMEA200/12iR-Ti 
      
 
60-3DMEAs are the ideal solution for acute slices, because the three dimensionally shaped electrodes are 
intended to penetrate dead cell layers. Using conventional flat electrodes, the electrodes may interface with 
the damaged cell layer rather than with the healthy cells. The three dimensional electrode of a 3D MEA may 
be able to penetrate this cell layer and contact the healthy cells above better. 
The tip-shaped electrode results in a larger surface area, etched from glass with a diameter of 100 µm. 
The spatial resolution is limited. 59 electrodes and one reference electrode are aligned in an 8 x 8 grid  
with interelectrode distances of 200 µm. 
The Titanium nitride (TiN) electrodes are 20 µm high and have a diameter of about 12 µm at the base, 
ending in a fine small tip. 
Tracks and contact pads are made of Titanium (Ti); the insulation material is Silicone nitride (SiN). 
Using 60-3DMEAs 
The same material is used for standard MEAs and 60-3DMEAs. Therefore, they are also heat-stabilized.  
They can be autoclaved and coated with different procedures for cell and tissue cultures. 
Due to the production process and the fine tip, there may be more variations in the electrode impedance, 




3.2  MEA Design and Production 
A standard MEA biosensor has a square recording area of 700 µm to 5 mm length. In this area, 
60 electrodes are aligned in an 8 x 8 grid with interelectrode distances of 100, 200, or 500 µm. Planar  
TiN (titanium nitride) electrodes are available in sizes of 10, 20, and 30 µm, and three-dimensional TiN  
electrodes have a diameter of > 12 µm at the base with a very fine tip. Standard MEAs are useful for  
a wide variety of applications. Different geometries match the anatomical properties of the preparation. 
Most MEAs are available with a substrate-integrated reference electrode replacing the silver pellet in the 
bath. All electrodes can either be used for recording or for stimulation.  
In principle MEA electrodes are not arranged symmetrical, so the MEA chip has to be placed inside the 
amplifier in the recommended manner. 
Several other MEA types and layouts that are dedicated to special applications are also available, please  
see chapter “MEA Types and Layouts” for more details. 
The biological sample can be positioned directly on the recording area; the MEA serves as a culture and 
perfusion chamber. A temperature controller controls the temperature in the culture chamber. Various 
culture chambers are available, for example, with leak proof lid or with semipermeable seal. An incubator 
is not necessarily required, long-term recordings in the MEA culture chamber are possible over several 
weeks or even months. 
For cell or slice cultures, MEAs have to be coated with standard procedures before use to improve the cell 
attachment and growth, please read chapter “ MEA Coating”. 
Spike activity can be detected at distances of up to 100 µm from a neuron in an acute brain slice.  
Typically, signal sources are within a radius of 30 µm around the electrode center. The smaller the distance, 
the higher are the extracellular signals. The higher the spatial resolution, the lower the numbers of units 
that are picked up by a single electrode, that is, the less effort has to be put into the spike sorting. 
Multi Channel Systems provides MEAs with the highest spatial resolution in the market. HighDenseMEAs 
have electrodes with a diameter of only 10 µm arranged in a distance of only 30 µm (center to center).  
The challenge of manufacturing very small electrodes and at the same time keeping the impedance and  
the noise level down has been met by introducing the electrode material Titanium nitride (TiN). 
The NMI in Reutlingen, Germany (www.nmi.de), produces MEAs from very pure fine quality and highly 
biocompatible materials. The NMI is a research institute, with which Multi Channel Systems has 
collaborated in many projects and over many years. 
Quality controls and production processes have been improved over the last years so that MEAs are always 
of a fine consistent quality at very reasonable prices. 
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4.11  256MEA for Use with MEA2100-256- and USB-MEA256-Systems 
256MEA30/8-ITO, 256MEA60/10iR-ITO, 256MEA100/30-ITO, 256MEA200/30-ITO, and 256ThinMEA  
    
 
The 25 MEAs have to be used with MEA2100-256- and USB-MEA256-Systems. Please refer to the 
respective manual for detailed information. 
 
The 256MEA contains 252 recording, a d our ground electr des arranged in a 16 x 16 layout grid 
embedded in a transparent glass substrate. The contact to the amplifier is provided by a double ring  
of contact pads arou d the rim of t  MEA. The standard material for MEAs is also used for 256MEAs:  
The electrodes re from titanium nitride (TiN) with a si icon nitrid  (SiN) isolator, and contact pads and 
tracks are made of transparent indium tin oxide (ITO).  
 
The spacing of the electrodes in the 16 x16 grid averages 30, 60, 100 µm or 200 µm between the 
electrod s. The electro e diameter of 30 µm result  in an impedance of <100 k:. The electrode diameter 
of 10 µm results in an impedance of approximately 250 to 400 k:. The dimension of the glass carrier  
is 49 x 49 x 1 mm as usual. 256MEAs are stable in a temperature range from 0 ° - 125 °C. 
 
The 256MEA is only MEA type, which is rotationally symmetric. 
 
256ThinMEAs are only 180 µm "thick", ideally suited for high-resolution imaging. 256ThinMEAs are like 
standard MEAs, but the electrodes are embedded in a very thin and delicate glass substrate on a robust 
ceramic carrier. The thin glass allows the use of oil immersion objectives with a high numerical aperture. 
Like 256MEAs, 252 electrodes are arranged in a 16 x 16 layout grid with electrode diameter of 30 µm,  
and interelectrode distance of 200 µm (256ThinMEA200/30-ITO). 
 
Using 256MEAs 
The same material is used for standard MEAs and 256MEAs. Therefore, they are equally robust and heat-
stabilized. They can be autoclaved and coated with different procedures for cell and tissue cultures. 
Using 256ThinMEAs 
256ThinMEAs are heat-stabilized and can be autoclaved. They can also be coated with different procedures 








1.3.2 In vitro Neuronal Cultures and MEAs 
 
Combined with immunostaining, MEAs have been used to study and identify neuronal 
types, analyse electrical activity in long term cultures and follow synaptogenesis. 
Examples include the use of MEAs to study excitatory and inhibitory synapses in long 
term culture of rat cortical neurons for up to 35 days in vitro (DIV) (Ito, Komatsu and 
Gohara, 2013). This study used antibody staining against vesicular glutamate transporter 
1 (VGluT1) and vesicular transporter of γ-aminobutyric acid (VGAT) to investigate the 
distribution and densities of glutamatergic and GABAergic synapses which they then 
compared to the electrical recordings obtained from the MEAs. They found a correlation 
between synaptic densities and electrical activity as an increase in glutamatergic and 
GABAergic synapses was accompanied with an increase in electrical activity from 7 DIV 
and reached a plateau after 28 DIV which was when synapses reached their final mature 
state.  
 
With advances in lithographic techniques, researchers began fabricating their own custom 
MEAs in order to adapt the electrode layouts to fit the experimental design and to avoid 
restrictions imposed by the fixed layouts provided commercially. High density CMOS-
based MEAs containing over 11,000 electrodes were used by Bakkum et al., 2013, to 
investigate axonal action potential propagation by culturing rat cortical neurons on them. 
One of their measurements included conduction velocity, which ranged between about 
0.2 and 1.8 m/s. Based on those measurements they concluded that these velocities were 
recorded from unmyelinated axons. 
 
1.3.3 Microelectrodes in vivo 
 
Microelectrodes are also being used in vivo to study the CNS in order to obtain a more 
detailed use of its neuronal structure and to look at highly localised drug delivery. 
Microelectrodes for stimulating and recording are aligned at the tip of a probe which is 
stereotactically placed in a region of the brain (Figure 1.5).  
 
High density recording silicon probes (Figure 1.5B), of up to 512 channels, have been 
used to study the electroanatomical boundaries of layers and regions in the hippocampus 
and neocortex of rats (Berényi et al., 2014). This system allowed the simultaneous 
recordings of local potentials and the unit activity from hundreds of sites while the animal 
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could move freely. This was achieved by having ultra-flexible connections and a 
miniaturised microdrive that allowed the probe to move to the vicinity of the desired 





















Figure 1.5: Examples of several probes with a series of microelectrodes for in vivo use. (A) Seven 
neural probes made from silicon on the back of a U.S penny fabricated by the University of Michigan. 
(B) High density silicon probe connected to a printed circuit board via a flexible ribbon cable that can 
transmit from 256 channels. Microelectrodes are embedded in the probes as indicated by the arrows 





voltage-stress on the encapsulating dielectrics. Typical cell
thresholds for stimulation are 10–20 !A, but stimulating
currents can reach 100 !A or more. Since the conducting
substrate below the leads and the extracellular fluid above
them both act as ground planes, interchannel crosstalk is
virtually negligible on such probes, and the small area of
the lithographically defined leads minimizes shunt capac-
itance so that signal attenuation is negligible as well. Site
impedances are dominated by the series capacitance of the
metal-electrolyte double layer. Recording sites are usually
formed using gold or platinum, although anodically formed
iridium oxide [40], [41] is increasingly used. It produces
significantly lower recording impedances than other
materials and is essential for stimulating sites, permitting
more than 20 times the charge delivery to tissue than
platinum or gold at the same voltage [15], [42].
Sites are thought to average the potential field seen in
tissue over their area. For recording from small cells, site
areas of 100 !m2 have often been used, although larger
areas of 300–400 !m2 have been more typical recently to
reduce thermal electrode noise, which is inversely related
to area. For stimulating sites, 1000 !m2 is suitable for
current levels of about !70 !A at supply voltages of !5 V,
limited by the spreading resistances in tissue near the
site [43].
Fig. 3 shows several neural probes on the back of a U.S.
penny. More than 7500 such devices have been supplied to
the neuroscience community by the University of
Michigan and have changed research directions in systems
neurophysiology. One of the additional benefits of using
silicon as the substrate material is that circuitry for site
Fig. 3. Several different probe designs shown on the back of a U.S. penny.
Fig. 4. A 64-site probe on a U.S. postage stamp. The sites are spac d
100 !m in depth with shanks on 200 !m centers. The probe is
configured for mounting in a 3-D array.
Wise et al. : Microelectrodes, Microelectronics, and Implantable Neural Microsystems
Vol. 96, No. 7, July 2008 | Proceedings of the IEEE 1187
male Long-Evans rats (400–640 g; 3–10 mo old) were implanted with
high-density, 256-site silicon probes under isoflurane anesthesia as
described earlier (Vandecasteele et al. 2012). The probes and the
polyimide interconnect cable were manufactured by NeuroNexus
(http://www.neuronexus.com). In two rats, two probes were implanted; in
one rat the probes were placed in the same hemisphere, whereas in the
other they were placed symmetrically in the two hemispheres (Fig. 1).
During surgery, the tips of the shanks are inserted into the superficial
cortical layers or !1 mm above the intended subcortical target. After
recovery, the probe is moved gradually until the target layer is reached
using 70- to 150-!m rotations per day until most or all shanks record
units and the probe has reached the desired target. The operated animals
were housed in individual cages.
Neuronal activity in the neocortex and/or the hippocampus was re-
corded while the animals were running in a 240-cm long linear maze,
performing a delayed alternation task in a similar-sized T-maze for water
reward, or freely exploring an open-field platform. The neuronal activity
during rest/sleep in the home cage preceding and following the waking
sessions was also recorded. The wide-band signal was low-pass filtered
and downsampled to 1,250 Hz to generate the LFP and high-pass filtered
("0.8 kHz) for spike detection. Malfunctioning recording sites (due to
high impedance, cross talk, and short circuit) were removed from the
analysis. Operated mice (male, 8–20 wk) were also housed individually
after surgery. Details of surgery, optogenetic methods, and behavioral
tests are available in Stark et al. (2012).
Histology
Following the termination of the experiments, the animals were deeply
anesthetized and transcardially perfused first with 0.9% saline solution
Fig. 1. System overview. A: high-channel-count (256 sites) silicon probe connected to a printed circuit board via a flexible polyimide ribbon cable. The printed
circuit board contains 8 separate 32-channel signal multiplexers (4 on each side) and accessory circuit elements. B: a simulated headstage input signal illustrating
a spike waveform on 1 of the 32 channels and various levels of direct current (DC) on the remaining 31 channels (1 ms). a.u., Arbitrary units. C: time-shared
multiplexed signal transmitting the 32 channels shown in B. D: circuit schematics and working principle of the multiplexer and a zoomed segment of the time
epoch shown by rectangle in C. The multiplexer chip receives the input signals and is driven by both the clock signal of the main microcontroller and the
complementary clock bits generated by the clock divider. The horizontal line separates circuits contained in the headstage and the main box. Middle part: zoomed
segment of the multiplexed signal shown in B. The reset line resets the clock bits to “00000” after every 32 steps to ensure the proper channel order. The trigger
signal is timed to sample the “tail” of each transmitted signal snippet (marked by black triangles). The 2 large steps (red) correspond to the 2 digital samples
at the trough of the spike waveform on input channel 3. Right part: numerical representation of the analog-to-digital (A/D)-converted multiplexed line (readout
from the A/D card) and its demultiplexed form after the software reconstruction of the digitized samples. CPU, central processing unit.
Innovative Methodology
1133512-CHANNEL NEURONAL RECORDING IN BEHAVING RODENTS
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Microfluidics, or mini labs-on a chip, have become very popular over the last few 
decades. Microfluidics allows delivery of drugs, solutions or reactive mixtures to be 
delivered faster, with smaller volumes of substrates and can be used to produce isolated 
chemical environments similar to those found in the human body (Park et al., 2012). This 
type of system has also been extensively used to study and model the nervous system by 
constraining neurons to grow in a more neuro-architectonically valid orientation. 
Campenot, 1977 first introduced an in vitro three compartment device (Figure 1.6A) that 
separated neuronal cultures with localised fluidic control. Dissociated neurons from super 
cervical ganglia of newborn rats were cultured in the central chamber and neurite growth 
was guided into either of the other two chambers by adding nerve growth factor (NGF). 
Neuronal growth was guided into the chambers as growth was only observed along the 
200 μm tracks formed between the collagen scratches previously done using insect pins. 
Growth was not found to not cross over the scratches. Recent studies still utilise these 
Campenot style chambers to study axon-glia interactions (Park et al., 2009). However, 
the chambers are connected with much more precise features as the microchannels 
measure 15 μm in width and are separated by 60 μm (Figure 1.6B). The ability to 
fabricate micron level features has arisen due to the introduction of photolithography 









Figure 1.6: Chambers for neuronal growth control and guidance. (A) Campenot chamber made 
up of three compartments labelled a, b and c. Dissociated neurons were cultured in chamber a and 
NGF was added into the other chambers b and/or c. Neuronal growth was only observed in the 
chambers that had NGF and growth was observed to occur within the etched channels (from 
Campenot, 1977). (B) A more recent compartmentalised microfluidic device that was based off 
Campenot. Neurons were cultured in the middle soma compartment and oligodendrocyte were added 
in the surrounding compartment where they could only interact with axons that grew through the 15 
μm microchannels (from Park et al., 2009). 
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FIG. 1. A petri dish (35 mm, Falcon, viewed from above) divided
into three chambers by a Teflon divider (7.5 mm high) that is sealed
to the floor of the dish (a collagen-coated coverslip) with silicone
grease. The floor of the narrow (1 X 5 mm) central chamber (a) in
which the neurons were plated is transected by a series of parallel
scratches which guided the growing neurites into the left (b) and right
(c) side chambers. See text for further details.
provided with polystyrene coverslip floors that were coated with
a film of dried collagen. A rake made by cementing together
twenty insect pins was used to make 20 parallel scratches about
200,m apart on the collagen-coated coverslip. Neuri es
growing on the collagen surface tended not to cross the
scratches, and their growth was, therefore, guided along the
200,-m-wide collagen tracks between the scratches. To as-
semble the system, the scratched region was first coated with
growth medium. Then a Teflon divider (see Fig. 1), which
served to partition the petri dish into three chambers, was sealed
to the coverslip with silicone grease (Dow Corning, high vac-
uum grease) previously applied to the entire lower surface of
the divider through a blunted 22-gauge hypodermic needle.
The grease was loaded into a syringe and autoclaved before
application. The divider was seated so that the scratches crossed
the floor of a narrow central chamber (1 X 5 mm) at right angles
to its long dimension and entered into the chambers flanking
it at the left and right. The coating of growth medium on the
collagen in the scratched region prevented the silicone grease
from adhering there, but the grease pressed against the collagen
surface firmly enough to prevent significant flow of medium
between the central and side chambers. Seals made in this
manner were usually tight enough to prevent any detectable
equalization of fluid-level differences (approximately 5 mm)
set up between the chambers for at least 4 days; that is, an up-
ward going meniscus was maintained in the side chambers for
this time while the fluid level in the central chamber was low.
However, the seals could be penetrated by growing neurites.
Dissociated neurons plated into the central chamber reaggre-
gated to produce one or a few small clusters of somas per col-
lagen track. Their neurites usually avoided crossing the
scratches and, thus, were guided towards the partitions sepa-
rating the central and side chambers. They would usually
continue to grow beneath the partitions, emerging into the side
chambers after about 3-6 days in culture.
7S NGF was prepared as described (16). In most experiments,
neurons were plated into the central chamber, which contained
NGF (1 ,g/ml), and growth into side chambers containing ei-
ther the same NGF concentration or no added NGF was com-
pared. Also, in some experiments outgrowth occurred with
NGF in all three chambers and NGF was subsequently with-
drawn from one side chamber and/or the central chamber. In
all experiments the fluid level in chambers to which no NGF
was added (-NGF) was always maintained at a higher level
than adjoining chambers containing NGF (+NGF) so that any
flow through the seal would dilute the NGF in the +NGF
chamber rather than add NGF to the -NGF chamber. The
fluid levels in the left and right chambers were always main-
tained at the same level. Diffusion of small amounts of NGF
through the seals has not been ruled out, but dramatic effects
were observed in these experiments, indicating that diffusion
was not significant.
RESULTS
The appearance of the neurons 25 days after they were plated
into the central chamber (see Methods) is shown in Fig. 2; a is
a montage of photomicrographs showing two of the collagen
tracks in the central chamber. The scratches bordering the
tracks are seen at the upper and lower edges and through the
center of the montage, and the edges of the silicone grease seals
are at the left and right edges of the montage. Three clusters
of somas and a single soma were present, and their neurites
formed bundles that aligned parallel with the scratches and
entered the grease seals (1 Asg of NGF was present per ml in the
central chamber when these neurons were plated, but was
withdrawn 2 days later, see below). Fig. 2b shows the neurite
bundles on the same collagen tracks in the left chamber, which
continuously contained NGF. The edge of the grease seal from
wh ch the neurites emerged is at the r ght edge of this mon-
tage.
In most cultures, neurites crossed the barriers when 1 Mg of
NGF was present per ml on both sides, but neurites never
crossed from +NGF central chambers into -NGF side cham-
bers. Within the central ch mber the neurites ent red the edges
of the grease seals regardless of the NGF content of the side
chambers, but none grew the full distance under the grease and
emerged into a side chamber to which no NGF had been
added.
Before the culture system had been sufficiently perfected,
neurites on many of the collagen tracks in most cultures failed
to cross barriers even when NGF was present on both sides, and
in an occasional culture, no neurites crossed. However, the
striking feature of the early experiments was that neurites never
emerged into -NGF side chambers. In one experiment, which
will serve as an example, 14 cultures were set out, 7 of which
had NGF added to the central chamber and both side cham-
bers. In the remaining 7 cultures, NGF was added only to the
central and left chambers. After 6 days in culture, neurites had
crossed into 11 of the 21 +NGF chambers, and after 14 days
they had entered 20 of them. In contrast, during the 22 days that
the cultures were maintained, no neurites entered any of the
7 -NGF chambers. Refinement of the culture system resulted
in very reliable crossing of neurites into +NGF side chambers,
but, again, neurites were never observed to emerge into -NGF
side chambers. In five cultures with +NGF left chambers and
-NGF right chambers that were maintained for 9 days, neu-
rites emerged into the +NGF chambers on 43 collagen tracks
out of a possible 49 (88%), but none emerged into the -NGF
chambers.
If NGF was withdrawn from a side chamber, the growth of
Cell Biology: Campenot
Figure 1.
Schematic illustration of the microfluidic compartmentalized CNS neuron co-culture platform.
(a) 3D-view of the circular device, (b) cross-sectional view showing the physical isolation of
axons and OLs from neuronal soma and dendrites, and (c) circular and square design culture
platforms with cross-sectional views showing a minute difference in fluidic levels for fluidic
isolation. The circular compartment in the center of the circular device is an open access
compartment for neurons and is connected to the outer ring-shaped axon/glia compartment for
OLs through arrays of axon-guiding microfluidic channels.
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Figure 1.7: Photolithography process for fabricating microchannels. In order to fabricate 
microfluidic channels, a ‘mold’ has to be created called the master wafer. The microfluidic design is 
on the photomask and depending on if a negative or positive photoresist is used its design will be 
transferred onto the master wafer. 
 
Depending on what is investigated, microfluidic devices are fabricated with a different 
number of compartments. A study by Coquinco et al., 2014 designed and fabricated a 
microfluidic device with three compartments to study synaptic competition in vitro using 
rat cortical neurons. Neurons in each compartment were treated in a different way. They 
found that treating neurons in one of the compartments by inhibiting synaptic input 
activity using muscimol (GABAAR agonist) caused the increase in synapse number and 
axon elongation of the neurons cultured in the opposing un-treated chamber (Figure 1.8). 
Another study investigated nerve injury by culturing rat CNS neurons in a two-
compartment microfluidic device where the cell body remained in the first compartment 
and axons grew through microchannels and into the second compartment in localised 
chemical treatments were applied to study axonal regeneration using myelin inhibitors 
such as NOGO-66 and myelin associated glycoprotein MAG (Park et al., 2008). 























Figure 1.8: Illustration of 3 compartment microfluidic design used to study synaptic 
competition. Wells are connected to 3 separate compartments in which rat CNS neurons are cultured. 
Myelin inhibitors are added in the wells of one of the compartments and any effects in synaptic and 
axonal growth of the neurons in the other 2 compartments are observed (from Coquinco et al., 2014). 
 
1.5 MEA and Microchannel Integration 
 
As electrodes on MEAs are spatially fixed it means that electrical activity recorded from 
neuronal cell cultures is random and it depends on the proximity of the cells to the 
electrode. This means that if no cells grow over an area of electrodes then that region 
becomes redundant. This issue can be resolved by encouraging neuronal growth over the 
available electrodes by guiding growth using the aforementioned microfluidic channels. 
 
Feber et al., 2015 designed and fabricated a two-compartment model that interfaces with 
a custom MEA where one compartment was used for stimulation and the other for 
recording. They also modified the microchannels in order to improve the unidirectional 
growth of axons by adding barbs throughout the channels. This prevented axons in the 
recording compartment from growing back into the stimulating compartment and 
therefore affect the electrical recordings. 
 
Another more recent study used custom MEAs with integrated microchannels (Figure 
1.9) to investigate the effects of myelinated and unmyelinated Schwann cells (SCs) have 
on axonal conduction (Sakai et al., 2017). The microchannels were aligned over indium 
tin oxide (ITO) electrodes and  measured 50 µm in width, 6 µm in height and 2000 µm 
in length. Dorsal root ganglia (DRG) neurons and SCs were cultured for up to 32 DIV. 
The compared three different cultures, neuron mono-cultures, neuron/SC co-cultures and 
neuron/SC myelin cultures by measuring conduction delays between 12 and 32 DIV. It 
et al. (2006), neuronal populations were grown separately in three
chemically isolated environments. Microgrooves between the compart-
ments allowed only axons to traverse between the compartment
barriers, while fluidic pressure prevented the exchange of solutions
between compartments (Fig. 1) (Park et al., 2006). To distinguish the
source of afferents from the two lateral input compartments, neurons
in each compartment were differentially labeled by transfection with
YFP- or mcherry-tagged synaptophysin (Fig. 1b) prior to plating
(AMAXA nucleofection). At a later age, the GABAAR agonist, muscimol,
was used to reduce the activity of neurons in only one lateral compart-
ment (Fig. 1a) while the other two compartments remained untreated.
Muscimol induced inhibition causes a shift in synapse distribution
To ensure that chronic inhibition with muscimol did not lead to
desensitization of the GABA receptors, acute (Fig. 2a) and chronic
(Fig. 2b) inhibition of neuronal activity with this treatment was
confirmed by electrophysiological whole-cell patch clamp recording of
cortical cells in standard culture conditions. In all cases, spontaneous
network burst firing was rapidly eliminated by muscimol treatment,
whereas quantal glutamate transmission and synaptic connectivity
were retained. These changes remained constant even when assessed
48 h later. The data demonstrate that muscimol treatment silences all
synchronous activity while synaptic connectivity remains intact.
At DIV 12–14,muscimol (10 μM)was applied to one lateral compart-
ment for 48 h. Following muscimol treatment neurons were fixed (1%
PFA followed by methanol) and the center compartment (target) neu-
ronswere immunostained for thepostsynapticmarker, PSD-95 (Affinity
BioReagents). Axons from the muscimol treated compartment formed
fewer synapses (as defined by colocalized synaptophysin and PSD-95
clusters) than axons from the untreated compartment (Fig. 3, 15.41 ±
2.40 and 28.69 ± 4.19 synapses/field respectively; t-test, p b 0.0078,
n = 32). Control cultures, in which neither lateral compartment was
treated with muscimol, had synapse numbers similar to those from
the muscimol treated compartment (Fig. 3a, ANOVA: p b 0.0001,
Bonferroni post-test, where ncontrol = 90). This surprising result indi-
cates that treatment of one input with muscimol results in enhanced
synapse numbers from the opposing compartment's inputs.
To identify potential mechanisms underlying this difference, we
interfered with several signaling pathways only within the center com-
partment (Fig. 4a). NMDARs are central players in activity dependent
developmental competition due to their role as “Hebbian” coincidence
detectors (Cull-Candy, 2004) and their subunit composition changes
as neuronsmature (Liu et al., 2004). Application of the NMDAR antago-
nist, APV (50 μM), specifically to neurons in the center compartment
(Fig. 4c, left), prevented themuscimol induced synaptic shift (muscimol
treated: 12.13± 2.20 synapses/field, untreated: 12.29± 1.57 synapses/
field; t-test: p = 0.95, n = 38). NMDAR activity leads to the activation
of CamKII (Bayer et al., 2001)which in turn results in AMPAR phosphor-
ylation and enhanced insertion into the postsynaptic membrane
(Malinow and Malenka, 2002); a candidate mechanism for increases
in synapticweighting such as LTP. Treatment of the center compartment
neurons with a CamKII inhibitor, KN-93 (1 μM) (Fig. 4c, middle), also
prevented the competitive effects induced by muscimol application
(muscimol treated: 11.14 ± 1.79 synapses/field, untreated: 12.32 ±
1.33 synapses/field; t-test: p = 0.60, n = 37). Previous studies have
reported a link between long term depression and synapse elimination
(Bastrikova et al., 2008) andprevention of GluA2 receptor internalization
Fig. 1. Experimental set-up: a) illustration of the 3 compartment microfluidic device competition experiment. Each pair of wells is connected by a narrow channel to form a single
compartment. Embryonic neurons are placed into the wells and allowed to flow through into the channels. b) Magnified view of the 3 compartment chamber viewed directly from
above (center of the device, perpendicularly across the three channels). The compartment channels are separated by a series ofmicrogrooveswhosewidth and length allowonly for axonal
projections to pass through into the adjacent compartments. The image (40×magnification) shows that only axons pass through the intercompartment microgrooves and into the next
compartmentwhile the cell bodies remain in their original chamber. The center compartmenthouses the ‘target’neurons (unlabeled). The lateral compartment's neurons are differentially
labeled with two different fluorescent proteins for purposes of identification of the compartment of origin.
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was found that the conduction delay was reduced in neuron/SC co-cultures between 12 
and 27 DIV. The results were not as conclusive for the neuron/SC myelin culture as there 













Figure 1.9: Illustrations of microtunnels aligned over electrodes of custom MEA. DRG neurons 
are seeded in the soma compartment, which only allows axonal growth through the microchannels that 
are seeded with Schwann cells. Each microtunnel is aligned over 8 electrodes, 1 stimulating (white) 
and 7 recording (black) electrodes. Scale bar = 100 μm. (From Sakai et al., 2017). 
 
Using microfluidic devices with integrated electrodes is a very important advancement in 
studying neurodegenerative diseases such as MS. These devices allow the measurements 
of neuronal conduction velocities, which as mentioned previously, are an indicator of how 
thick and compact the myelin sheath is (Jakovcevski et al., 2009). Myelin can be 
identified by investigating the expression of myelin markers, such as MBP. However, this 
alone is not a reliable indicator as it does not show if the axon is properly ensheathed with 
myelin because MBP is not only expressed by compact myelin but also by early myelin. 
Measuring conduction velocity will accurately chart the progress of myelination in vitro 
as myelin matures the conduction velocity will be faster. Therefore, measuring 
conduction is potentially a more reliable, accurate and repeatable way to investigate 









Fig. 1 Schematic illustrations and a micrograph of the microtunnel culture device. The 
culture device has a soma compartment connected by 8 microtunnels. Each microtunnel has a 
stimulating electrode (white) and 7 recording electrodes (black) to record neuronal responses to 
electrical stimulation at multiple sites along the axon. After seeding neurons and Schwann cells 
in the soma compartment, neuronal cell bodies were kept in the soma compartment, while the 
axons grew and Schwann cells migrated in the microtunnels. Scale bar: 100 µm. 
  
























1.6 Research Aims 
 
The research performed in this thesis has focused on developing a biochip that could be 
used to study human and mouse neuronal cultures in vitro. The biochip developed would 
have the ability to be used in developing novel in vitro models for diseases like multiple 
sclerosis. In order to achieve this the following had to be accomplished: 
 
1. Design and fabricate functional custom microelectrode arrays. 
2. Design and fabricate microfluidic microchannels. 
3. Culture and differentiate human neural stem cells on custom microelectrode arrays 
and microchannels. 
4. Measure conduction velocity from myelinating cultures.  
 
Using MEAs with microchannels requires smaller volumes for culture when compared to 
standard petri dishes/wells, and therefore fewer cells due to the smaller surface area. This 
means that animal usage is reduced for investigations. Replacing animal cells with human 
neuronal cells completely eliminates the use of animals which was the ultimate goal of 
my thesis. Another advantage of MEAs is that they allow for real-time electrical recording 
and manipulation of neuronal cell cultures at any given moment and over long periods of 
time. Similarly, microchannels play an important role in the biochip as the cultures can 
be spatially segregated and therefore better mimic the cells environment in the human 
CNS and PNS. The ability to measure the conduction velocity throughout the culture 
period using MEAs should allow for a more accurate and novel method for assessing 
myelination in vitro. For example, an increase in conduction velocity could be an 
indicator that myelination is occurring and the myelin sheath is becoming more compact, 











Development and Fabrication of Recording 








Microelectrode arrays (MEAs) have revolutionised our ability to examine brain activity 
in vivo and in vitro in real time across hundreds of electrodes, giving unprecedented 
insight into neuronal network function. The addition of microfluidics to deliver drugs and 
shape neuronal growth holds the promise of coupling such measurements with 
biochemical and pharmacological experiments. As a step towards this goal, I constructed 
a customised system to measure neuronal activity in real time that could incorporate both 
commercially available and custom MEAs and microfluidic modules. I developed 
methodologies to rapidly fabricate MEAs from design to useful end product. The final 
version of custom MEAs had a layout with both stimulating and recording electrodes to 
enable the study of neurodegeneration and myelination through activity analysis and 
evoked conduction velocity measurement. To complement the custom MEAs, 
microfluidic microchannels were modelled, designed and fabricated using several 
methodologies and aligned over the stimulating and recording electrodes. The purpose of 
the microchannels was to provide separate compartments between which relatively long 
stretches of  only axons would grow and where different types of cells could potentially 
be cultured in either compartment. Therefore, the final product was a custom MEA with 
microchannels that can be used for a series of high throughout experiments to develop in 

















Microelectrodes arrays (MEAs) have been used over recent years for both in vivo (Jensen, 
Yoshida and Hofmann, 2006)  and in vitro (Xiang et al., 2007) applications. Their ability 
to obtain simultaneous extracellular recordings from numerous electrodes means that 
such arrays can be used to study any excitable biological tissue but also importantly the 
network activity of multiple excitable units. Some of the in vitro applications include 
studying neural activity of cells found in the central and peripheral nervous systems 
(Obien et al., 2015; Sperry et al., 2018). Other applications are drug discovery for 
neurodegenerative diseases (Scelfo et al., 2012) as well as cardiovascular diseases (Melle 
et al., 2020). Commercially available MEAs have different features to accommodate what 
needs to be studied. For example, Multichannel Systems provide arrays called 
“ThinMEAs” with a thickness of 180 μm which are ideal for high resolution imaging. 
Most common commercially available MEAs feature planar electrodes and these are used 
when culturing a layer of cells on top of them. Three-dimensional electrode MEAs are 
also available that are used to study tissue slices, as it is important to penetrate the 
damaged outer layer (Johnstone et al., 2010). Standard planar MEAs used in in vitro cell 
cultures have a matrix of about 60 electrodes concentrated in the central part of the array 













Figure 2.1: Example of standard microelectrode array (MEA). Consists of 60 electrodes of which 
1 is the reference ground electrode. Different versions of these are available with the differences being 
the electrode diameters (10 μm or 30 μm) and the interelectrode distance (100 μm or 200 μm). (From 




3.2  MEA Design and Production 
A standard MEA biosensor has a square recording area of 700 µm to 5 mm length. In this area, 
60 electrodes are aligned in an 8 x 8 grid with interelectrode distances of 100, 200, or 500 µm. Planar  
TiN (titanium nitride) electrodes are available in sizes of 10, 20, and 30 µm, and three-dimensional TiN  
electrodes have a diameter of > 12 µm at the base with a very fine tip. Standard MEAs are useful for  
a wide variety of applications. Different geometries match the anatomical properties of the preparation. 
Most MEAs are available with a substrate-integrated reference electrode replacing the silver pellet in the 
bath. All electrodes can either be used for recording or for stimulation.  
In principle MEA electrodes are not arranged symmetrical, so the MEA chip has to be placed inside the 
amplifier in the recommended manner. 
Several other MEA types and layouts that are dedicated to special applications are also available, please  
see chapter “MEA Types and Layouts” for more details. 
The bio ogical sample can be position d directly on the recording area; the MEA serves as a culture and 
perfusion chamber. A temperature controller controls the temperature in the culture chamber. Various 
culture chambers are available, for example, with leak proof lid or with semipermeable seal. An incubator 
is not necessarily required, long-term recordings in the MEA culture chamber are possible over several 
weeks or even months. 
For cell or slice cultures, MEAs have to be coated with standard procedures before use to improve the cell 
attachment nd growth, please read chapt r “ MEA Coating”. 
Spike activity can be d tected at dista ces of up to 100 µm from a neuron in an acute brain slice.  
Typically, signal sources are within a radius of 30 µm around the electrode center. The smaller the distance, 
the higher are the extracellular signals. The higher the spatial resolution, the lower the numbers of units 
that are picked up by a single electrode, that is, the less effort has to be put into the spike sorting. 
Multi Channel Systems provides MEAs with the highest spatial resolution in the market. HighDenseMEAs 
have electrodes with a diameter of only 10 µm arranged in a distance of only 30 µm (center to center).  
The challenge of manufacturing very small electrodes and at the same time keeping the impedance and  
the noise level down has been met by introducing the electrode material Titanium nitride (TiN). 
The NMI in Reutlingen, Germany (www.nmi.de), produces MEAs from very pure fine quality and highly 
biocompatible materials. The NMI is a research institute, with which Multi Channel Systems has 
collaborated in many projects and over many years. 
Quality controls and production processes have been improved over the last years so that MEAs are always 
of a fine consistent quality at very reasonable prices. 
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The ability to manipulate the microenvironment around neurons with microfluidics has 
been a particularly successful method to couple electrical measurement and 
pharmacology manipulation in in vitro and in vivo recordings (Kim et al., 2012; Lee et 
al., 2015). Microfluidics is a powerful technique to deliver drugs to tissue and has also 
become very popular over the last few years as it allows to carry out investigations much 
faster using smaller volumes as well as also produce environments similar to those found 
in the human body (Achyuta et al., 2013). In in vitro scenarios, microfluidics have been 
successfully used to study axon-glia interactions by culturing neurons and glia in separate 
compartments and then observing their interaction with time (Park et al., 2009).   
 
Here, both MEAs and microchannels have been designed and fabricated so that it was 
possible to align the microchannels over stimulating and recording electrodes in an 
integrated biochip to enable the integration of both technologies in a single module. The 
aim was to use the biochip to study neurodegeneration in neuronal models (see Chapters 
3 and 4). The microchannels purpose was to restrict neuronal cell bodies in a stimulating 
compartment and allow axonal growth through to a recording compartment. This would 
be an ideal modality to assess myelination in vitro as it would enable calculation of 
evoked conduction velocity which is an indicator of myelin compactness (Mozafari et al., 
2015). As will be reported in the following chapters, although I was unsuccessful in 
enabling through-channel growth in my biochips, the results here show proof-of-principle 

















2.2.1 Development of a Flexible System to Record from Microelectrode 
Arrays 
 
To enable recording from both commercial and custom MEAs, I constructed a flexible 
lab-built system to monitor electrode activity as commercial array readers are specifically 
designed for the equivalent MEAs of the manufacturers. Currently there are several 
different commercially available recording devices, such as the ones offered by Multi 
Channel Systems (Reutlingen, Germany), Alpha MED Scientific (Osaka, Japan) and 
Axion Biosystems (Georgia, USA). These devices are capable of recording from 64 to 
768 electrodes simultaneously, however, the main issue we faced regarding these was 
their cost and the fact that the holding module for electrode arrays was fixed and would 
not allow radical redesign of electrode pads and electrode configurations. 
 
2.2.1.1 Signal Amplification 
 
A Model 3600 amplifier was purchased from A-M Systems (Washington, USA) at a 
fraction of the cost of commercial array amplifiers. It had a 16-channel capability and 
eleven gain settings ranging from x2 to x20 000,  eight low-pass filters ranging from 100 
Hz to 20 kHz, eight high-pass filters ranging from 0.3 Hz to 500 Hz and a notch filter (50 
or 60 Hz) per channel. Signals were pre-amplified by a x10 headstage (Omnetics, 
Minnesota, USA) which was located next to the array and then passed data to the Model 
3600 amplifier.  
 
A device to flexibly hold and interface the MEAs to the pre-amplifier headstage was 
fabricated in the electronics workshop. It consisted of a holding plate and a top plate 
which contained  spring pins (PD8JS-2.2, Coda-Systems, Essex, UK) that had a tip 
diameter of 1 mm and a working travel of 0.45 mm which were used to interface with the 
electrode contact pads of the MEAs (Figure 2.12). In total three recording devices (RD1, 
RD2 and RD3) (Figure 2.10) were fabricated with the help of the electronics workshop 
each at different arrangements of spring pins and device to amplifier connections in order 
to enable recording from all 59 electrodes of commercial MEAs and allow recording and 
stimulation when using custom MEAs. The pins were connected to the pre-amplifier 
headstage through a nano strip connector (NPD-18-WD-18.0-C-GS, Omnetics). Each 
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cable was soldered to one pin with the exception of the ground and x10Ref cables that 
were both soldered onto the single ground pin. 
 
2.2.1.2 Signal Digitisation 
 
Analogue signals from the amplifier were digitised through a digital data acquisition 
system (PCle-6343, National Instruments, Texas, USA). The digital signal was viewed in 
real-time in Clampex (Molecular Devices, California, USA). All 16 channels could be 
viewed simultaneously in Clampex.  
 
2.2.2 Design and Fabrication of Custom MEAs 
 
2.2.2.1 Designing of Custom MEAs 
 
The designing of the custom MEAs were carried out using AutoCAD (Autodesk, Inc, 
California, USA). Throughout the project several different electrode configurations were 
trialled  (Table 2.1) and these will be discussed in further detail below 
 
2.2.2.1.1 Epigem MEA Design 
 
The first design, V1.0, can be seen in Figure 2.2A which had 16 separate recording 
electrodes (red), 16 stimulating electrodes (green) that were connected to a single 
electrode contact pad and 1 ground electrode (dark green). The electrode contact pads 
measured 2.2 x 2.2 mm and were separated by 200 μm. The diameter for both the 
recording and stimulating electrodes was 20 μm and 60 μm for the ground electrode. The 
distance between the stimulating and recording electrodes was 1 mm.  
 
This design was sent to Epigem Limited (Redcar, UK), who were the industrial partner 
responsible for fabricating and providing custom MEAs for my project. After several 
iterations of discussions and design, the arrays (Figure 2.2B) were received. They 
measured 49 x 49 mm and were made using poly(methyl methacrylate) (PMMA). The 
material used for the electrodes, tracks and contact pads was gold. After testing these 
custom MEAs with cells (detailed in Chapter 3) it was found that cells were not adherent 
for the  prolonged period of time required for neuronal culture. Following issues with 
peeling off of the tracks after a single use, it was found that all of the electrode tracks 
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were exposed, and the tracks were not insulated. This meant that these arrays were not 
able to measure local changes in electrical potential to be detected at the electrodes. 
Following further discussions with Epigem, it was decided to fabricate the custom MEAs 
at the nanofabrication facility at Heriot-Watt University because they were unable to 
fabricate the arrays on any other surface other than PMMA or offer an insulating layer.  
 
2.2.2.1.2 Heriot-Watt University MEA Designs 
 
Several new electrode configurations were then designed in AutoCAD to improve the 
electrode placement for accurate conduction velocity recordings as well as to have fully 
functional electrode arrays (Figure 2.3). The designs were based on observations made 
of the axonal lengths of human cerebral cortical neurons (hCCNs) in my differentiated 
cultures (see Chapter 3). 
 
The design, V2.0, features a total of 16 recording electrodes (red) in 8 groups of 2, 
separated by 500 μm (Figure 2.3A). The stimulating electrodes (green) were arranged in 
2 groups of 4 that horizontally align to the respective recording electrodes. The distance 
between the stimulating and first recording electrode was 1 mm and 1.5 mm from the 
second electrode. Both the stimulating and recording electrodes had a diameter of 30 μm. 
There is a single ground electrode (dark green), measuring 500 x 500 μm situated in 
between the two groups of recording electrodes. 
 
The design, V3.0 (Figure 2.3C), had the same configuration of recording and stimulating 
electrodes as that of V2.0. However, this time there were 8 ground electrodes connected 
to one contact pad (dark green) that were aligned parallel to the stimulating and recording 
electrodes. The stimulating and ground electrodes had a dimeter of 80 μm and were 400 
μm apart. The recording electrodes were 50 μm in diameter and the distance between the 
first recording electrode and ground was 600 μm, which meant it was 1 mm from the 
stimulating electrode. Also, the distance between the two recording electrodes was kept 
at 500 μm. 
 
The designs, V3.2 and V3.4  (Figures 2.3E and 2.3F) also featured the same 
configuration of recording, stimulating and ground electrodes as V3.0. However, some 
dimensions were altered. The stimulating, recording and ground electrodes had a diameter 
of 50 μm. The difference between V3.2 and V3.4 was that the ground electrodes were 
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400 μm and 200 μm apart respectively.  The remaining dimensions were kept the same 
as V3.0.  
 
Finally, design V4.0 had a different configuration of recording electrodes than all the 
previous ones (Figure 2.3G). It featured 4 sets of 4 recordings electrodes with each being 
500 μm apart and each set of 4 was separated by 3 mm from each other. All the electrodes 
had a diameter of 50 μm. The first recording electrode was 800 μm away from the ground 
which in turn the ground electrode was 200 μm apart from the stimulating electrode.   
 
The design in Figure 2.3H is a representative design for the insulating layer that would 
be applied on top of the whole electrode array. It only featured the electrode contact pads 
and the stimulating, ground and recording electrodes with all the tracks absent. All these 
AutoCAD designs were sent to Micro Lithography Services Limited (Chelmsford, UK) 
to be made into a film photomask. 
 















V1.0 16 - 20 μm diameter 16 - 20 μm diameter
1 - 60 μm 
diameter 1 mm N/A
V2.0 8 - 30 μm diameter
16 - 30 μm diameter. 
8 groups of 2 
separated by 500 μm 
1 measuring 
500 x 500 
μm
1 and 1.5 mm N/A
V3.0
8 - 80 μm 
diameter
16 - 50 μm diameter. 
8 groups of 2 
separated by 500 μm 
8 - 80 μm 
diameter 1 and 1.5 mm 400 μm 
V3.2
8 - 50 μm 
diameter
16 - 50 μm diameter. 
8 groups of 2 
separated by 500 μm 
8 - 50 μm 
diameter 1 and 1.5 mm 400 μm 
V3.4
8 - 50 μm 
diameter
16 - 50 μm diameter. 
8 groups of 2 
separated by 500 μm 
8 - 50 μm 
diameter 1 and 1.5 mm 200 μm 
V4.0
4 - 50 μm 
diameter
16 - 50 μm diameter. 
4 groups of 4 
separated by 500 μm 
4 - 50 μm 

































Figure 2.2: First custom microelectrode array design. (A) AutoCAD design showing recording 
electrodes (red), stimulating electrodes (green) and ground electrode (dark green). (B) MEA fabricated 
by Epigem with gold electrodes on PMMA. (C) Microscope image of electrode configuration showing 
stimulating (green arrow) and recording (red arrow) electrodes with the single ground (dark green 










































Figure 2.3: Updated custom MEA designs. All images show the recording electrodes in red, 
stimulating electrodes in green and ground electrodes in dark green. (A) Version 2.0 array 
configuration and (B) closer look at the design. (C) Version 3.0 array configuration and (D) closer 
look at the design. Closer look at (E) version 3.2, (F) version 3.4 and (G) version 4.0 of the array. (H) 







2.2.2.2 Fabrication of Custom MEAs 
 
The custom MEAs were fabricated at the Heriot - Watt University nanofabrication 
facility. Instead of PMMA as the substrate, borosilicate was used. The borosilicate was 
cut to measure 49 x 49 mm using a DAD3220 Wafer Dicing Saw (DISCO Corporation, 
Tokyo, Japan) (Figure 2.5C). The electrode designs and the insulating patterns were 
transferred onto the borosilicate using photolithography.  
 
The steps followed for the photolithography process for both the Ti and SiO2 deposition 
are detailed below (Figure 2.4). 
 
2.2.2.2.1 Cleaning of Substrate 
 
The borosilicate substrate was washed using acetone and diluted Decon 90 (Decon 
Laboratories Ltd, East Sussex, UK). It was then rinsed with de-ionised (DI) water and 
blow dried using a filtered air gun. This was done in order to make sure the borosilicate 
surface was dust free and completely clean before starting the process.  
 
2.2.2.2.2 1st Spin Coating  
 
The borosilicate was then placed onto the spin coater SPIN 150 (SPS Europe, Putten, 
Netherlands) (Figure 2.5A) and was held in place by a vacuum seal. Negative photoresist, 
AZ nLOF 2070 (MicroChemicals, Ulm, Germany) was carefully placed over the whole 
surface of the borosilicate making sure to avoid any air bubbles. Once that was done, it 
was the spun at 3500 rpm for 40 seconds. The negative photoresist used is for forming a 
7 μm layer, however, in this case it was diluted to form a 1 μm layer once spun. After this 
process, the substrate was hard baked at 95°C for 3 minutes.  
 
2.2.2.2.3 Alignment and UV Exposure  
 
The next step involved aligning one of the multielectrode designs film photomask with 
the prepared substrate. This was done using an MJB3 Mask Aligner (SÜSS MicroTec, 
Garching, Germany) (Figure 2.5B). The film photomask was placed onto the mask holder 
and was then loaded and secured onto the aligner. The substrate was positioned on the 
substrate holder that held it in placing using vacuum suction and was then slid under the 
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photomask. The substrate was brought into contact with the film photomask and then 
pulled the separation lever in order to be able to align the design with the substrate. The 
alignment was done by adjusting the x and y axis micrometres. Once the alignment was 
achieved, the separation lever was pushed back so that the substrate was back into contact 
with the film photomask. The substrate was then UV exposed for 40 seconds and once 
that was done the substrate was carefully removed from the mask aligner. A post exposure 




The substrate was then developed using the AZ 726 MIF (metal ion free) developer 
(Microchemicals). It was initially placed in the developer for 60 seconds and was closely 
monitored for another 15 to 30 seconds until the design features became visible. The 
substrate was washed in diluted Decon 90 for about 30 seconds, then rinsed with DI water 
and blow dried with a filtered air gun.  
 
2.2.2.2.5 Electrode Deposition  
 
Once this process was done, it was time to deposit titanium (Ti) onto the substrate. The 
Ti was deposited by a technique called physical vapour deposition (PVD) using a Minilab 
080 (Moorfield Nanotechnology, Knutsford, UK) (Figure 2.6A-B). This involved an 
electron beam directed onto the metal that then evaporates and deposits onto the substrate. 
The borosilicate substrate was placed into an external chamber with the side to be coated 
facing downwards. The external chamber had to be degassed, in order to reach the same 
vacuum levels as the main chamber containing the Ti filled crucible, before sliding the 
substrate into the main chamber. During this, the parameters required were inputted into 
the SQM-160 rate/thickness film deposition monitor (Inficon, Bad Ragaz, Switzerland). 
These included the thickness of the metal layer to be deposited, the density and the Z-
Ratio of the metal to be deposited. The thickness was set to 10 kÅ (1000 nm), the density 
of Ti at 4.500 and the Z-Ratio of Ti at 0.628. Once the substrate was secured and the main 
chamber door locked, the electron beam was directed onto the Ti using the controller 
knobs. The power was slowly increased up to 100 mA before opening the shutter to allow 
for the Ti to evaporate onto the borosilicate substrate. The rate was monitored and was 
kept between 2 to 3 Å/s. The shutter automatically closed, and the electron beam turned 
off when the Ti layer reached 1000 nm. The substrate was then carefully removed from 
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the main chamber into the external chamber, which was then pressurized to room 
temperature before opening to collect the substrate.  
 
The electrode deposition formed a layer of Ti across the whole surface of the borosilicate. 
Therefore, the next step involved removing the excess Ti to leave behind only the array 
design. This was carried out by dissolving the negative photoresist previously applied 
using TechniStrip NI555 at 80°C (MicroChemicals) until all the unwanted layer of Ti was 
removed. Dissolving the negative resist meant that the Ti layer that was deposited on top 
of it was also removed leaving behind just the Ti array design.  
 
2.2.2.2.6 2nd Spin Coating  
 
The next step was to prepare the surface for the deposition of the silicon dioxide (SiO2) 
insulating layer. The photolithography process was similar to what was described in 
section 2.2.2.2.3. However, this time the insulating design photomask was used instead 
and an AZ 1505 positive photoresist (MicroChemicals) was used. The settings for the 
spin coater (Figure 2.5A) were 2000 rpm for 30 seconds. Also, the substrate was 
developed in an AZ 351B Developer MIC (metal ion containing) (MicroChemicals) 
which was used in a 1:4 dilution (1 part developer and 4 parts DI water). The substrate 
was then washed as previously and taken for SiO2 deposition.  
 
2.2.2.2.7 Insulator Deposition  
 
The SiO2 was deposited using the same process as the Ti, however the density and Z-
Ratio parameters were changed to 2.648 and 1.000 respectively. The thickness of SiO2 
was 500 nm. Following the deposition, the next step was to remove the SiO2 from the 
electrodes and contact pads as those were the areas that needed to be exposed. In this 
case, the positive photoresist was removed using acetone which only left behind SiO2 on 
the tracks connecting the electrodes to the contact pads. 
 
2.2.2.2.8 Laser Lithography 
 
After testing these custom MEAs it was found that the tracks were not always fully 
insulated, or the electrodes not exposed (Figure 2.13). These issues were resolved by 
using a DWL 66+ (Heidelberg Instruments Mikrotechnik, Heidelberg, Germany) (Figure 
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2.5D) laser lithography system. This machine is able to laser etch structures down to 300 
nm and able to do direct photoresist patterning. Therefore, it meant that the step of 
aligning the film photomask and exposing with UV was no longer necessary. The array 
designs were adjusted in KLayout (Matthias Köfferlein, Germany) in order to be read by 
the laser writer software. The borosilicate substrate, that was previously spin coated with 
a layer of negative photoresist, was placed onto the stage and then the rest was done 
through the software package provided by Heidelberg Instruments. The write-head 
automatically aligned itself with the substrate before it began etching the array design 
onto the photoresist. Once this was done, the same steps previously described for the Ti 
deposition were carried out, however this time the Ti thickness was set to 150 nm. The 
insulating design was also laser etched instead of using a film photomask. This meant that 
the electrodes and contact pads were precisely cut out and therefore exposed following 






































Figure 2.4: Step by step photolithography process for metal and insulator deposition. (A) A layer 
of negative photoresist was spin coated onto borosilicate. UV exposed negative photoresist became 
cross linked and the unexposed parts were dissolved with AZ 726 MIF developer. Titanium was then 
deposited over the whole surface of the borosilicate using physical vapour deposition. Finally, the 
negative photoresist was dissolved using TechniStrip NI555 which resulted in the removal of 
unwanted titanium, leaving behind titanium in the desired pattern. (B) The same steps were repeated 
for depositing the silicon dioxide (insulator) layer but instead a positive photoresist was used. UV 
exposed positive photoresist became degraded and was dissolved with AZ 351B MIC developer. 
Following the deposition of silicon dioxide, the positive photoresist was removed using acetone, to 


































Figure 2.5: Equipment used for photolithography. (A) Spin coater for applying layer of either 
positive or negative photoresist onto borosilicate. (B) Photomask aligner for aligning film photomask 
over photoresist coated borosilicate and for UV exposure. (C) Dicing saw used for cutting borosilicate 
to measure 49 x 49 mm. (D) Laser lithography system for etching array design into photoresist without 










































Figure 2.6: Equipment used for electrode deposition and evaluating custom MEAs. (A) Physical 
vapour deposition machine used for the layer deposition of titanium and silicon dioxide onto 
borosilicate. The vacuum sealed main chamber (blue arrow) was where the deposition occurs. (B) The 
borosilicate was initially placed in the external chamber (black arrow) before it was slid into the main 
chamber once a vacuum was reached in the external chamber. (C) Zygo 3D surface profiler used for 







2.2.2.3 Evaluating Surface of Custom and Commercial MEAs 
 
2.2.2.3.1 Imaging Surface Features 
 
The integrity of the custom MEAs was investigated using a NewView 5000 3D surface 
profiler (Zygo Corporation, Pennsylvania, USA) (Figure 2.6C) and analysed using 
MetroPro software (Zygo Corporation, Pennsylvania, USA). This machine uses a 
technique called coherence scanning interferometry (CSI) to scan the surface using white 
light interferometry to measure and image the topography of a surface and can resolve 
sub-micron x-y features. A single light source is split into two by a beam splitter, the light 
waves travel in different directions before they merge, and the light is sent to the detector 
to produce interference.  
 
The custom MEA was placed onto the stage and using the stage x-y control knob the 
features of the array were found using a 10x objective. Once the feature to be investigated 
was found, the focus Z control knob was adjusted upwards or downwards until bands of 
light and dark lines called fringes were formed. The fringes were adjusted, if necessary, 
using the stage tip and tilt knobs. The light intensity was adjusted and ranged between 70 
– 75% in order to avoid saturation before the measure button was clicked to scan the 
surface and collect the data. This resulted in a false coloured image of the surface and a 
surface profile graph plot (Figures 2.13 – 2.15). This technique also allowed for 
evaluation of the thickness of each layer on the substrate. In order to do this, a virtual line 
was drawn along two different features. Then through the “surface profile menu” of the 
software, selected “show controller” followed by the “inspect” button twice to bring two 
virtual lines onto the graph (arrowhead) (Figure 2.13C). The two virtual lines were first 
placed along a horizontal section of the graph before pressing the “level” button. Then 
one of the lines was moved to a lower or higher section of the graph in order to obtain a 
measurement. The software used for this analysis was MetroPro (Zygo Corporation).  
 
2.2.2.3.2 Electrical Integrity of Electrodes 
 
To measure the level of insulation and electrical integrity of electrodes, I measured the 
impedance (Z) of each electrode. This was carried out using an Omega-Tip-Z (World 
Precision Instruments, Florida, USA) electrometer. A polydimethylsiloxane (PDMS) 
module was placed on top of the electrodes to form a well in which sodium chloride (150 
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mM) was added as a conducting liquid. Each electrodes impedance, in Ohms, was 
measured individually by placing the probe on each electrode contact pad. The electrodes 
impedance was regularly checked after use in culture to check the integrity of the 
individual electrodes.  
 
2.2.3 Design and Fabrication of Microfluidic Microchannels  
 
2.2.3.1 3D Printed Module  
 
Initially a 3D printed module was made that would separate cells into two different 
compartments with a barrier in between. The module was designed in AutoCAD before 
it was converted into an .stl file that could be read by a 3D printer. The 3D printer used 
was the Ember by Autodesk (California, USA) (Dr. Ferry Melchels Lab) which is a 
stereolithography (SLA) type printer. This type of 3D printer was chosen as the features 
necessary for the channels were in the micron scale which a fused deposition modelling 
(FDM) printer cannot achieve. The X and Y - axes resolution of the Ember was 50 μm 
and had a 10 to 100 μm Z – axis resolution. The module measured 1 x 1 cm and was 
comprised of two compartments separated by a 1 mm barrier. The bottom of the barrier 
that would be in contact with the custom MEA had a series of microchannels measuring 
100 μm in width and 100 μm in depth. The channels were separated by 200 μm from each 
other. The resin used for 3D printing the module was the standard PR48 Autodesk resin.  
 
2.2.3.2 Microchannel Fabrication using Soft Lithography 
 
An alternative method was to add microfluidic channels on top of the custom MEA to 
restrict the neuronal cell bodies in the stimulating area and guide the axons to the 
recording electrodes. Therefore, this was taken into account when designing the 
microchannels as they had to align with the electrode configurations of the custom MEAs. 
The microchannels were designed using Adobe Illustrator (Autodesk) and were then sent 
to Micro Lithography Services to be produced into a film photomask. The features of the 
design included two separate compartments 100 μm apart connected by a microchannel 
measuring 10 μm wide. The compartment where the cell bodies would be restricted in 
measured 100 μm wide and the second compartment where the axons would grow into 
measured 300 μm wide. The second compartment also had pillars embedded in it, and 
that was added in order to avoid it from collapsing and breaking. 
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The soft lithography protocol (MicroChem, 2015) to prepare PDMS devices was similar 
to the photolithography protocol used when fabricating custom MEAs, however, had 
different parameters (Figure 2.7). A test grade silicon wafer (SILI-0005, PI-KEM 
Limited) with a diameter of 7.62 cm and thickness 380 μm (± 50 μm) was used instead 
of a borosilicate substrate.  
 
2.2.3.2.1 Spin Coating and UV Exposure 
 
The wafer was placed onto the spin coater (WS-650MZ-32NPP, Laurell Technologies 
Corporation) and held in place by a vacuum (Figure 2.8A). The negative photoresist SU-
8 2025 (Microchem) was spun onto the wafer in two stages. First stage at 500 rpm for 10 
seconds with an acceleration of 100 rpm/s and the second stage at 3000 rpm for 39 
seconds with an acceleration of 300 rpm/s. These settings gave a film thickness of 25 μm. 
The wafer was soft baked at 65°C for a 1 minute, then at 95°C for 5 minutes and back 
down to 65°C for another minute. Film photomasks with the designs were then carefully 
placed on top of the wafer making sure to not move them once in contact with it. The 
wafer was then exposed to UV for 41 seconds (Figure 2.7B) before carrying out the post 
exposure bake at the same temperatures and times as the soft bake. The clear parts of the 
photomask (the two compartments and microchannels) became cross-linked and the dark 
parts of the photomask did not. This meant that the uncross-linked areas were removed 




The wafer was submerged in SU-8 developer and sonicated for 60 seconds. It was then 
washed with isopropanol and blow dried with an air gun. The wafer was placed back into 
the developer for a further 60 seconds but not sonicated. The same washing steps were 
done until the wafer was shiny clean. If any streaks were still visible, the wafer was placed 
back into the developer for a further 60 seconds and repeated the process until they were 
no longer present.  
 
Finally, the wafer can be used as a mould to produce the microchannels for as long as it 
can be kept intact. The surface of the wafer is hydrophilic which meant that it would be 
difficult to peel off the PDMS from it without leaving any residues or breaking the wafer. 
A drop of trichloro (1H,1H,2H,2H-perfluorooctyl) silane (448931, Sigma-Aldrich, 
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Missouri, USA) was added onto the wafer and left to evaporate at room temperature in a 
fume hood, making sure to close the top of the petri dish. The purpose of this was to make 
the surface hydrophobic and therefore avoid the issues mentioned earlier. The wafer was 
kept in a petri dish (Figure 2.9B). 
  
2.2.3.2.3 PDMS Preparation  
 
Once this was completed, PDMS was prepared by mixing Sylgard 184 silicone elastomer 
base with the curing agent at a 10:1 ratio. PDMS was then poured over the wafer and 
before curing, air bubbles were removed using a vacuum chamber. The PDMS cured in 
an hour at 60°C. Once cured, PDMS modules (microchannels) were carefully cut out 
using a scalpel trying to avoid damaging any of the features on the wafer. Holes were 
then cut out using a 6 mm biopsy punch on either side to form wells (Figure 2.9B). This 
was also carefully done in order to avoid damaging the microchannels. 
 
When replacing the film photomask with a quartz photomask, the same protocol for soft 
lithography was followed when producing the wafer. The only difference was instead of 
placing the film photomask on top of the wafer prior to UV exposure a quartz photomask 
was used instead. 
 
2.2.3.2.4 PDMS Device Bonding 
 
The PDMS modules fabricated were then bonded onto custom MEAs, polystyrene wells 
of tissue culture plates and borosilicate coverslips before culturing cells in them 
(discussed in detail in Chapters 3 and 4). Before bonding was carried out the surfaces had 
to be made hydrophilic. This was achieved by placing the PDMS modules and the 
surfaces they would bond onto into a Zepto plasma system (Diener Electronic, Ebhausen, 
Germany) (Figure 2.8C). Finally, the PDMS microchannels had to be carefully aligned 
with the stimulating, ground and recording electrodes before bonding onto the MEAs. 
This was done by hand with the aid of an inverted microscope. 
 
2.2.3.3 Microchannel Flow Modeling Simulations 
 
To better predict the behaviour of fluids and cells in the microfluidic module and refine 
the design of channels, flow modeling simulations were carried out. The microchannel 
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designs made in AutoCAD were imported into ANSYS Discovery SpaceClaim (Ansys 
Inc, Pennsylvania, USA) software where they were converted into an .sab geometry file. 
The file was then imported in ANSYS Workbench (Ansys Inc, Pennsylvania, USA) 
where a mesh was created on the surfaces labelled inlet, outlet and walls. The layer 
heights of the designs were set to 25 μm. The programme then generated the mesh from 
all the input data. The mesh was then transferred into ANSYS Fluent where the 
simulations were carried out. The input pressure was set to 67.7 Pa and 22.6 Pa at the 
outlet. Operating pressure was set to 45.1 Pa. The input and output pressures were 
calculated from the height of fluid in the input and output end wells. The height in the 
input end was 6.9 mm and 2.3 mm in the output end. The simulations were done over a 
period of 60 seconds. Once the simulations were complete, the data was exported and 
later analysed using Microsoft Excel. The flow simulations were carried out by Janez 
Javornik (Erasmus Plus Student, Dr. Euan Brown’s Lab). 
 
The volume transferred from the input well and into the output well through the 
microchannels per 24 hours was calculated as follows. The flow rate (Q) for each 
microchannel was calculated by multiplying the area (A) and the average velocity (v) (Q 
= A x v). The time (T) it takes to fill in the microchannel of known volume was calculated 
by dividing the volume (V) by the flow rate (T = V / Q). The volume transferred per 
second was calculated by dividing the V by T. This value was multiplied by 86,400 





























Figure 2.7: Soft lithography process to produce microchannels. (A) A layer of SU-8 (negative 
photoresist) was spin coated onto a silicon wafer. A photomask was placed over the SU-8 layered 
silicon wafer after a soft bake step. Following UV exposure, the exposed regions became cross linked 
and the unexposed parts were dissolved with developer. Polydimethylsiloxane (PDMS) was prepared 
and poured over the wafer mold created. The PDMS with embedded microchannels was then carefully 
removed once it had cured (60°C for 1 hour). The wafer mold could be then used to produce more 


































Figure 2.8: Equipment used in soft lithography process for making microchannels. (A) Spin 
coater for applying layer of SU-8 onto silicon wafer. (B) UV lamp for exposure step. (C) Plasma 



































Figure 2.9: Example of PDMS module with microchannels. (A) Quartz photomask with different 
microchannel designs. The desired pattern was clear to allow UV light to pass through and form that 
pattern onto the SU-8. (B) PDMS covered silicon wafer (silver disc at bottom of petri dish) shown on 
the left. The microchannel design produced (arrow from quartz photomask) can be seen. The PDMS 
cut out is shown on the right. PDMS module comprised of two well compartments with the 
microchannels in between them (arrowhead). Cells were cultured in the left compartment and media 
alone was added in the right compartment. The volume in the left compartment was greater than that 
in the right compartment in order to allow media to flow from one compartment to the other. Scale 








2.3.1 Development of System to Record from MEAs 
 
The recording devices, RD1 and RD2, (Figure 2.10A and 2.10B) both have the same 
arrangement of spring pins, forming a square with a total of 60 pins (16 on each side). As 
the amplifier is only capable of recording from 16 different electrodes it was necessary to 
be able to swap from one side to another easily in order to record from the whole 
commercial MEAs when necessary. As can be seen, the tops of these devices were 
different, and this is because RD2 (Figure 2.10B) is the new and improved version of 
RD1 (Figure 2.10A). When recording from a different side, the ground cables had to also 
be moved and this regular change put a strain on the cables which in turn kept breaking 
off and needing to be re-soldered. Also, the other 16 cables were loosely soldered on top 
of the device and the same issue arose as they kept breaking off. Temporary fixes were 
done; however, it was important that these issues were addressed in the new device.  
 
RD2 (Figure 2.10B) had no cables exposed and the ground cables were soldered onto 
one single ground point. Also, the cables interfaced the pins using a more robust 
connector that meant the regular changing of the recording side did not cause any issues 
with the cables breaking off and having to worry if any inactivity or activity recorded was 
due the connectivity of the cables to the pins. Finally, the recording device RD3 (Figure 
2.10C) was the one produced to hold custom MEAs. It has a total of nineteen pins, sixteen 
for recording, two for stimulating and one ground. 
 
2.3.1.1 Evaluating Recording Devices 
 
After initial tests of RD1, it was found that the stage of the microscope (Brunel 
Microscopes Ltd, Chippenham, UK) was too thick to allow a clear focus on the cells with 
the objectives supplied with the microscope (Figure 2.11A). Therefore, the original stage 
was replaced with a 2  millimetre (mm) thick aluminium sheet with a cut-out that would 
allow the objectives to move through it freely. An additional sheet of aluminium with a 
circular cut-out (30 mm diameter) was then placed on top as a surface for the Peltier 
device (Figure 2.11B). Thermal paste was applied on both the aluminium sheet and the 
bottom of the recording device before aligning the circular Peltier device onto them. It 
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was important to keep our cultures in the MEAs at 37°C and using a Peltier was a simple, 



































Figure 2.10: Evolution of the custom recording device. (A) First (RD1) and (B) upgraded (RD2) 
recording devices fabricated for holding and recording from commercial MEAs. Preamplifier 
headstage (blue arrowhead) connected to the pins through the nano strip connecting cables (blue 
arrow).  (C) Close up view of pin configuration (total of 60 pins) and (D) base of device where the 
MEA is placed. (E) Recording device (RD3) for custom MEAs featuring 16 recording pins (arrow for 
16 cable connections), 2 stimulating pins (red cable) and 1 ground pin (black cable in between the two 
































Figure 2.11: Microscope set up alterations for MEA recordings. (A) Original microscope stage 
that did not allow for imaging whilst recording from MEAs. (B) Current microscope stage where 
original stage was replaced with a thin aluminium sheet. Circular Peltier device (arrow) attached to 





2.3.2 Evaluating the Surface Properties of Custom and Commercial MEAs 
 
Several different iterations of custom MEAs were fabricated. One of these can be seen in 
Figure 2.12A with a PDMS two-well module bonded on top of it.   
 
2.3.2.1 Imaging Surface Features 
 
The electrodes of V2.0 MEAs fabricated using a film photomask were found to not be 
exposed as the 3D imaging indicated no differences in thickness when compared to the 
insulated tracks (Figure 2.13A). The height of the track (Ti and SiO2) compared to the 
surface plane (SiO2 layer) was approximately 900 nm. This was expected as for the V2.0 
MEAs, the layer thickness was set to 1000 nm and 500 nm for Ti and SiO2  respectively 
(Figure 2.13C).  
 
The electrodes of V3.0 MEAs were exposed as the 3D image showed that the thickness 
of tracks was greater than that of the electrodes which meant that they were not insulated 
(Figure 2.14A). Relative to the electrode (Ti layer), the track (Ti and SiO2) was 95 nm 
above it. In turn, the electrode was raised by 73 nm from the surface plane (SiO2 layer) 
(Figure 2.14C). Therefore, the total thickness of the layers was 263 nm as the Ti layer 
was 168 nm and the insulating SiO2 layer was 95 nm in depth. 
 
The surface of a commercial MEA (60MEA200/30iR-Ti) was also analysed. It was found 
that the electrodes of the commercial MEAs were raised above the surface plane by about 
300 nm (Figure 2.15).  
 
2.3.2.2 Electrical Integrity of Electrodes 
 
When evaluating electrode quality by measuring the impedance, if the impedance 
measured was zero it meant that the array was not properly insulated. On the other hand, 
if the resistance was infinite it meant that the electrodes were not exposed at all, were 
broken or were completely covered with SiO2. Initially, it was found that not all electrodes 
were properly exposed as no resistance was measured from them. This was the case for 
the first custom MEAs that were fabricated using film photomasks, whereas the upgraded 
laser etched custom MEAs did not have this issue. The mean impedance calculated from 
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5 custom MEAs (80 electrodes in total) was 56.7 kΩ. The impedance of the commercial 




























Figure 2.12: Features of custom and commercial MEAs. (A) On the left, one of the final versions 
of custom MEA fabricated at the Heriot Watt Nanofabrication facility. A series of 16 contact pads can 
be seen along the right side of the MEA which connect to the recording electrodes through the visible 
tracks. The other 3 contact pads visible are connected to the stimulating and ground electrodes. The 
electrodes are concentrated in one area near the centre of the MEA and the image on the right shows 
a few of these electrodes. More details on the module with two wells over the MEA will be explained 
in Section 2.4.3. Scale bar = 500 μm.  (B) A commercial MEA (60MEA200/30iR-Ti) comprised of 
60 contact pads and tracks connecting to 59 recording electrodes and 1 reference ground electrode. 
The electrodes are concentrated in the centre of the MEA and are laid out as seen in the image on the 
right. Scale bar = 200 μm. 
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Figure 2.13: 3D profile of electrodes and tracks of first custom MEA fabricated using a film 
photomask. (A) 3D image of two electrodes – stimulating and ground in parallel, with the tracks on 
either side. In this MEA the electrodes were not exposed as no changes in height between the tracks 
and the electrodes were observed. (B) Scan showing cross-section line over electrode track. (C) Profile 
plot that shows the differences in height along the cross-section line. Virtual dashed lines used for 
calculating differences in height of features indicated by white arrowheads. In this case the track was 
































Figure 2.14: 3D surface profile of electrode and track of upgraded custom MEA (V3.2) 
fabricated using laser lithography instead of a film photomask. (A) 3D image of electrode (green) 
and track (blue). (B) Scan showing cross-section line across part of the insulated track, the exposed 
electrode and insulated surface of the MEA. (C) Profile plot showing the differences in height along 
the cross-section line. The insulated track is 95 nm above the exposed electrode which in turn is 73 


































Figure 2.15: 3D surface profile of commercial MEA electrodes. (A) 3D image of the electrodes 
that are raised above the surface of the commercial MEA. (B) Scan showing cross-section line across 
one electrode. (C) Profile plot that shows the differences in height along the cross-section line. This 






2.3.3 Fabricated Microfluidic Microchannels 
 
2.3.3.1 3D Printing and Cell Survival 
 
The 3D printed module comprised of two compartments separated by microchannels 
(Figure 2.16). Following initial tests with culturing neuronal cells in the presence of the 
3D printed module it was concluded that it would be of no use, as cell death was observed 
after a few days in culture. It was also noted that the minimum channel width of 100 μm 
was far too large to prevent cells from entering the second well from the first. This was 
not the case for the fabricated PDMS modules with embedded microchannels as PDMS 













Figure 2.16: 3D printed compartments with microchannels. (A) Top view and (B) bottom view of 
3D printed module with embedded microchannels (arrow). 
 
 
2.3.3.2 Microchannel Flow Modelling 
 
The flow simulations showed that laminar flow could be achieved in the microchannels 
measuring 5 and 10 μm in width (Figure 2.17) with the pressure used in the input well. 
Laminar flow occurs when fluid flows in parallel layers with no disruption. This was 
observed in the flow simulations as inside the microchannels there was a red ‘fast’ flow 
band. The peak velocities varied between the three designs as expected. The peak velocity 
for the microchannels measuring 10 μm wide by 100 μm in length was 48.4 μm/s with 
the average velocity along the microchannels being 13.8 μm/s (Figure 2.17A). The 




μm/s and an average velocity of 6.89 μm/s (Figure 2.17B). Finally, the peak flow velocity 
of the microchannels measuring 5 μm by 50 μm was 24.4 μm/s with the average velocity 
being 10.1 μm/s (Figure 2.17C). The flow velocity measured in the wells on either side 
of the microchannels was very low (around 1 μm/s) and was not laminar.  
 
To estimate the exchange rate of solution between the two sides through the 
microchannels I calculated the volume transferred per 24 hours. The volume transferred 
was calculated to be 2.4 μl / 24 hours for the microchannels measuring 10 μm wide by 
100 μm in length, 0.6 μl / 24 hours for the microchannels measuring 5 μm wide by 100 
μm in length and 0.9 μl / 24 hours for the microchannels measuring 5 μm wide by 50 μm 
in length. 
 
2.3.3.3 PDMS Microchannels 
 
The first PDMS devices fabricated did not have smooth features and the microchannels 
were not consistently 10 μm wide (Figure 2.18). This was due to the film photomask 
used and therefore, the final devices were fabricated using a chrome coated quartz 
photomask (Figure 2.9A). Unlike with a film photomask, using a quartz photomask 
allows for fabricating devices with sub-micron features. Therefore, the designs sent to 
Micro Lithography Services had altered microchannel widths measuring 5 μm instead of 
10 μm.  
 
The PDMS devices fabricated using a quartz photomask had perfectly smooth features 
and the feature dimensions came out as expected. The microchannels were 5 μm in width 
and either 50 μm or 100 μm in length (Figure 2.19). 
 
2.3.3.4 Microchannel Alignment  
 
PDMS microchannels had to be aligned with the electrodes of the custom MEAs and the 
wells on either side had to be sealed to prevent media loss over the culture period. Plasma 
treating the PDMS surface and the surface of the custom MEA resulted in a strong bond 
between the two. The channels were aligned following the plasma treatment in order to 
establish a proper seal. PDMS microchannels were also bonded onto borosilicate 
coverslips and tissue culture treated wells. The seal formed on borosilicate coverslips and 
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custom MEAs lasted up to 6 weeks without leakage of media whereas on the tissue culture 





































Figure 2.17: Flow modeling of microfluidic microchannels. The images on the left show the flow 
velocity along 3 different microchannel dimensions. Laminar flow was seen to occur in all the designs.  
The graphs on the right side, show the varying velocities that occur within the microchannels. The 
peak flow velocity for the (A) microchannels measuring 10 μm by 100 μm was 48.4 μm/s, (B) 13.0 
μm/s for the microchannels measuring 5 μm by 100 μm and (C) 24.4 μm/s for the microchannels 
measuring 5 μm by 50 μm. All microchannels had a height set to 25 μm. Scale bar = 20 μm. 




































Figure 2.18: Fabricated microchannels in PDMS using film photomask. (A) Magnified view (4x) 
showing the full design of the PDMS device. The circular features seen are pillars to prevent that 
compartment from collapsing and breaking. Scale bar = 200 μm. (B) PDMS design aligned over 
stimulating (green arrow) and recording (red arrow) electrodes of one of the earlier custom MEA 
versions (V2.0). Scale bar = 200 μm. (C) Magnified view of a single microchannel on the left (scale 
bar = 100 μm). A closer look at the approximately 10 μm in width microchannel in between the two 



































Figure 2.19: Fabricated microchannels in PDMS using quartz photomask. (A) PDMS device with 
microchannels bonded on top of one of the final version MEAs (left). The microchannels were aligned 
with the electrode pattern and one such example can be seen in the image to the right. The stimulating 
(green arrow) and ground (dark green arrow) electrodes are in the compartment to the left of the 
microchannel with one recording (red arrow) electrode to the right of it. (B) Closer view of one 
microchannel measuring 5 μm in width and 50 μm in length. (C) Closer view of one microchannel 









This chapter focuses on the development and fabrication of MEAs and microfluidic 
microchannels as well as the integration of these into a unitary biochip. In addition, I 
describe here a simple to fabricate holder recording device that enables recording from 
many different configurations of MEAs. The increase in availability of commercial 
MEAs, as well as their vast applications, has led to an increase in research groups that 
use them as an extra technique to supplement and enhance their results. However, this is 
usually limited by the prohibitive cost of such systems ranging between £50,000 to 
£100,000. Companies like Multichannel Systems (Reutlingen, Germany), Axion 
Biosystems (Georgia, USA) and Alpha MED Scientific (Osaka, Japan) have been 
developing different systems and configurations of MEAs to suit the needs of different 
applications. The present system, though limited to 16 channels, cost less than £20,000 
to construct. 
 
The most common MEAs and the ones I used, are the standard 60MEAs provided by 
Multichannel Systems which allow direct cell culture onto them. There are several other 
MEA types and layouts however, for the purpose of what I was to study none were ideal. 
The main reason was that the interelectrode distances for the majority of the MEAs 
provided by Multichannel Systems varied between 30 μm to 200 μm versions. As the aim 
of the custom MEAs was to measure conduction velocity it was important for the 
electrodes to be spaced apart optimally to allow for several nodes of Ranvier to be 
positioned between the stimulating and recording electrodes. Thus, the interelectrode 
distance had to be greater than 200 μm. Therefore, several designs were developed until 
the most ideal one was found, which would allow stimulation and recording in order to 
calculate conduction velocity. This process, as well as that to fabricate custom MEAs, 
together with the issues that arose and how these were fixed have been addressed in this 
chapter.  
 
In order to achieve the aims of my research it was necessary to develop microfluidic 
channels that would ensure the separation of cells and their structures in two different 
compartments. Microfluidics, just like MEAs, can be used in many different applications 
due its flexibility in being able to produce micron level structures to accommodate 
research demands. In this chapter, I show the process of developing a way of separating 
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cells and their structures by using microchannels that were narrow enough to prevent cells 
from one compartment to entering the second one. 
 
When put together, custom MEAs and microchannels meant that neuronal cells could be 
cultured in one compartment where they could then be stimulated, and their processes 
would grow through the microchannels and into the second compartment where the 
recording electrodes are situated.  
 
2.4.1 Development of System to Record from MEAs 
 
The first step of my PhD was to acquire the required set up that would allow recording 
from multiple electrodes and which I could then use for all my futures experiments. Each 
company who produces MEAs have their own proprietary recording equipment. When 
looking at the available options such as those from Multichannel Systems, Axion 
Biosystems and Alpha MED Scientific, it became apparent that the costs of such 
equipment was much higher than our available budget. Therefore, an alternative method 
had to be sourced that would still allow for multiple simultaneous recordings. The 
commercially available set ups are all-in-one systems, consisting of the MEA holder, 
amplifier and temperature control, integrated together. Therefore, each of these 
components had to be either fabricated or purchased separately.  
 
The main component of the set-up was the amplifier, and the A-M Systems Model 3600 
amplifier had 16-channels which meant that simultaneous recordings from 16 separate 
electrodes could be carried out. The all-in-one set up from Multichannel Systems has the 
capabilities of recording from 60 up to 256 electrodes. In our case, 16 electrodes were 
enough and if needed the set up could be expanded by adding a second 16-channel 
amplifier.  
 
The holder where the MEAs would be held in place and interfaced with the amplifier was 
important to be as versatile as possible. The holder’s dimensions were set to those of the 
commercial standard 60MEA by Multichannel Systems, however, the holder size could 
be adjusted to fit any MEA as long as the pins interfacing the MEA contact pads to the 
amplifier were of the same layout. In this case the 60 spring pins were arranged in a square 
by having 16 pins on each side. Spring contact pins were chosen instead of any other 
interface connectors as they would reduce the chances of damaging the electrode contact 
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pads after continuous use. Damaging the surface of the contact pad would grant the MEAs 
useless as the signal obtained would be worse or even non-existent. This pin arrangement 
allowed for recording from the standard 60MEA (60MEA200/30iR-Ti), however, only 
from one side at a time due to the 16-channel limitation. The initial recording device 
functioned adequately but it was quickly decided that a more robust device was necessary. 
The first recording device required regular maintenance in the form of re-soldering cable 
connections and making sure the ground connection was in place after every use. Since 
upgrading the recording device these issues were no longer present as nano strip cables 
were not soldered on the top of the device to each pin directly. Instead they were 
‘packaged’ inside a female pin connector that interfaced the pins through a male pin 
connector that was attached onto the top of the device, with one on each side.  
 
An alternative recording device had to be fabricated to be able to interface with the contact 
pad layout of the custom MEAs. A set layout for the contact pads for all the custom MEAs 
was chosen and that was 16 contact pads on one side, 2 on another and 1 more on another 
side (Figure 2.12A). Unlike the recording device (RD2) used for the commercial MEAs 
this device was robust and required no connector changes to be able to record from 
different sides.  
 
When purchasing an all-in-one system, the software package included allows for viewing 
the traces of all the electrodes in one window in real time. Possible open source software 
such as NeuroRighter (Rolston, Gross and Potter, 2009) were tested but it was concluded 
that the best real-time recording software was Clampex (Molecular Devices, California, 
USA). The pCLAMP software package included everything necessary for real-time 
recording from 16-channels and for post processing the data.  
 
2.4.2 Design and Fabrication of Custom MEAs 
 
Initial electrode designs were sent to Epigem, the industrial partner, who then fabricated 
and sent back the MEAs for testing. The MEAs sent back were initially tested by 
attempting to culture different cell types on them. After several attempts it was found that 
the cells would not grow for more than a few days and cell adherence was an issue. 
Furthermore, after just one use, the gold tracks and electrodes began peeling off and 
detaching. It was later found out that these MEAs were not properly insulated and the 
surface layer on which the cells were grown on was SU-8 which was not modified in any 
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way to be biocompatible and therefore not suitable for cell culture (Xue et al., 2014). The 
importance of these two features was explained, however, Epigem was unable to provide 
a solution as they were limited in the equipment available for manufacture. 
 
This led to me having to find an alternative route in obtaining these custom MEAs. Instead 
of having to outsource the MEAs, the nanofabrication facility at Heriot Watt offered all 
the necessary equipment to fabricate my custom MEAs in house. The initial designs, 
V1.0, included 16 stimulating electrodes in parallel to 16 recording electrodes separated 
by 1 mm. The distance between the recording and stimulating electrode plays an 
important factor, as if it was too small then that might not be sufficient to obtain any 
useful data from because there may not be sufficient numbers of nodes of Ranvier 
between them. The internode length varies throughout the central and peripheral nervous 
systems. For example, in rat layer V cortex it ranges between 27 μm to 154 μm 
(Arancibia-Cárcamo et al., 2017). 
 
The V1.0 design was later altered to having 8 groups of  2 recording electrodes in parallel 
to 8 stimulating electrodes with 8 ground electrodes between them. The distance between 
the stimulating and first recording electrode was kept at 1 mm. These upgraded designs 
(V3.0, V3.2 and V3.4) were done to improve the accuracy of the conduction velocity 
recordings. Knowing the time it takes between an electrical recording and the stimulus 
artefact allows one to calculate the conduction velocity as the distance between the 
stimulating and recording electrodes is also known. However, being able to calculate the 
conduction velocity from the action potentials recorded between two recording electrodes 
would be more accurate which is why the new designs had recording electrodes in parallel 
to each other. Therefore, all the custom MEAs from then on included that electrode design 
layout.  
 
Another alteration was the use of titanium (Ti) instead of gold (Au) for the electrodes. 
The reasoning behind this was mostly about cost as Ti was a cheap and widely used metal 
on MEAs (Ghane-Motlagh and Sawan, 2013). Knowing that the surface of the MEA was 
important in maintaining a healthy cell culture, several different options were looked at 
before selecting silicon dioxide (SiO2). It was decided to use SiO2 instead of any other 
insulating material as it has a very high dielectric strength and was reported to be 




Initially, the custom MEAs were fabricated using a film photomask to transfer the 
electrode and insulation patterns onto the photomask. The reason for the non-exposure of 
the electrodes from those first custom MEAs was most likely due the use of film 
photomasks which are known to be less reliable when dealing with features below 20 μm 
(Orabona et al., 2013). It could have also been due to issues with misaligning the 
photomasks prior to UV exposure as even the slightest misalignment, due to the micron 
features, meant that the electrodes would end up insulated instead. This issue was 
resolved once the electrode and insulation patterns were laser etched onto the photoresist 
instead of using a film photomask. The quality of the deposition was also evaluated by 
measuring the impedance of each electrode. For some electrodes, the impedance 
measured was negligible meaning that they were not fully insulated. This could have been 
due to parts of the track being exposed as some tracks were slightly damaged and not 
fully formed. The mean electrode impedance of the custom array was 56.7 kΩ (50 μm 
electrodes). This was comparable to the electrode impedance stated by Multichannel 
Systems for their 30 μm electrodes which is <  100 kΩ. Increasing the electrode diameter 
causes a decrease in impedance. Having a lower impedance was important so that there 
was less electrical interference in the traces, thus a better signal to noise ratio (Nam and 
Wheeler, 2011). 
 
The deposition layer of Ti and SiO2 was reduced from the initial 1000 nm and 500 nm 
down to 150 nm and 100 nm respectively. This was because it was thought that having a 
difference of at least 500 nm between the electrode and the surface plane may have been 
an issue with the cells growing over the electrodes. Therefore, reducing the thickness 
difference between the Ti and SiO2 to about 50 nm would mean that would not be an 
issue. However, it was found that changing this did not affect cellular growth over the 
electrodes as no differences were observed. This seems to be confirmed by previous 
studies as the difference between the metal and insulating layers varies between several 
hundred nanometres. For example, one study that also used Ti as the metal but silicon 
nitride (Si3N4) instead of  SiO2 had a difference of 200 nm between the two (Ryynänen et 
al., 2011). 
 
2.4.3 Design and Fabrication of Microfluidic Microchannels 
 
The custom MEAs were designed in such a way to allow for stimulation of the neuronal 
cell bodies and recording from the axons. The commercially available MEAs do not have 
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any way of controlling which cells go where, and as a result they grow across the whole 
surface without any restriction. Therefore, this was addressed by designing and 
fabricating microchannels that would restrict neuronal cell bodies to the recording 
compartment and only allow their processes to grow into the recording compartment.  
 
2.4.3.1 3D Printed Module 
 
Initially, the possibility of using a 3D printed module with embedded microchannels 
seemed attractive and flexible. The 3D printed module consisted of two compartments 
separated by a barrier with embedded microchannels. The lowest dimension possible for 
the microchannels was 100 μm in width and 100 μm in depth. This was due to the 
resolution limitations by the Ember 3D printer, even though it was stated by Autodesk 
that 50 μm resolution could be achieved in the X  and Y - axes. When we tried printing 
smaller microchannels ( < 100 μm), these did not come out well as the microchannels 
were irregular and some did not even form properly. Another issue which quickly arose 
was that when culturing human neural stem cells and mouse AtT20 cells within the 3D 
printed module the cells did not survive for more than 24 hours. This implied that the 
resin used was not biocompatible. 
 
2.4.3.2 PDMS Microchannels 
 
Previous studies have shown successful ways of separating different cell structures and 
cell types in different compartments using microfluidics (Majumdar et al., 2011; Park et 
al., 2014). Majumdar et al., (2011) fabricated a two-chamber module separated by 
microchannels measuring 100 μm wide and 5 μm high in which they cultured rat 
dissociated hippocampal neurons in one compartment and glial cells in the other. Park et 
al., designed a microfludic module where primary CNS neurons from rats were cultured 
in a central compartment that was connected to six surrounding compartments in which 
axons would solely grow through. The microchannels separating the compartments 
measured 20 μm wide, 10,000 μm long and 3 μm  high.  
 
These designs were assessed and taken into consideration when designing my 
microfluidic microchannels. Therefore, the concept was to have one microchannel in 
between two larger compartments. It was also important for this design to perfectly align 
over the electrode layout of the custom MEAs. This meant that each custom MEA 
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electrode layout had to have the same microchannel layout so that it would perfectly align 
with it. One compartment would align over the stimulating electrode, the other over the 
recording electrode and the microchannel would be in between the two. The compartment 
that aligns over the recording electrode was three times bigger than the one over the 
stimulating electrode as more surface area was needed for the several processes that 
would be growing into that compartment. Due to its size, this compartment had pillars 
embedded in it in order to avoid it from collapsing and breaking. 
 
My first microchannels were fabricated using a film photomask for the soft lithography 
process and measured 10 μm in width. This was at the lower end of the resolution of a 
film photomask but for a first trial run for scoping the range it was ideal, as film 
photomasks are cheap, easy to handle and quick to fabricate. The issue with these first 
microchannels was that the edges of all the features were not smooth. This meant that the 
microchannels did not have the intended measurements of 10 μm in width and 25 μm in 
depth. This “roughness” along all the features was most likely caused by the UV light 
diffracting slightly through the film photomask and causing unwanted regions to become 
cured. To reduce this “roughness” the film photomask was held in place by adding a 
weight on top of it, which reduced any movements during the curing process and 
subsequently reduced any diffracted UV light to hit unwanted areas of SU-8. This made 
the features less “rough” however not to the extent of those microchannels fabricated 
using a quartz photomask. Using a quartz photomask instead of a film photomask 
produced accurate and smooth features.  
 
When testing the initial PDMS devices, it was found that the cells were not always 
restricted by the microchannels and some were able to flow through and into the second 
compartment. In order to resolve this, the microchannel dimension had to be reduced. It 
was therefore decided to update the designs by reducing the width of the microchannels 
from 10 μm to 5 μm. These updated designs would be the final ones used throughout the 
whole of my PhD and we decided to have them fabricated on a quartz photomask instead 
of a film photomask. A quartz photomask allows for a much higher feature resolution 
below 1 μm, is more robust, and the quality of the design on the silicon master wafer is 
better than that of a film photomask. The only downside was its cost, which was 5 times 
that of a film photomask, hence the quartz photomask, was only used once I knew these 




The PDMS devices fabricated from the silicon master wafer prepared using a quartz 
photomask had smooth features and the microchannels measured exactly as they were 
intended to be. As mentioned, the main aim for reducing the microchannel width was to 
restrict any cells from flowing from the seeding compartment into the other. This was 
achieved and shown in more detail in Chapter 3.  
 
2.4.3.3 Microchannel Flow Modelling 
 
Once the PDMS modules were fabricated, holes were punched out on each side making 
sure to not damage the microchannels in between. The reason for this was to create two 
well compartments that would allow easy access for seeding cells and media changes 
(Figure 2.19A). Cells were seeded into one compartment and media alone in the other 
compartment. A higher volume of media was placed in the cell seeding compartment in 
order to achieve a slow flow from one compartment to another (Park et al., 2012). This 
gentle flow would guide the cells towards the microchannels where they would be 
restricted and therefore adhere. However, to my knowledge the flow rates and forces in 
such channels are not often looked at. To better refine the design and understand the 
forces potentially acting on cells and their processes we carried out modelling of the flow 
and pressures in the microchannel designs. 
 
The nature of the flow in the microchannels had two important implications for the later 
experiments. The lack of laminar flow in the input well means that the cultured cells 
placed  in the feeder compartment for culture would have time to settle and the relatively 
low flow rate would effectively mimic the static conditions in standard cell culture 
conditions. Meanwhile, the laminar flow in the microchannels ensured that solution 
exchange occurred between the two wells compartments. 
  
The flow modelling carried out showed that when the liquid height in one compartment 
was 6.9 mm and 2.3 mm in the other compartment laminar flow was achieved within the 
microchannels and the liquid did flow from the higher volume compartment and into the 
lower volume compartment. An average flow velocity ranging between 6.89 and 13.8 
μm/s for the microchannels measuring 5 x 100 μm and 10 x 100 μm respectively was 
comparable to a previous study which used 2 μm polystyrene monodisperse microspheres 
to measure flow through channels (16 channels; 85 μm wide, 18 mm long, 45 μm high) 





A more cost-effective way of measuring from MEAs was set-up as well fabricating an 
adaptable recording device which holds MEAs. Custom MEA fabrication was improved 
by using a laser writer for patterning the insulation layout instead of photolithography. 
No more issues with misalignment or complete coverage of the SiO2 insulating layer was 
observed since adopting this technique. Microchannel features were improved drastically 
by replacing the film photomask used during the UV exposure of the soft 
photolithography process with a quartz photomask. The microchannels fabricated 
measured the exact dimensions required and the walls were smooth. Finally, the 











Substrates for Shaping and Monitoring hiPSC 



















The majority of in vitro disease studies are carried out in animal (principally rodent) 
models. However, since the introduction of human embryonic stem cells (hESCs) and 
more recently the ethically derived human induced pluripotent stem cells (hiPSCs), these 
models can now be complimented or even surpassed with the use of human cell lines. In 
many cases, this may produce results that are much more relevant to human disease. 
Unfortunately, several significant barriers exist to their large-scale adoption. In vitro 
neurons form axonal processes, synapses and are active but they are not organised into 
layers and cell body/axon tracts as they are in vivo. To begin to address this issue towards 
developing a model to examine human neurodegenerations, I used differentiated hiPSCs 
and tried to assess their growth on different surfaces and through microchannels. I 
successfully differentiated hiPSCs into cortical and dopaminergic neurons which were 
kept in culture for up to 6 weeks. The cells were cultured on a variety of surfaces, 
including polystyrene, borosilicate, silicon nitride, silicon dioxide and SU-8. Their 
electrical properties were analysed using patch clamp electrophysiology, commercial and 
custom microelectrode arrays (MEAs). Data from these experiments showed that cortical 
neurons formed no synaptic inputs and were still electrically silent after 4 weeks in vitro 
whereas dopaminergic neurons formed synapses and exhibited spontaneous electrical 
activity as early as 2 weeks in vitro. Microchannels varying in width and length (5 or 10 
μm in width and 50 or 100 μm  in length) were tested with cortical neurons to see if axonal 
growth could be induced through them. 5 μm wide microchannels allowed for the 
separation of the cell bodies of cortical neurons from the axons in two different 
compartments on polystyrene and borosilicate. This data is an important step in 
developing stratified models where electrical activity, compartmentalisation of neuronal 
anatomy and degeneration can be studied in vitro. 














Animal models have been used for several decades to study human diseases. One example 
includes experimental autoimmune encephalomyelitis (EAE) which is the most 
commonly studied animal model for multiple sclerosis (MS) and it is believed to be the 
closest pathology model of MS (Franklin, 2015). Since the introduction of the EAE model 
(Rivers and Schwentker, 1935), it has helped us improve our understanding of the 
mechanisms of MS as well as develop drugs for its treatment (Farooqi, Gran and 
Constantinescu, 2010). However, animal models do not always reflect the same outcomes 
when the same drugs are tested on humans. In regard to MS, this is due to there being 
several differences between human and rodents. For example, in humans, myelination 
takes decades due to the complexity of the brain, whereas in mice, myelination only takes 
about 2 weeks (Semple et al., 2013). 
 
Since the discovery of human induced pluripotent stem cells (hiPSCs) (Takahashi and 
Yamanaka, 2006), it has led to the increase in availability of human cell lines that can be 
used to develop novel human models. hiPSCs are generated from adult fibroblasts which 
makes their usage ethical unlike human embryonic stem cells (hESCs) whose use sparked 
controversy within the scientific community due to the ethics behind their sourcing (Di 
Ruscio et al., 2015). 
 
Dissociated neuronal in vitro cultures are functional and allow for neurons to be 
investigated pharmacologically and visually. However, these dissociated and 
‘disorganised’ cultures do not offer the same neuronal architecture as in vivo studies offer 
due to the disordered connectivity of neurons (Taylor et al., 2010). Brain slices are an 
alternative to in vivo studies as they offer the same connectivity (Morin et al., 2006). As 
mixed neural and glial cell co-cultures do not allow the study of localised interactions of 
axons and glial cells due to the presence of the cell bodies it would be advantageous to 
grow such cells in a way that would control their topology in vitro. One such study, 
developed a circular compartmentalised microfluidic device that isolated axons from cell 
bodies allowing the glial cells to only interact with the axons although electrical activity 
was not measured (Park et al., 2009). 
 
Here, human neural stem cells (hNSCs) were differentiated into cerebral cortical neurons 
and dopaminergic neurons. They were cultured on commercial and custom 
microelectrode arrays (MEAs) as well as polystyrene wells and borosilicate coverslips 
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that were previously pre-coated with either SureBond-XF or laminin. This allowed a 
detailed evaluation of their excitability and synaptic maturity in long term cultures. This 
data, alongside that obtained from patch clamp electrophysiology improves our 
understanding of their electrical behavioural organisation and development in vitro. 
Alongside the successful long-term cultures of the differentiated neurons, hCCNs were 
grown in a PDMS microfluidic device in which I was able to show that the cell bodies 
can be separated from the axons. This was an important step in developing a custom MEA 


































3.2.1 Culture and Expansion of iPSC-derived human neural stem cells 
 
Culture media and hNSCs used were obtained from Axol Bioscience (Cambridge, UK). 
The hNSCs originated from female newborn cord blood CD34+ cells. For culture and 
expansion, the protocols provided by Axol Bioscience were followed with slight 
modifications that are detailed below. Initially, hNSCs were expanded on sterile 6-well 
tissue culture plates (Corning Inc) that were previously pre-coated with SureBond-XF 
(Xeno Free) 1x working solution for 4 hours at 37°C. The 1x SureBond-XF was prepared 
fresh each time from the 200x stock by diluting with D-PBS (without calcium and 
magnesium). Alternative tests were carried out where instead of pre-coating the culture 
surface with SureBond-XF, laminin was used at 20 μg/ml and incubated at 37°C for 30 
minutes. The hNSCs were plated in Plating-XF medium at a density of 70,000 per cm2 
and incubated for 24 hours before fully replacing with Neural Expansion-XF medium that 
was freshly supplemented with 20 ng/ml of epidermal growth factor (EGF) and 20 ng/ml 
of fibroblast growth factor (FGF). Full media changes of Neural Expansion-XF medium 
were carried out every 2 days up until the culture was 80% confluent and that took about 
4 to 6 days to occur. Once confluent, the hNSCs were detached using Unlock-XF 
medium. Unlock-XF medium was brought up to room temperature and 5 minutes before 
adding to the hNSCs was warmed in a 37°C bead bath. The hNSCs were washed twice 
with pre-warmed D-PBS (without calcium and magnesium) before adding 1 ml of 
Unlock-XF medium (6-well plate). The plate was incubated for 6 minutes at 37°C. The 
cells were gently transferred into a 15 ml Falcon tube and a 4:1 ratio of pre-warmed 
Expansion-XF medium to Unlock-XF medium was pipetted to stop the reaction. The cells 
were centrifuged at 200 x g for 5 minutes. The cell pellet was resuspended in Plating-XF, 
counted and re-plated into a 6 – well plate for further expansion. The hNSCs were 
passaged another 2 times (total of 3 passages) before they were cryopreserved in Neural 
Expansion-XF medium (without any supplements) and 10% dimethyl sulfoxide (DMSO). 







3.2.2 Differentiation of hNSCs to Human Cerebral Cortical Neurons 
 
The protocol provided by Axol Bioscience was followed for differentiation of hNSCs to 
human cerebral cortical neurons (hCCNs). The required numbers of hNSCs were thawed 
and seeded at a density of 100,000 cells per cm2  using Plating-XF medium. A full medium 
change was carried out using Neural Expansion-XF medium without any growth factors 
after 24 hours at 37°C. The cells were incubated for a further 24 hours and then another 
full medium change was carried it using Neural Differentiation-XF medium. Half 
medium changes with pre-warmed Neural Differentiation-XF medium were done every 
3 days. After about 6 to 8 days, once a pure population of hCCNs was reached, half the 
media was replaced with Neural Maintenance-XF medium. After 24 hours, half the media 
was again replaced with Neural Maintenance-XF medium and from then onwards half 
media changes were carried out every 3 days. All the media used was pre-warmed at 37°C 
and cells were incubated at 37°C and 5% CO2. The differentiation process was carried 
out on different surfaces which included polystyrene wells, borosilicate coverslips, 
silicon nitride Si3N4 (commercial MEA, Multichannel Systems), SU-8 (custom MEA 
V1.0, Epigem) and silicon dioxide SiO2 (custom MEA V3.0, V3.2 and V3.4). 
 
3.2.3 Differentiation of hNSCs to Human Dopaminergic Neurons 
 
hNSCs were plated at a density of 30,000 cells per cm2  using Plating-XF medium. Before 
plating, the polystyrene wells were pre-coated using SureBond-XF following the same 
steps discussed in section 3.2.1. After 24 hours, a full media change was carried out using 
STEMdiffTM dopaminergic neuron differentiation medium (STEMCELL Technologies) 
supplemented with 200 ng/ml of sonic hedgehog (SHH) protein (GF174, Millipore. Full 
media changes were done daily for 14 days. The cells were then detached and re-plated 
at a density of 20,000 cells cm2 onto a SureBond-XF pre-coated surface using Plating-XF 
medium. The cells were re-plated on commercial and custom MEAs that were plasma 
treated prior to coating with SureBond-XF. A full medium changed was carried out after 
24 hours using STEMdiffTM dopaminergic neuron maturation medium 1. Full media 
changes were performed every 2 days for 5 days. From day 19 onwards, full media 
changes were performed using STEMdiffTM  dopaminergic neuron maturation medium 2 
every 2 days. All the media used was pre-warmed at 37°C and cells were incubated at 




3.2.4 Microelectrode Electrophysiology 
 
Recordings were obtained from 0 to 4 weeks hCCNs in the whole cell configuration at 
room temperature (20°C). Microelectrodes were pulled from borosilicate glass using a 
Flaming/Brown P-87 micropipette puller. The microelectrodes were pulled to a resistance 
ranging between 3 to 7 MΩ. Intracellular and extracellular solutions were prepared 
following those used in previous literature and already established in the Brown Lab. 
Intracellular solution (mM): 120 K-Gluconate, 25 KCl, 4 MgATP, 2 NaGTP, 10 EGTA, 
1 CaCl2 and 10 HEPES, 290 Osm/kg, pH 7.2. Extracellular solution (mM): 129 NaCl, 5 
KCl, 2 CaCl2, 1 MgCl2, 30 Glucose, 25 HEPES, 311 Osm/kg, pH 7.4. The osmolarity 
was checked using an automatic cryoscopic osmometer OSMOMAT 030 (Gonotec). If 
the osmolarity was higher than wanted it was reduced by adding distilled water, if it was 
lower, sucrose was added to increase it.  
 
Three protocols were used to acquire relevant data: 
1) Voltage clamp recording from a holding potential of -60 mV to + 60 mV in 200 
ms + 10mV steps. This was used to obtain current-voltage (I/V) relationships and 
current densities for sodium channels. 
2) Current clamp recording from a holding potential of -60 mV, with a 25 pA current 
step and the steps were 250 ms in duration. This was done to determine the ability 
of a cell to fire action potentials upon current injection. 
3) Continuous voltage clamp recording from a holding potential of -60 mV. This was 
used to detect synaptic potentials and the presence of functional synapses. 
 
Data analysis: All data acquired was analysed offline using WinWCP V5.54 (open 
source, Strathclyde Electrophysiology Software) and Clampfit 10 and 11.1 software for 
Windows (Molecular Devices Corporation, California, USA). 
 
The data obtained through patch clamp were exported from WinWCP as an .abf file in 







3.2.5 Recording from Commercial MEAs 
 
hNSCs were plated at a density of 100,000 cells per cm2 on the commercial 
60MEA200/30iR-Ti-gr MEA’s (Multichannel systems). The hNSCs were differentiated 
and maintained in culture following the protocols from sections 3.2.2 and 3.2.3. A 
fluorinated ethylene-propylene (FEP) membrane (ALA MEA-MEM-SHEET) was placed 
over the ring of the MEA and secured in place using an O – ring. This allowed for the 
culture to remain sterile when using the MEA outside of the tissue culture hood. The 
membranes are permeable to CO2 and O2 and can therefore be kept on the MEA’s 
throughout the whole experimental time period. FEP membrane covers were removed 
only when changing media.  
 
The membrane sealed MEA was then placed into the holder of the recording device (RD2) 
and left for 5 minutes in order for the temperature to be at 37°C before beginning the 
recordings. A one-minute gap-free protocol was set up on Clampex 10 software. To avoid 
any loss of electrical recordings, the low and high pass filters of the amplifier were 
adjusted until the optimal range was found. The settings used on the A-M systems Model 
3600 amplifier were 3 Hz high pass filter, 1 kHz low pass filter, x20,000 gain, notch filter 
on and GND setting selected. Two recordings were acquired from each side of the MEA, 
for a total of eight. Representative images of each side were also taken using the Retiga 
R1 camera and Micro-Manager Open Source Microscopy Software. Once done, the 
MEAs were placed back into the incubator for future use. The MEAs were carefully 
transported to avoid as much disturbance as possible. This process was repeated for all 
commercial MEA recordings.  
  
3.2.6 Recording from Custom MEAs 
 
Before culturing cells on the custom MEAs, the PDMS module containing the 
microchannels had to be aligned with the electrodes. The custom MEAs together with the 
PDMS modules were plasma coated to ensure better bonding of the PDMS onto the 
surface of the MEA. The microchannels were then aligned over the electrodes by hand 
using a compound microscope. hNSCs were seeded in one of the compartments whilst 
the second compartment only contained media. To ensure the flow from one compartment 
to the other, the volume in the cell contained compartment was higher than that of the 
second compartment (300 μl : 100 μl). The hNSCs were cultured and differentiated 
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following the same protocols detailed in sections 3.2.2 and 3.2.3. An FEP membrane was 
also placed over the PDMS modules before transporting the custom MEAs for recording. 
The custom MEAs were placed into their dedicated recording device and the same 
recording protocol as detailed in section 3.2.5 was used.  
 
3.2.7 Analysis of MEA Recordings 
 
All data acquired was analysed offline using Clampfit 10 and 11.1 software for Windows 
(Molecular Devices Corporation, California, USA) and Excel 2019 (Microsoft, 
Washington, USA).  
 
Each data file consisted of 16 traces, representing a single recording from 16 separate 
electrodes. Before further analysis, all traces were filtered using a lowpass Boxcar filter 
with smoothing points set to 15. To separate the ‘fast’ from the ‘slow’ waveforms, the 
threshold search tool was used. The baseline was set to 0 and the trigger marker was set 
below the peaks of the spikes. For example, if the trigger marker was set to 50μV, any 
spike above that was selected. The pre- and post-trigger lengths were both set at 1 ms 
(millisecond). In the event rejection section, the minimum allowed duration was set at 0.1 
ms and the maximum allowed duration at 3 ms. With these values set, the threshold search 
was run, and all events detected were then saved. The waveforms sorted within this range 
were classified as ‘fast’ and the ones that did not were classified as ‘slow’. The half-width 
data produced from this search were copied into Excel for further analysis. This was 
repeated for all other traces analysed. 
 
For ‘slow’ waveforms, a template search was carried out. Firstly, the traces were 
decimated by a factor of 10 in order to increase the sampling interval so that a template 
could be created. Then, a representative waveform was selected to create a template. That 
template was then used in the template search to scan through the trace and select all 
waveforms resembling it. All the waveforms collected for that trace were then saved for 
further analysis. A new template had to be created for each trace analysed. The individual 
waveforms detected were then averaged to produce an average waveform representative 






Coverslips were washed with PBS pre-warmed to 37°C before fixation in 4% 
paraformaldehyde for 10 minutes at room temperature (RT; 20°C). Following fixation, 
the coverslips were washed 3 times with ice cold PBS and the cells were then 
permeabilised with 0.1% Triton X-100 for 10 minutes at RT. The coverslips were 
subsequently washed 3 times for 5 minutes each time with PBS containing 0.1% Tween-
20 at RT before a 30 minute incubation at RT in PBS containing 1% BSA and 0.1% 
Tween-20. This step was done to prevent non-specific antibody binding. After this, the 
primary antibody was diluted in PBS containing 1% BSA and 0.1% Tween-20 and added 
to cells which were incubated for 1 hour at RT. The coverslips were then washed 3 times 
for 5 minutes each time with PBS containing 0.1% Tween-20 at RT. The secondary 
antibodies were diluted in PBS containing 1% BSA and added to the cells which were 
incubated for 1 hour at RT in the dark. All secondary antibodies were conjugated to 
AlexaFluor fluorescent dyes. Coverslips were then washed 3 times for 5 minutes each 
time with PBS in the dark at RT. Cells were then incubated for 1 min in the dark following 
the addition of 0.1 μg/ml DAPI. Finally, the coverslips were washed with PBS 3 times at 
RT in the dark before they were mounted on glass microscope slides with the mounting 
medium Mowiol® 4-88. The slides were then stored at 4°C until analysis. All reagents 
were acquired from Sigma-Aldrich and all antibodies were from Abcam. A list of 
antibodies used and their dilutions can be found in Table 3.1. 
 
3.2.9 Drugs and Compounds 
 
All drugs used were diluted from concentrated stock and pipetted directly to the MEA. 
The drugs used were: tetrodotoxin (TTX; 1 μM; Tocris, 1069) and triethylammonium 











Table 3.1: Table illustrating the primary and secondary antibodies used, their description 
and the dilutions used. 
 
 
3.2.10 Graphs and Statistics 
 
All graphs and statistical analysis were carried out in Prism 8 (GraphPad Software, San 
Diego, USA). Data were tested for normality in order to choose appropriate statistical 
tests. For parametric and multiple independent samples, a one-way ANOVA was 
performed. For non-parametric and multiple independent samples, a Kruskal-Wallis test 
with a Dunn’s multiple comparisons test was performed. Statistical significance was 
accepted at probabilities of equal to or less than 0.05. A p-value of less than 0.05 is shown 
as a single asterisk (*). Data are presented as the mean ± standard deviation or the standard 
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3.3.1 Immunocytochemical Characterisation of Human Cerebral Cortical 
Neurons 
 
To determine if the human cerebral cortical neuron (hCCN) differentiation protocol was 
producing human cortical-like neurons, the cultures were stained for Tbr1, an early 
cortical neuron marker. At week 0, pre-differentiation, the cultures did not express Tbr1. 
Tbr1 positive neurons were identified from week 1 with the percentage of Tbr1 positive 
cells being nearly 100% (n = 4). By week 4, the population of hCCNs increased and the 
density was about 90%. The cells at week 4 still expressed Tbr1 and again Tbr1 positive 





















Figure 3.1: Immunocytochemistry of differentiated cerebral cortical-like neurons. Human neural 
stem cells were differentiated into cerebral cortical neurons and cultured for 4 weeks. Cultures were 
immunostained for the cortical neuron marker Tbr1 (red) and a nuclear stain DAPI (blue). The third 
column is a merged image of Tbr1 and DAPI. At week 0, the cultures were human neural stem cells 
and not yet differentiated, hence no Tbr1 expression. Tbr1 expression was observed from as early as 









3.3.2 Culture of Human Neural Stem Cells on Different Surfaces 
 
The hNSCs adhered and were able to proliferate over time when cultured on polystyrene 
pre-treated with SureBond-XF (Axol Bioscience, Cambridge, UK) (Figure 3.2A). 
However, this was not the case on the commercial MEAs. Unlike polystyrene wells, the 
surface of the commercial MEA consisted of silicon nitride. The culture of hNSCs on 
commercial MEAs was problematic as the hNSCs did not adhere onto the surface of the 
MEA in the same way as they did on a tissue culture treated polystyrene well. The MEAs 
were pre-treated with SureBond-XF before plating the hNSCs but after 1 day in vitro 
(DIV) the morphology of the culture was not like that of hNSCs cultured on polystyrene. 
More cellular debris was present in the MEAs after 1 DIV and the cells adhered did not 
have distinct cell bodies and processes. After 3 DIV, the cell density present on the MEAs 
was below 25% which was much lower than what was seen with the cultures on 
polystyrene (Figure 3.2B). On polystyrene, after 3 DIV the cell density observed was 
over 75%. 
 
Pre-treating the culture surface with laminin instead of SureBond-XF had no positive 
effects as the same outcome was found on the commercial MEAs. There was again a 
reduction cell density at 3 DIV and the morphology of the cells at 1 DIV was similar to 
that of the cultures using SureBond-XF (Figure 3.3B). The hNSCs culture on laminin 
treated polystyrene had a similar morphology to those cultured on SureBond-XF treated 
polystyrene at 1 DIV. However, by 3 DIV, the laminin cultures did not proliferate to the 
same extent as the SureBond-XF cultures. The cell density at 3 DIV of the laminin 























Figure 3.2: Culture of human neural stem cells on SureBond-XF coated polystyrene and 
commercial MEAs. (A) hNSCs cultured on tissue culture treated polystyrene wells at 1 (left) and 3 
(right) days in vitro. (B) hNSCs cultured on commercial MEAs (silicon nitride surface) at 1 (left) and 

















Figure 3.3: Culture of human neural stem cells on laminin coated polystyrene and commercial 
MEAs. (A) hNSCs cultured on tissue culture treated polystyrene wells at 1 (left) and 3 (right) days in 
vitro. (B) hNSCs cultured on commercial MEAs (silicon nitride surface) at 1 (left) and 3 (right) days 
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3.3.3 Culture and Differentiation of Human Neural Stem Cells in 
Microchannels 
 
hNSCs were successfully cultured and differentiated through polydimethylsiloxane 
(PDMS) microchannels that were bonded onto pre-treated with SureBond-XF 
polystyrene wells and borosilicate coverslips. The cells were only plated into the left-
hand side compartment (Figure 3.4A). During and after differentiation (by week 1) an 
increase in axonal length was observed. The axons extended from the first compartment, 
through the microchannels and into the second compartment (Figure 3.4B and 3.4C) 
 
The first PDMS microchannels that were tested did not provide complete restriction of 
the cell bodies, which caused a number of cell bodies to pass through and adhere into the 
second compartment (Figure 3.4B). The microchannels were designed to measure 10 μm 
in width, 100 μm in length and 25 μm in height. However, due to the ‘roughness’ of the 
walls, the microchannel width varied and measured between 10 to 20 μm. The issue of 
the cell bodies passing through into the second right-hand side compartment was resolved 
by reducing the width of the microchannels to 5 μm. The 5 μm microchannels were 
fabricated using a quartz photomask instead of a film photomask which solved the issue 
of the ‘roughness’ (Figure 3.4C). No cell bodies were present in the second compartment 
of the 5 μm PDMS microchannels as all of these were restricted by the microchannels to 
the left-hand side compartment. Only axons were observed to grow through the 
microchannels and in the right-hand side compartment (Figure 3.4C). The differentiated 
hCCNs were maintained for up to 2 weeks in polystyrene wells and up to 5 weeks on 































Figure 3.4: Human cerebral cortical neurons cultured in PDMS microchannels. (A) PDMS 
module bonded (left; scale bar = 500 μm) onto polystyrene with two compartments separated by 
microchannels (right; scale bar = 100 μm). Human neural stem cells seeded only into left compartment 
and differentiated into cerebral cortical neurons.  (B) Axonal growth into second compartment but 
also cell bodies were able to pass through microchannel and adhere in the second compartment. The 
first microchannels fabricated had a variable width between 10 to 20 μm (n = 6). The differentiated 
hCCNs were maintained for up to 2 weeks on polystyrene wells. (C) Cerebral cortical neurons cultured 
in upgraded microchannels with a 5 μm width. Cell bodies remained in the left compartment and only 
the axons were able to growth through the microchannels and into the second compartment (n = 6). 
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3.3.4 Development of Ion Channels and Synaptic Inputs 
 
In this section the development of electrical maturity of axons, and the formation of 
synapses were followed in hCCN and human dopaminergic neuron cultures using 
conventional electrophysiology. 
 
3.3.4.1 Ion Channels 
 
Voltage sensitive sodium currents were identified in all hCCNs from week 0 to week 4 
(n = 25) (Figure 3.5A and 3.5B). The addition of 1 μM TTX to the extracellular solution 
resulted in the blocking of these sodium currents after 5 minutes (Figure 3.5C). The 
channels were identified  in all the human dopaminergic neurons from week 0 to week 4 
(Figure 3.6A and 3.6B). The currents were also blocked by the addition of 1 μM TTX 
and 10 μM tetraethylammonium (TEA) to the extracellular solution (Figure 3.6C).  
 
When corrected for whole cell capacitance, the sodium current density increased from 
weeks 0 to 4 and from weeks 0 to 6 in hCCNs and human dopaminergic neurons (tyrosine 
hydroxylase positive, TH+) respectively (n = 4 to 7 for hCCNs per time point; n = 3 to 8 
for TH-positive or negative cells per time point) (Figure 3.7A and 3.7B). In regard to 
hCCNs, the performance of a Kruskal-Wallis test indicated that for voltage-gated sodium 
(NaV) currents the increase of time in culture on current density was significant (p = 
0.016). The increase in current density of NaV currents from week 0 to week 4 was found 
to be statistically significant (Dunn’s multiple comparison test) as p = 0.0278. No 
statistical difference was found when comparing the other weeks with each other as p > 
0.05 (Figure 3.7A). 
 
When differentiating hNSCs to dopaminergic neurons, about 25% of the cultures 
consisted of dopaminergic neurons. Both TH+ and TH- cells had voltage-sensitive 
currents. A one-way ANOVA showed that for NaV currents, the effect of time in culture 
on current density was significant for TH+ cells but was not significant for TH- cells 
(TH+: p < 0.0001; TH-: p = 0.326). A two-sided Dunnett test showed that for TH+ cells, 
the NaV current density was significantly different between week 0 and week 6 (p = 
0.002). No statistical difference was observed when comparing the other weeks as p > 






























Figure 3.5: Voltage-dependent currents in human cerebral cortical neurons. Representative 
whole cell voltage clamp recordings showing voltage dependent sodium currents (arrow) at (A) 0 
weeks (n = 4) and (B) 4 weeks in vitro (n = 4) (C) Representative whole cell voltage recording after 5 




































Figure 3.6: Voltage-dependent currents in human dopaminergic neurons. Representative whole 
cell voltage clamp recordings showing voltage dependent currents at (A) 0 weeks and (B) 6 weeks in 
vitro. (C) Representative whole cell voltage recording after the addition of 1 μM TTX and 10 mM 
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Figure 3.828- Time-dependent changes in passive membrane properties. Graphs showing changes in 
(A) whole cell capacitance and (B) input resistance in TH-positive and TH-negative cells from 0 to 6 
weeks post-differentiation. Error bars ± S.E.M. *indicates statistical significance using a one-way 























Figure 3.929- Voltage-dependent currents in hiPSC-derived dopaminergic neurons. Representative 
whole cell voltage clamp recordings showing voltage-dependent currents at (A) 0 weeks and (B) 6 weeks 
(TH-positive) post-differentiation. (C) Representative whole cell voltage clamp recording after the 


































Figure 3.7: NaV current properties in human cerebral cortical and dopaminergic neurons. (A) 
Mean NaV current densities of hCCNs from weeks 0 to 4. (B) Mean NaV current densities of TH+ and 
TH- cells from weeks 0 to 6. Data are presented as the means ± SEM. Statistical significance, p < 0.05 






















































































Figure 3.1030- NaV and KV current properties in hiPSC-derived dopaminergic neurons. Graphs 
showing (A) mean current densities for NaV currents for TH-positive and TH-negative cells from 0-6 
weeks post-differentiation and (B) NaV I/V relationships for week 0 and week 6 TH-positive/TH-negative 
cells. Graphs showing (C) mean current densities for KV currents for TH-positive and TH-negative cells 
from 0-6 weeks post-differentiation and (D) KV I/V relationships for week 0 and week 6 TH-positive/TH-
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3.3.4.1 Synaptic Inputs 
 
hCCNs were co-stained with the presynaptic marker synaptophysin and the NMDA 
receptor associated protein PSD-95 at 4 weeks in order to determine if they form 
synapses. The same co-stain was carried out for human dopaminergic neurons at 6 weeks 
post differentiation. Neither PSD-95 or synaptophysin were expressed by hCCNs at 4 
weeks (Figure 3.8A), however, staining was seen for both in dopaminergic neurons at 6 
weeks (Figure 3.8B). 
 
To determine the electrical presence of synaptic currents, hCCNs were held at -60 mV 
potential in the whole-cell voltage clamp configuration. Cells were sampled from weeks 
0 to 4. No excitatory spontaneous postsynaptic currents (ESPCs) were observed in all the 
cells tested between week 0 to 4 (Figure 3.9A) (n = 25). As expected, this was not the 
case for dopaminergic neurons. ESPCs were observed from as early as week 2 in both 
dopaminergic neurons and TH- cells. The percentage of cells with synaptic currents 















Figure 3.8: Human cerebral cortical neurons form no synapses in culture. (A) Representative 
images of hCCNs co-stained with the postsynaptic marker PSD-95, presynaptic marker synaptophysin 
(SYP) and DAPI. (B) For comparison, representative images of human dopaminergic neurons co-
stained for PSD-95 and synaptophysin. Right most image is a composite of the PSD-95 and 



























Figure 3.1232- TH-positive neurons form synapses in culture. (A) Representative confocal images of 
the same field of week 6 cells stained for (top to bottom) TH, PSD-95 (postsynaptic marker) and 
Synaptophysin (presynaptic marker). (B) A composite image of the PSD-95 and Synaptophysin staining 





























Figure 3.1232- TH-positive neurons form synapses in culture. (A) Representative confocal images of 
the same field of week 6 cells stained for (top to bottom) TH, PSD-95 (postsynaptic marker) and 
Synaptophysin (presynaptic marker). (B) A c mposite image of the PSD-95 and Synaptophysin staining 





























Figure 3.1232- TH-positive neurons form synapses in culture. (A) Representative confocal images of 
the same field of week 6 cells stain d for (top to bottom) TH, PSD-95 (postsynaptic marker) and 
Synaptophysin (presynaptic marker). (B) A composite image of the PSD-95 and Synaptophysin staining 
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Figure 3.9: Synaptic currents in human cerebral cortical and dopaminergic neurons. (A) 
Representative whole cell voltage clamp recordings from a holding potential of -60 mV of hCCNs at 
week 0 and 4. Traces indicate no development of ESPSCs. (B) Representative whole cell voltage 
clamp recordings from a holding potential of -80 mV of human dopaminergic neurons at weeks 0 and 
6. Trace at week 6 indicates the development of ESPCs in dopaminergic cultures. (C) Graph showing 
percentage of TH+ and TH- cells that display synaptic currents. Synaptic currents are present from 























































Figure 3.1333- Synaptic currents in hiPSC-derived neurons. (A) Representative whole cell voltage 
clamp recordings from a holding potential of -80 mV in week 0 and week 6 cells showing the 
development of ESPSCs. Graphs showing (B) the percentage of TH-positive and TH-negative cells that 
displayed synaptic currents and (C) the mean total area under ESPSCs during 60 second recordings from 
0-6 weeks post-differentiation (n=3-8 per week). Error bars ± S.E.M. *indicates statistical significance 





































Figure 3.1333- Synaptic currents in hi -derived neuro s. (A) Re res t tive whole cell voltage 
clamp recordings from a holding potential of -80 mV in week 0 nd week 6 cells showing th  
development of ESPSCs. Graphs showing (B) the percentage of TH-positive and TH-negative cells that 
displayed synaptic curre ts and (C) the mean total area under ESPSCs during 60 second recordings from 
0-6 weeks post-differentiation (n=3-8 per week). Error bars ± S.E.M. *indicates statistical significance 
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Figure 3.1333- Synaptic currents in hiPSC-derived neurons. (A) Representative whole cell voltage 
clamp recordings from a holding potential of -80 mV in week 0 and week 6 cells showing the 
development of ESPSCs. Graphs showing (B) the percentage of TH-positive and TH-negative cells that 
displayed synaptic currents and (C) the mean total area under ESPSCs during 60 second recordings from 
0-6 weeks post-differentiation (n=3-8 per week). Error bars ± S.E.M. *indicates statistical significance 
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3.3.5 Activity of Human Dopaminergic Cultures culture on MEAs 
 
Unlike hCCNs, I was able to maintain human dopaminergic cultures over 4 weeks in vitro 
on both commercial and custom MEAs (Figure 3.10A - C and Figure 3.11A - C). The 
hNSCs were differentiated on polystyrene wells and were detached and re-plated onto the 
commercial and custom MEAs at 2 weeks. The human dopaminergic cultures were 
maintained for up to 6 weeks on the MEAs. The cultures were tested from week 4 to 6. 
As expected, the dopaminergic cultures were spontaneously excitable from week 4. 
Electrical activity was recorded on both commercial and custom MEAs throughout the 
period they were cultured on them (between 4 and 6 weeks). The representative traces, at 
each week shows how highly active the dopaminergic cultures are (Figure 3.10D and 
3.11D). 
 
The results from the commercial and custom MEAs were pooled together in order to 
analyse the electrical activity observed and the waveform characteristics. At week 4, 
55.5% ± 7.4% (mean ± standard error of mean) of the channels were active (n = 6). One 
electrode on the MEA equates to one channel. The percentage of active channels at weeks 
5 and 6 were 47.9% ± 20.6% and 73.2% ± 14.6% respectively (Figure 3.12A).  A 
Kruskal-Wallis test with a Dunn’s multiple comparisons test was carried out but no 
statistical significant differences were found between the three weeks as p > 0.05. 
 
The electrically active channels were further analysed in a way to classify ‘fast’ and 
‘slow’ waveform activity. Waveforms that were within 0.1 ms and 3 ms in duration were 
classified as ‘fast’ and the remaining as ‘slow’ (Figure 3.12B). The percentage of active 
channels containing ‘fast’ and ‘slow’ waveform activity was fairly similar between 4 to 
6 WIV as it ranged between 27.1% to 30.7% and 69.3% to 72.9% respectively (Figure 
3.12C). 
 
The half-width of the ‘fast’ and ‘slow’ waveforms indicated that the ‘fast’ activity 
recorded between 4 to 6 WIV was similar (Figure 3.13) unlike that of the ‘slow’ activity 
which became narrower with time (Figure 3.14). The half-width is measured as the width 
halfway from the peak amplitude (Figure 3.13A; dashed line). The number of ‘fast’ 
waveforms detected from one representative channel at 4, 5 and 6 WIV (Figure 3.13A; 
left) were then averaged to form one waveform (Figure 3.13; right). The half-width 
measured at 4 WIV was 0.12 ms + 0.004 ms (mean ± standard error of mean; 8 spikes), 
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at 5 WIV was 0.13 ms ± 0.006 ms (9 spikes) and at 6 WIV was 0.12 ms ± 0.007 ms (6 
spikes). No statistical significance was found between the ‘fast’ waveforms at 4 to 6 WIV 
as p > 0.05 (One-Way Anova with a Holm-Sidak’s multiple comparisons test). 
 
The number of ‘slow’ waveforms detected from one representative channel at 4, 5 and 6 
WIV (Figure 3.14A; left) were then averaged to form one waveform (Figure 3.14; 
right). The average half-widths of ‘slow’ waveforms was reduced with time. The half-
width measured at 4 WIV was 100.0 ms + 7.5 ms (mean ± standard deviation; 20 spikes), 
at 5 WIV was 72.6 ms ± 3.6 ms (15 spikes) and at 6 WIV was 39.3 ms ± 2.1 ms (31 
spikes). A Kruskal-Wallis test with a Dunn’s multiple comparisons test was carried out 
and the difference in half-widths between 4 and 5 WIV was not significant (p = 0.0837). 
The decrease in half-width between 4 and 6 WIV was highly significant (p < 0.0001; 
Kruskal-Wallis test with a Dunn’s multiple comparisons test). The decrease in half-width 
between 5 and 6 WIV was also highly significantly different (p < 0.0001; Kruskal-Wallis 



































Figure 3.10: Spontaneously excitable human dopaminergic cultures recorded on commercial 
MEAs. (A) Commercial standard MEA used (left) for measuring electrical activity of human 
dopaminergic cultures. Representative image of culture at 4 weeks (right). Representative images of 
dopaminergic cultures at (B) 5 weeks and (C) 6 weeks. Scale bar = 50 μm. (D) Representative trace 
of one active electrode showing that the cultures are highly excitable between 4 to 6 weeks in vitro. 
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Figure 3.11: Spontaneously excitable human dopaminergic cultures recorded on commercial 
MEAs. (A) Custom MEA used (left) for measuring electrical activity of human dopaminergic cultures. 
Representative image of culture at 4 weeks (right). Representative images of dopaminergic cultures at 
(B) 5 weeks and (C) 6 weeks. Scale bar = 50 μm. (D) Representative trace of one active electrode 
showing that the cultures are highly excitable and bursting activity between 4 to 6 weeks in vitro. 
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Figure 3.12: Electrical activity recorded from human dopaminergic neuron cultures on 
commercial and custom MEAs. (A) Percentage of electrically active channels at 4 (n =6), 5 (n =4) 
and 6 (n = 3) weeks in vitro. (B) Active channels were classified as having ‘fast’ (0.1 ms to 3 ms 
duration) and ‘slow’ (greater than 3 ms duration) waveform activity. (C) Percentage of active channels 
that had ‘fast’ and ‘slow’ waveform activity remained on about the same levels throughout weeks 4 to 
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Figure 3.13: ‘Fast’ waveform activity from human dopaminergic neuron cultures recorded on 
commercial and custom MEAs. (A) Three representative ‘fast’ waveforms recorded at 4, 5 and 6 
WIV. Left traces show all the waveforms sorted from one active channel; 4 WIV = 8 spikes, 5 WIV 
= 9 spikes, 6 WIV = 6 spikes. The trace on the right is the average of all the waveforms. Arrow points 
to half-width (dashed line) of the average waveform at 4 WIV. (B) Average half-width of ‘fast’ 
waveforms showing little changes throughout the three weeks. Data are presented as the mean and 
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Figure 3.14: ‘Slow’ waveform activity from human dopaminergic neuron cultures recorded on 
commercial and custom MEAs. (A) Three representative ‘slow’ waveforms recorded at 4, 5 and 6 
WIV. Left traces show all the waveforms sorted from one active channel; 4 WIV = 20 spikes, 5 WIV 
= 15 spikes, 6 WIV = 31 spikes. The trace on the right is the average of all the waveforms. (B) Average 
half-width of ‘slow’ waveforms  showing a reduction throughout the three weeks. Data are presented 
as the mean and standard error of the mean used for error bars. Asterisks indicate statistical 
significance, **** p < 0.0001. 
  






















This chapter has focused on establishing the long-term culture and differentiation of 
human neural stem cells (hNSCs) into human cerebral cortical neurons (hCCNs) and 
human dopaminergic neurons. The aim was to develop an alternative in vitro model to 
study neurodegeneration, neuronal function and myelination without the use of animals. 
The ability to use human cells has been made available since the discovery of human 
embryonic stem cells (hESCs) in the late 1990s (Thomson et al., 1998) and later on the 
discovery of the more ethical human induced pluripotent stem cells (iPSCs) (Takahashi 
and Yamanaka, 2006).  
 
The availability of hiPSCs was ideal as it meant that I could potentially differentiate them 
into any type of neuron. A decision was made to differentiate into cerebral cortical 
neurons as they are present in the central nervous system (CNS) which is where 
demyelination occurs, causing diseases such as multiple sclerosis, and they possess 
exceptionally long axons, ranging between 10 to 20 mm (Mohan et al., 2015). The 
protocol used for differentiating hNSCs to hCCNs was provided by the hNSCs supplier 
Axol Bioscience. Following their protocol, I was able to establish a long-term culture and 
differentiation of hNSCs, however, that was initially only possible on polystyrene wells 
and borosilicate coverslips. As I wanted to measure electrical activity of these cultures it 
was important to maintain these cultures long term on microelectrode arrays (MEAs). 
 
Measuring the conduction velocity is one way to assess myelination in vivo (Steffens, 
Dibaj and Schomburg, 2012) and one way to do this in vitro it is ideal to separate the 
neuronal cell bodies and axons in different compartments in order to stimulate and record 
from them respectively. The microchannels fabricated that were previously discussed in 
Chapter 2 were tested using hNSCs and differentiating into hCCNs. These tests aided in 
developing a PDMS module with embedded microchannels that successfully restricted 
cell bodies in a separate compartment to axons. However, as the hCCNs were not 
electrically active within the time course of my studies, I was unable to test this aspect of 
their electrical activity. Other studies have used microchannels aligned across multiple 
electrodes to measure conduction velocity in rat dorsal root ganglion (DRG) cells co-
cultured with Schwann cells (SCs) though rather low conduction velocities were observed 
(peaked at 0.59 m/s) (Sakai et al., 2017).  
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hNSCs, were also differentiated into dopaminergic neurons and were compared to hCCNs 
electrically using voltage clamp and MEAs (both commercial and custom arrays). These 
methods allowed for following and validation of the electrical properties and functions 
when cultured over a period of up to 6 weeks. 
 
3.4.1 Immunocytochemical Characterisation of Human Cerebral Cortical 
Neurons 
 
The adult cortex consists of a six layered structured and each layer can be identified 
separately using the suitable layer specific markers (Livesey et al., 2015). Tbr1 is an early 
cortical marker that is expressed by layer 6 cortical neurons (Shi et al., 2012). Axol 
Bioscience, the supplier of the hNSCs and the protocol, state that their protocol produces 
a highly pure population of cortical neurons (>95%). This was confirmed from positive 
staining of Tbr1 from as early as week 1 post differentiation in over 95% of the cell 
culture. The cultures expressed Tbr1 throughout the 4-week period, with the population 
of hCCNs being over 99%. It cannot be definitely concluded that all the red stained cells 
are hCCNs as a negative control was not carried out and future experiments should 
include negative controls for immunofluorescence staining. 
 
3.4.2 Culture of Human Neural Stem Cells on Different Surfaces 
 
Initially hNSCs were cultured and proliferated on tissue cultured treated polystyrene well 
plates before they were differentiated in hCCNs. No issues with the cultures occurred and 
was able to maintain the differentiated cultures for at least 4 weeks. However, problems 
were encountered when culturing and differentiating the hNSCs on other surfaces such 
as those of the commercial and custom MEAs. One of the surfaces that was tested was 
that of the custom MEA fabricated by Epigem. The custom MEA (V1.0) was pre-coated 
with SureBond-XF but as soon as 24 hours after seeding the cells, they began to detach. 
This occurred as the surface was later found to not be what was asked but instead was 
SU-8, which is known to be bioincompatible when not chemically altered (Xue et al., 
2014). 
 
A similar issue was observed when culturing hNSCs onto the commercial standard MEA 
(60MEA200/30iR-Ti) from Multichannel Systems (Reutlingen, Germany). The silicon 
nitride (Si3N4) surface was made hydrophilic prior to pre-coating with SureBond-XF but 
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cultures could not be maintained beyond 2 weeks. The cells began to detach from the 
surface from as early as 3 days in vitro (DIV) and by the time differentiation occurred (3 
to 10 DIV) there were very few cells remaining.  
 
Instead of using SureBond-XF I tried pre-coating the surfaces with laminin to see if that 
would improve cell adherence and growth on the commercial MEA. No improvement 
was found when using laminin and therefore I decided to revert back to using SureBond-
XF as laminin also caused the cells to aggregate which did not improve the expansion 
process. Therefore, from that point onwards, SureBond-XF was used throughout the 
whole of my PhD for pre-coating surfaces when culturing and differentiating hNSCs. 
 
3.4.3 Culture and Differentiation of Human Neural Stem Cells in 
Microchannels 
 
It is well known that having a constricting barrier helps prevent the movement of cells 
into unwanted regions. Being able to manipulate the topology of the cells in culture is 
advantageous when compared to conventional dissociated neuronal cultures as this 
method offers a more in vivo type approach and also maintains something of a normal 
nervous system geometry (Yi et al., 2015). For example, having microchannels between 
two compartments to separate neuron cell bodies from the axons allows axonal 
interactions with glial cells to be studied (Park et al., 2012). Later studies using embryonic 
day 16 rat neurons and microchannels successfully allowed the study of axonal growth 
by applied localised biomolecular treatments although electrical recording was not 
incorporated into this system (Park et al., 2014).  
 
I designed a similar concept microfluidic device which consisted of two compartments 
separated by a 10 μm in width microchannel. Due to problems with the fabrication of the 
first microchannels, explained in Chapter 2, the width of microchannels varied and ranged 
between 10 to 20 μm. It was therefore found early on that when culturing and 
differentiating hNSCs in one compartment of the PDMS microchannels, the cell bodies 
were able to flow and adhere into the second compartment. The issue of the cell bodies 
entering the second compartment was resolved by using a quartz photomask for the 
fabrication process and also reducing the width of the microchannels to 5 μm. As 
expected, this resulted in the cell bodies to remain in the compartment they were seeded 
as they were unable to flow through the 5 μm constriction. Therefore, this meant that only 
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axons were able to pass through and grow into the second right-hand side compartment. 
I was thus able to attain excellent separation in a similar way to Park et al., (2014) though 
using hCCNs. 
 
3.4.4 Development of Ion Channels and Synaptic Inputs 
 
Since voltage-gated ion channels play a crucial role in the generation and propagation of 
action potentials (Hodgkin and Huxley, 1952) as well as their distribution and density 
change with time (Lai and Jan, 2006) it was necessary to follow the changes in channel 
density in these human neuronal cultures against time. Furthermore, it was necessary to 
know the electrical state of the cultures in detail in order to validate the MEA derived 
electricals signals which are extracellular.  
 
In hCCNs, Nav currents were negligible at week 0, but increased week by week up to 
week 4 in parallel with axonal growth. In order to determine the true changes in current 
density it was important to correct for cell capacitance, which is an electrical 
measurement of cell surface area. This correction indicates that the NaV current densities 
increased weekly despite changes in cell surface area. Implying as seen in the electrical 
traces that the cultured neurons became increasingly excitable. 
 
The same analysis was carried out with human dopaminergic cultures which showed NaV 
current densities that also increased weekly up to week 6 (no differences were observed 
between TH+ and TH- cells). As the channel densities in both cultures were remarkably 
similar and matched quite well the previously reports from hCCNs (Shi et al., 2012) Nav 
expression was unlikely to be the reason for the spontaneous excitability of the 
dopaminergic cultures versus the electrical silence of the hCCNs. 
 
The reason for the difference was more likely to be due to the lack of synaptic 
inputs/synaptic maturity seen in the hCCNs electrically which was illustrated by the 
complete lack of the immunocytochemical presence of pre and postsynaptic markers 
synaptophysin and PSD-95. This was not the case for dopaminergic neurons as TH+ cells 
expressed synaptophysin and PSD-95 as well as had an abundance of postsynaptic 
potentials. However, hCCNs express these markers in long term cultures at 112 DIV and 
synaptic density was significantly increased by 300 DIV (Odawara et al., 2016). This 
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indicates that hCCNs, require a much longer time period to mature and begin to form 
synapses when compared to human dopaminergic neurons. 
3.4.5 Activity of Human Dopaminergic Cultures culture on MEAs 
 
I was able to culture human dopaminergic neurons on commercial and custom MEAs 
even though I was unable to culture and expand hNSCs on them. This was achieved by 
differentiating hNSCs into human dopaminergic neurons on polystyrene wells and at 2 
weeks they were detached and transferred onto commercial and custom MEAs were they 
remained in culture for up to 6 weeks.  
 
It was previously found by Dr Matthew Euston (PhD student in Dr Brown’s lab) that TH 
positive neurons (dopaminergic neurons) reached a steady level of approximately 25% of 
the whole culture at 4 to 6 weeks. This data was obtained from single cell patch-clamp 
electrophysiology experiments. Therefore, it was decided to electrically analyse these 
cultures during that time period using commercial and custom MEAs as a way to compare 
the two techniques and to validate the different forms of electrical activity seen in MEA 
recordings of these cultures. 
 
As expected, the cultures were spontaneously active during the whole three-week period 
I studied, with the average percentage of active channels ranging between 47.9% to 
73.1%. The active channels were analysed for spike-like behaviour and the resulting 
spikes sorted into two groups, ‘fast’ and ‘slow’,  based on their waveform duration. 
Waveforms that were less than 3 ms in duration were classified as ‘fast’ and waveforms 
with a duration greater than 3 ms were classified as ‘slow’. It was interestingly found that 
percentage of ‘fast’ and ‘slow’ spikes remained at about the same levels of approximately 
30% ‘fast and 70% ‘slow’ over the entire period studied (4 to 6 weeks). Analysing the 
half-widths of the ‘fast’ waveforms, indicated that the ‘fast’ activity recorded in the 
dopaminergic cultures remained unchanged as it was between 0.12 – 0.13 ms. It could be 
deduced that the ‘fast’ activity observed was from axonal action potentials whose neurons 
had reached maturation at or prior to week 4 in vitro.  
 
Unlike the ‘fast’ waveforms which were unchanged by time in culture, ‘slow’ waveforms 
became narrower as the weeks in vitro progressed. At 4 WIV, the mean half-width was 
100.0 ms and by 6 WIV the mean half-width was significantly reduced to 39.3 ms. It 
seems likely that such slow waveforms represent slow non-action potential related 
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potentials, such as synaptic and generator potentials. The narrowing of the ‘slow’ 
waveforms was most likely due to the maturation of these synapses in culture. This 
behaviour was also observed by Euston, (2017), who showed that by 6 WIV there was an 
increase in number and strength of synapses. It is also well known that synaptic 
development refinement and reconfiguration occurs in cultures (Goda and Davis, 2003). 
Synapse formation was confirmed by the co-localisation of the presynaptic marker 
synaptophysin with the postsynaptic marker PSD-95, which is an NMDA receptor-
associated protein. Therefore, NMDA and AMPA receptors may be responsible for the 
spontaneous synaptic currents observed which were completely removed with the 
addition of antagonists of these receptors (Euston, 2017). This can also explain the 
reduction in half-width of the ‘slow’ waveforms as synaptic plasticity is critical during 
the development and maturation of neural networks (Shi et al., 1999).  
 
The results obtained from the commercial and custom MEAs allow an analysis of the 
whole human dopaminergic neuron culture that is able to report the entire network 
behaviour of the culture and could potentially be used to study development and 
pharmacology of this system. This provides a broader understanding of how the culture 





Human cerebral cortical neurons (hCCNs) and human dopaminergic neurons were 
successfully differentiated from human induced pluripotent stem cells (hiPSCs). Their 
development was followed electrically (voltage-clamp and MEAs) and 
immunocytochemically. Both were found to have voltage-gated sodium channels, but 
only human dopaminergic neurons formed synapses during the period of culture. Issues 
with differentiating and culture of hCCNs on MEAs meant that it was not possible to 
record from them in vitro. However, differentiated dopaminergic neurons were 
successfully cultured on custom MEAs (V3.2 and V3.4) and was able to record from them 











Development of Electrical Behaviour in Mouse 






The much greater availability of microelectrode arrays (MEAs) allows the development 
of more informative in vitro models to study various neurological diseases. MEAs 
potentially provide the ability to monitor over the long term the trajectory of electrical 
development and its alteration in pathology. Mouse spinal cord cultures have been used 
for decades as a model to study the process of myelination in the central nervous system 
(CNS). In the present study, I have cultured mouse spinal cord cells on commercial and 
custom MEAs from 2 to 52 days in vitro (DIV) to follow their electrical development. 
Recordings were carried out using a custom 16 channel recording device and various 
configurations of MEAs that allowed for the simultaneous recording from 16 channels. 
The cultures were found to be electrically active from as early as 2 DIV and remained so 
up until 52 DIV. I identified several distinct patterns of electrical activity that altered over 
time in culture. Spike waveforms were different pre- and post-myelination and the 
conduction time between electrodes enabled me to assess changes in nominal conduction 
velocity (NCV) which increased from 0.03 m/s at 2 DIV to 15.00 m/s at 24 DIV. The 
NCV changes were consistent with the ongoing process of in vitro myelination. 
Successful growth was achieved on custom MEAs and preliminary recordings were 
obtained, indicating improvements that could be made in the electrode configuration to 
better capture NCV. The approach shows the use of MEAs in conjunction with pre-
existing techniques can provide a much deeper understanding of the process of 







Studying the central nervous system (CNS) provides important information on 
understanding how it altered by neurodegenerative diseases such as multiple sclerosis 
(MS). These diseases are usually studied at the cellular level using mouse and rat models 
such as experimental allergic encephalopathy (EAE), which was introduced in the 1930s, 
to improve our understanding of multiple sclerosis (Rivers and Schwentker, 1935). This 
model requires a large number of animals for it to be of sufficient power, for example, it 
is estimated that 3 cohorts each of 12 animals are necessary to test the efficacy of a single 
drug (Bijland et al., 2019), which is why alternative or supplemental methods for 
following development in vitro are useful.  
 
The introduction of microelectrode arrays (MEAs) (Thomas et al., 1972) and their 
development since, allow the electrical behaviour of cultures to be followed across time 
and offer a highly data-rich temporally valid technique to investigate the CNS in vitro in 
long term cultures (Odawara et al., 2016). MEAs may have tens to hundreds planar 
electrodes that simultaneously provide recordings from the culture (commercially 
available by Multichannel Systems). Also, as repeated measures can be made non-
destructively from cultures, the use of MEAs as in vitro models is more advantageous 
when compared to some other techniques as it helps reduce the costs by requiring less 
animals, can be easily manipulated pharmacologically and allows for cell networks to be 
kept alive for extended periods of time so that long-term changes can be followed. The 
ability to produce customised MEAs adds a further benefit to optimise the electrode 
positioning to meet the specific requirements of the investigation.  
 
In this chapter, I developed and applied MEA technology to provide insight into the 
electrical development of mouse spinal cord cultures. Mouse spinal cord cultures were 
grown on commercial MEAs to study their differentiation and maturation by recording 
their electrical activity. The electrical activity recorded was used to interrogate the 
progress of synaptic formation, cell connectivity and myelination in vitro. The results add 
a finer grained insight into the influence of myelination on neuronal signalling and was 
comparable to data obtained from other techniques that demonstrate of the presence of 
myelin using immunocytochemistry (myelin basic protein) and electron microscopy 
(Thomson et al., 2006). I was able to fabricate and test custom MEAs as well as 
incorporate microchannels in order to improve the study of in vitro myelination. In the 
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time available however, it was unable to grow cells through the microchannels and 
therefore I was unable to make any NCV measurements with this method. Parts of this 







A total of 5 pregnant mice were used for all experiments in this chapter. The mice were 
bred and maintained in the Biological Services Facilities at the University of Glasgow. 
Embryonic day 13 (E13) mice were obtained by mating wild type mice Cnp+/+ with Cnp-
/- mice (Lappe-Siefke et al., 2003), both on a C57BL/6J (Charles River) background. 
Pregnant mice were killed on the morning of E13 by either Dr. Julia Edgar or Dr. Matthew 
Euston who also carried out the dissections. The embryos were removed from the uterine 
horns and immediately placed on ice in a sterile 10 cm petri dish. 
 
All mouse use was approved by the Ethical Committee of the University of Glasgow and 
licensed under the Animal [Scientific Procedures] Act 1986 project licence PPL60/3656. 
 
4.2.2 Mouse Myelinating Cell Cultures 
 
The number of embryos obtained varied between the 5 pregnant mice used. The spinal 
cords of E13 mice were dissected and incubated in 1 ml per 6 cords of 0.25% trypsin in 
HBSS minus calcium and magnesium for 15 minutes at 37°C. The digestion was then 
stopped by adding 1 ml per 6 cords of plating medium (50% DMEM, 25% HBSS and 
25% horse serum) plus 0.04 mg/ml DNase. The cells were then gently triturated before 
they were centrifuged at 800 rpm for 5 minutes. Following centrifugation, the cells were 
resuspended in plating medium and plated at approximately 150,000 cells per cm2 on 
commercial and custom MEAs. The MEAs were previously plasma treated and coated 
with Poly-L-lysine (PLL; Sigma). After about 1 hour of incubation at 37°C, the media in 
the MEAs was topped up to half the final volume with pre-warmed plating media. Then, 
at the end of the day, the other half of the volume was added using pre-warmed 
differentiation media and the cells were incubated at 37°C in 5% CO2. The differentiation 
medium was prepared with the following: DMEM supplemented with 30% D-glucose, 
10 μg/ml biotin, 50 μM hydrocortisone, 10 μg/ml insulin and 0.5% hormone mix (stock 
concentration 1 mg/ml apo-transferrin, 20 mM putrescine, 4 μM progesterone, and 6 μM 
selenium). Half media changes were carried out using serum free differentiation media 
three times a week up until 12 days in vitro (DIV). From 12 DIV onwards, half media 




For the experiments in this chapter, cells were plated on the MEAs at either 0 DIV or 14 
DIV.  
 
4.2.3 Recording from Commercial MEAs 
 
The mouse spinal cord cultures were maintained on commercial MEAs 
(60MEA200/30iR-Ti-gr; Multi Channel Systems, Reutlingen, Germany) from 2 to 52 
DIV over four separate sets of experiments. A fluorinated ethylene-propylene (FEP) 
membrane (ALA MEA-MEM-SHEET) was placed over the ring of the MEA and secured 
in place using an O – ring. This allowed for the cultures to remain sterile when using the 
MEAs outside of the tissue culture hood. The MEAs were periodically (three to four times 
a week) transferred from the incubator to the electrophysiology laboratory from the tissue 
culture room where the recordings were carried out. Out of all the MEA cultures used 
none were contaminated and were kept in cultures at different time periods ranging 
between 2 to 52 DIV. 
 
The membrane sealed MEA was then placed into a lab built custom recording device 
(RD2) and left for 5 minutes in order for the temperature to reach 37°C before beginning 
recordings. The temperature was controlled and maintained at 37°C using a Peltier device 
that was attached under the RD2 using thermal paste. The recordings were done in 
differentiation medium (media was not changed prior to recording).  A one-minute gap-
free protocol was set up on Clampex 10 software for Windows (Molecular Devices 
Corporation, California, USA). The signals were pre-amplified by a x10 pre-amplifier 
headstage (Omnetics, Minnesota, USA) and amplified by an A-M Systems Model 3600 
amplifier (Washington, USA).  Signals were digitally filtered at 3 Hz high pass filter, 1 
kHz low pass filter and amplified up to x20,000. A digital notch filter was used to remove 
50 or 60 Hz noise during recording. All recordings were differential AC coupled with the 
reference to ground. After acquiring two recordings from one side of the MEA, it was 
rotated, and recordings were made from the other 3 sides of the MEA. Representative 
images of each side were also taken using a Retiga R1 camera (Teledyne QImaging, 
Surrey, Canada) and Micro-Manager Open Source Microscopy Software. Once done, the 
MEAs were placed back into the incubator for future use. The MEAs were carefully 
transported to avoid disturbances and were kept at 37°C while on the RD2 for most of the 
time when outside of the incubator (between 20 to 25 minutes). Once the recordings were 
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obtained the MEAs were placed back into the incubator at 37°C in 5% CO2. This process 
was repeated for all commercial MEA recordings carried out 3 or 4 times a week.  
 
For the pharmacology experiments, neural activity modulators were added directly into 
MEA chamber after removing the FEP membrane (see section 4.2.8 for what compounds 
were used). A three-minute gap-free protocol was set up on Clampex 10 software and 
amplifier settings were as mentioned above. 
 
4.2.4 Preparing and Recording from Custom MEAs 
 
Before culturing cells on the custom MEAs, a PDMS module containing a single well or 
with two wells separated by microchannels (fabrication process explained in Chapter 2) 
had to be aligned with the electrodes. The custom MEAs together with the PDMS 
modules were plasma coated to ensure better bonding of the PDMS onto the surface of 
the MEA. The microchannels were aligned over the electrodes by hand using a compound 
microscope. For the single well PDMS module, the mouse cultures were seeded in the 
same way as when seeding a well of a multi-well culture plate. When using the PDMS 
containing microchannels, cells were seeded in one of the compartments whilst the 
second compartment only contained media. To ensure the flow from one compartment to 
the other, the volume in the cell seeded side was higher (300 μl) than that of the second 
compartment (100 μl). An FEP membrane was also placed over the PDMS module before 
transporting the custom MEAs for recording. The custom MEAs were placed into 
different custom recording device (RD3) from the commercial MEAs and the same 
recording protocol, as detailed in section 4.2.3, was used.  
 
4.2.5 Single Cell Recordings 
 
Whole-cell current clamp recordings were performed using an Axopatch 200B amplifier 
with a Digidata 1440A digital acquisition system and Clampex 10 software for Windows 
(Molecular Devices Corporation, California, USA). Experiments were performed using 
an extracellular solution containing identical ionic concentrations to the cell culture media 
(mM): 110.3 NaCl, 5.3 KCl, 1.8 CaCl2, 0.8 MgCl2, 10 HEPES, 25 glucose, pH 7.4. The 
pipette intracellular solution contained (mM): 135 K-gluconate, 2 MgCl2, 2 Na- ATP, 0.5 
Na-GTP, 10 HEPES, 0.5 EGTA, pH 7.2. Microelectrodes were pulled from borosilicate 
glass using a Flaming/Brown P-87 micropipette puller. The microelectrodes were pulled 
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to a resistance ranging between 3 to 8 MΩ. Neural activity modulators were added 
directly to the bath (see section 4.2.8 for compounds used). 
 
4.2.6 Analysis of Recordings 
 
All data acquired was analysed offline using Clampfit 10 and 11.1 software for Windows 
(Molecular Devices Corporation, California, USA) and Excel 2019 (Microsoft, 
Washington, USA).  
 
Each data file consisted of 16 traces, representing a single recording from 16 separate 
electrodes. As each MEA had four sides, 59 recordings were made from 59 different 
electrodes for each MEA. Before further analysis, all traces were filtered using a lowpass 
Boxcar filter with smoothing points set to 15. An initial superficial manual reading of the 
traces indicated two distinct waveforms that were classified as ‘fast’ and ‘slow’. To 
separate the ‘fast’ from the ‘slow’ waveforms, an automated threshold search tool was 
used.  
 
For ‘fast’ waveforms, the baseline was set to 0 and the trigger marker was set below the 
peaks of the spikes. For example, if the trigger marker was set to 50μV, any spike above 
that was selected. The pre- and post-trigger lengths were both set at 1 ms (millisecond). 
In the event rejection section, the minimum allowed duration was set at 0.1 ms and the 
maximum allowed duration at 3 ms, for the ‘fast’ waveforms. With these values set, the 
threshold search was run, and all events detected were then saved. Any anomalous events 
due to artefacts were manually rejected. The half-width and interevent interval data 
produced from this search were copied into Excel for further analysis. This was repeated 
for all other traces analysed. 
 
For ‘slow’ waveforms (duration greater than 3 ms), a similar template search was carried 
out. Firstly, a representative spike was selected to create a template. That template was 
then used in the template search to scan the trace and select all spikes resembling it. All 
the spikes collected for that trace were then saved for further analysis. A new template 
had to be created for each trace analysed due to variations in amplitudes and form. Any 
anomalous events due to artefacts were manually rejected. The half-width and interevent 
interval data produced from this search were copied into Excel for further analysis. This 
was repeated for all other traces analysed. For all the individual waveform detected at 
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each DIV, they were then averaged to produce one waveform representative of the day in 
vitro.  
 
Once separated into ‘fast’ and ‘slow’ spikes, the spike frequency of all active channels 
was calculated. Frequency was calculated by dividing the total number of spikes by 60 




The immunocytochemistry for all the mouse cultures shown in this chapter were carried 
out by Dr. Julia Edgars lab and we published the results in Bijland et al., 2019. The 
primary antibodies used were: mouse anti-CNP (SMI191; 1:1000; Cambridge 
Bioscience, Cambridge, UK), rabbit anti-Caspr (1:1000; kindly provided by Professor E. 
Peles), rabbit anti-ionized calcium binding adapter molecule 1 (Iba1; 019-19741; 1:800, 
Wako, Neuss, Germany), rabbit anti-PLP226 antiserum (N.P. Groome, Oxford Brookes 
University, Oxford, UK). Bound antibodies were visualised using appropriate 
combinations of species/isotype-specific fluorochrome-conjugated secondary antibodies 
which were: 488 goat-anti mouse IgG1 (A2112), 488 goat-anti rabbit IgG (A11008), 568 
goat anti-rabbit IgG (A11036). All Alexa Fluor, Life Technologies. Nuclei were stained 
with DAPI (2 μg/ml). 
 
4.2.8 Drugs and Compounds 
 
All drugs used were diluted from concentrated stock and pipetted directly to the MEA. 
The drugs used were: tetrodotoxin (TTX; 1 μM; Tocris, 1069), cyanquixaline (CNQX; 5 
μM; Tocris, 1090), picrotoxin (100 μM, Sigma- Aldrich, P1675). 
 
4.2.9 Graphs and Statistics 
 
All graphs and statistical analysis were carried out in Prism 8 (GraphPad Software, San 
Diego, USA). Data were tested for normality in order to choose appropriate statistical 
tests. The D'Agostino-Pearson and the Shapiro-Wilk normality tests were used. For 
parametric and multiple independent samples, a one-way ANOVA was performed. A 
Kolmogorov-Smirnov test was used for two sample data that were non-parametric. When 
data were parametric and had two samples an unpaired t-test was used. For non-
 
116 
parametric and multiple independent samples, the Kruskal-Wallis test with a Dunn’s 
multiple comparisons test was performed. Statistical significance was accepted at 
probabilities of equal to or less than 0.05. A p-value of less than 0.05 is shown as a single 
asterisk (*). Data are presented as the mean ± standard deviation or the standard error of 






4.3.1 Immunocytochemical and Morphological Characterisation of Mouse 
Spinal Cord Cultures 
 
4.3.1.1 Immunocytochemical Characterisation  
 
To better follow the process of myelination in culture, immunocytochemistry and 
fluorescence microscopy was carried out on representative cultures at different time 
points. The fluorescent images shown in Figure 4.1 were obtained from a recent paper to 
which I contributed (Bijland et al., 2019). Embryonic day 13 mouse spinal cord cultures 
are comprised of several cell types and structures such as axons, oligodendrocytes, 
astrocytes and microglia. These were observed throughout the culture progresses from 6 
to 28 DIV and indicates its cellular complexity (Figure 4.1A-E). 
  
The morphology of 2’ , 3’ -cyclic nucleotide 3’-phosphodiesterase (CNP) positive cells 
can be seen to change from 6 DIV to 28 DIV (Figure 4.1A). CNP is expressed early in 
the oligodendroglial lineage and is present in non-compact myelin (Trapp et al, 1988). 
Single myelin-like sheaths were observed at 12 DIV when compared to 6 DIV where the 
cells have a ‘lacy’ appearance. The myelin sheaths were more distinct at 21 DIV with 
fewer ‘lacy’ appearing cells and by 28 DIV a denser network of myelin sheaths was 
observed. 
 
Microglia were identified by to ionised calcium binding adaptor molecule 1 (IBA1) 
staining and were notably visible from 7 DIV. They begin to form multiple processes 
throughout the culture period up to 28 DIV (Figure 4.1B).  
 
Mouse spinal cord cultures also contained neuronal cells revealed by NeuN staining 
(neuronal nuclei; NeuN), astrocytes (glial fibrillary acidic protein; GFAP) and 
oligodendrocyte progenitor cells (OPCs) (neural/glial antigen 2; NG2) (Figures 4.1C-E) 
 
Co-staining of proteolipid protein (PLP/DM20), Caspr and phosphorylated neurofilament 
(NF), shows that by 28 DIV the axons were myelinated, and the internodes were separated 
by nodes of Ranvier (Figure 4.1F). PLP and DM20 are proteins present in myelin and 
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therefore a myelin marker. Caspr is a protein present in the paranodal regions of the nodes 
of Ranvier and NF is an axonal maker.  
 
4.3.1.2 Culture on Commercial MEAs  
 
Mouse spinal cord cells were successfully cultured on commercial MEAs (Figure 4.2). 
They adhered well onto the surface and remained healthy for several weeks in culture up 
to a total of 52 days. The morphology of the cultures on commercial MEAs was similar 
to those seen on multi-well polystyrene plates (Figures 4.2B-E).  
 
The cell bodies at 2 DIV (Figure 4.2B) were all of similar shape, whereas from 8 DIV 
(Figure 4.2C) there were different cell body morphologies observed in the culture (white 
arrows). The number of processes present also increased with time in culture, which could 
be clearly seen when comparing 21 DIV (Figure 4.2E) with the commercial MEA 
cultures of previous days. 
 
The cells were able to differentiate and proliferate on the MEAs which could be seen by 
the increase in cell density as the days in culture increased. After about 28 DIV, some cell 
death was observed as cells began to detach (Figure 4.2F). However, the cells that 




























Figure 4.1: Embryonic day 13 mouse spinal cord cells differentiate over time into the major 
neural cell types of the nervous system. (A) The morphology of CNP positive cells changes with 
time in culture. At 6 DIV, multiple cell process’ extend from the cell body and the cells have a ‘lacy’ 
appearance, as shown in the inset. By 21 DIV, many cells have extended multiple myelin-like sheaths 
and by 28 DIV few ‘lacy’ appearing cells are left and a dense network of myelin sheaths was visible. 
(B) Iba1 +ve microglia are present at all stages examined. At 7DIV most microglia appear amoeboid 
but branch out and extend multiple processes over time. (C) Antibody to NeuN labels neuronal nuclei 
and sometimes staining extends into the cytoplasm, but rarely enters the cell processes. (D) GFAP 
positive astrocytes are found throughout the culture, (E) as are NG2 +ve oligodendrocyte progenitor 
cells (OPCs). (F) Combined staining with antibodies to PLP/DM20, Caspr and phosphorylated 
neurofilament (NF), revealed that many axons are covered by consecutive sheaths with nodes of 





































Figure 4.2: Mouse spinal cord cultures on commercial MEAs. (A) Low power view of commercial 
microelectrode array (MEA) on the left. In the high-power image (right), four electrodes (black circles) 
can be observed in relation to the cell bodies (white arrows) and processes (including axons; blue 
arrowheads) of neurons and glia, on an MEA at 22 DIV. Representative images at (B) 2 DIV, (C) 8 
DIV (different cell body morphologies shown by white arrows), (D) 14 DIV, (E) 21 DIV, (F) 29 DIV, 












4.3.2 Electrical Activity of Mouse Myelinating Cultures 
 
Most data available focuses on mouse spinal cord cultures once myelination begins and 
up until it concludes. Therefore, I chose to study the activity of the cultures from as early 
as 2 days in vitro (DIV) up to 52 DIV. It was found that from as early as 2 DIV the mouse 
spinal cord cultures were electrically active. Different types of spike waveform activity 
were observed at different stages and two examples of active traces at 4 weeks in vitro 
(WIV) indicate this (Figure 4.3B). The cultures were found to be electrically active 
throughout the whole experimental period with a decrease observed only after 7 WIV.  
 
The average number of active channels throughout an eight-week period was measured 
and it was found that there were approximately between 9 and 33 active channels from a 
total of 59 channels during the experimental procedure. Between 1 and 7 WIV the number 
of active channels ranged between 21 and 33 (Figure 4.3C). 
 
To analyse the data for statistical significance a one-way ANOVA was performed as the 
data were found to be normally distributed. There was no statistical difference between 
the spontaneous activity measured at 1 WIV (n = 5) when compared to all the other weeks 
in vitro (p > 0.05). However, there was a significant increase in spontaneous activity 
between 2 WIV (n = 16) and 4 WIV (n = 13) (p = 0.0160).  A statistically significant 
increase in activity was also observed between 3 (n = 10) and 4 WIV (p = 0.0413).  From 
4 WIV onwards a decrease in spontaneous activity was observed but it was not 
statistically significant when compared to 5 (n = 9), 6 (n = 8) and 7 (n = 8) WIV (p > 
0.05). However, the decrease in activity observed from 4 WIV to 8 WIV (n = 4) was 
statistically significant (p = 0.0052). The decrease in active from 5 WIV to 8 WIV was 




























Figure 4.3: Average number of electrically active channels throughout an eight-week period of 
culture on commercial MEAs. Representative examples of (A) a non-active and (B) two active 
channels from 4 weeks in vitro. (C) All the data obtained from a total of eleven MEAs and averaged 
to show the varying electrical activity of mouse spinal cord cultures as they differentiate and mature. 
The n values for each week were as follows: week 1 = 5; week 2 = 16; week 3 = 10; week 4 = 13; 
week 5 = 9; week 6 = 8; week 7 = 8; week 8 = 4. Data are presented as the mean and standard error of 
































4.3.3 Pharmacological Assessment of Mouse Spinal Cord Cultures 
 
To establish if the electrical activity was due to synaptogenesis, electrical recordings were 
taken daily between 20 and 24 DIV. The results show that at least two types of waveforms 
were observed, ‘fast’ and ‘slow’, as well as burst like activity (Figure 4.4A). Additive 
pharmacology at 24 DIV demonstrated distinct in vivo network-like activity of spinal cord 
myelinating cultures (Figure 4.4B). The addition of 100 μM of picrotoxin, a GABAergic 
inhibitor, evoked a large increase in ‘fast’ spikes when compared to the control trace. The 
subsequent addition of 5 μM of tetrodotoxin (TTX), a voltage-gated sodium channel 
blocker, inhibited the fast spike-like activity as fewer spikes are present in the third trace 
versus the second one. Finally, 5 μM of cyanquixaline (CNQX), a blocker of the 
AMPA/kinate receptors, was added to the MEA bath which in turn further blocked nearly 
all spontaneous activity previously present.  
 
To complement the data obtained from the MEA recordings, single cell patch recordings 
were also carried out. Spontaneous electrical activity was observed in 68 out of 75 cells 
tested with an average spiking frequency being 2.13 ± 0.32 Hz (mean ± SEM). The 
activity was also enhanced with the addition of 100 μM of picrotoxin and completely 
blocked by 1 μM of TTX (Figure 4.4C).  
 
Comparing both techniques, it was deduced that mouse spinal cord myelinating cell 

































Figure 4.4: Myelinating cell cultures are spontaneously excitable. (A) Representative extracellular 
recordings from a single electrode between 20 and 24 DIV. (B) Additive pharmacology on a 24 DIV 
culture (sequential administration of drugs without washout) demonstrated in vivo-like neuronal 
network activity of spinal cord myelinating cultures. The traces show that addition of picrotoxin 
evokes a massive increase in ‘fast’ neuronal activity. Subsequent addition of TTX, inhibits most of 
the ‘fast’ spike-like activity. CNQX furthers blocks neuronal activity. (C) Examples of whole-cell 
current clamp recordings from single cells, presumably neurons, firing spontaneously at a resting 
potential of around -50 mV. Top, traces before and 5 minutes after the addition of 100 μM picrotoxin. 
Bottom, traces from a second cell before and 5 minutes after the addition of 1 μM TTX. TTX 
consistently blocked activity (n = 6 cells) whilst picrotoxin caused regular burst spiking in every cell 





4.3.4 Changes in of Electrical Activity with Time in Culture  
 
The waveforms were found to vary in duration across time. To better investigate these 
changes, 10,688 traces obtained from all commercial MEAs were analysed for alterations 
using waveform discrimination. ‘Fast’ waveforms were of less than 3 ms in duration and 
broadened with time in culture (Figure 4.5) ‘Slow’ waveforms were of greater than 3ms 
in duration and narrowed with time in culture (Figure 4.6).  
 
The number of ‘fast’ waveforms detected from one representative channel at 10, 27 and 
44 DIV are shown in Figure 4.5A (left), with the average spike waveform on the right. 
Without further analysis it was clear that the ‘fast’ waveforms varied at different days. 
This could be quantified by analysing the changes in half-widths of the spikes from 
representative channels (Figure 4.5B). The half-widths measured at 10 DIV were 0.31 ± 
0.04 (1082 spikes), at 27 DIV was 0.81 ± 0.09 (342 spikes) and at 44 DIV was 0.76 ± 
0.06 (30 spikes). The half-width is indicated by the double headed arrow at 10 DIV 
(Figure 4.5B). The representative half-width at 10 DIV (0.27 ± 0.02 ms; 64 spikes) was 
approximately three times less than that at 27 DIV (0.77 ± 0.06 ms; 238 spikes) and 44 
DIV (0.76 ± 0.06 ms; 30 spikes). The decrease in half-width at 27 and 44 DIV when 
compared to that at 10 DIV was highly statistically significant (p < 0.0001; unpaired t-
test as the data were normally distributed). The half-widths at 27 DIV and 44 DIV were 
about the same and were not significantly different (p = 1.08). The mean half-width 
duration of all ‘fast’ spikes was 0.59 ± 0.35 ms (mean ± standard deviation), measured 
from a total of 12,638 ‘fast’ spikes.  
 
The number of ‘slow’ spikes detected from one representative channel at 10, 27 and 44 
DIV are shown in Figure 4.6A (left), with the average spike waveform on the right. The 
half-widths measured at 10 DIV was 50.6 ± 8.6 (47 spikes), at 27 DIV was 34.1 ± 6.8 
(194 spikes) and at 44 DIV was 26.8 ± 8.1 (152 spikes). Unlike with ‘fast’ spikes, the 
half-width (indicated by double headed arrow at 44 DIV) narrowed with time (Figure 
4.6B). The representative half-width at 44 DIV (24.86 ± 5.30 ms; 12 spikes) was about 
two times greater than that at 10 DIV (48.52 ± 4.62; 12 spikes). This difference in half-
width between 44 DIV and 10 DIV was highly statistically significant (p < 0.0001; 
unpaired t-test as the data were normally distributed). The half-width being lower at 27 
DIV (33.32 ± 4.76 ms; 8 spikes) when compared to 10 DIV was also highly significantly 
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different as p < 0.0001 (unpaired t-test). The half-width was lower at 44 DIV than that at 
27 DIV and this difference was to be significantly difference as p = 0.0019 (unpaired t-
test). The mean half-width duration of all ‘slow’ waveforms was 40.89 ± 17.71 ms (mean 
± standard deviation), measured from a total of 12,524 ‘slow’ waveforms. 
 
The number of active channels of which ‘fast’ waveforms were present increased after 1 
WIV (0.3%; from 295 channels) up until 4 WIV (9.5%; from 708 channels). The 
percentage of active channels with ‘fast’ waveforms was 4% at 2 WIV (from 1062 
channels) and 7.2% at 3 WIV (from 531 channels). From week 5 to week 7 (1475 
channels) only four active channels presented activity consisting of ‘fast’ waveforms, 
with zero at week 8 (236 channels) (Figure 4.7).  
 
The number of active channels of which consisted of ‘slow’ waveforms ranged between 
30.5% at 3 WIV (from 531 channels) to 46.3% at 5 WIV (from 531 channels). There was 
an increase in ‘slow’ waveform activity from 4 weeks and onwards when compared to 
the first 3 weeks. The least amount of ‘slow’ waveform activity was recorded at 8 WIV 
(15.3%; from 236 channels) (Figure 4.7). A total of eleven commercial MEAs were used 
at different time periods throughout the eight-weeks of this investigation. One channel 







































Figure 4.5: ‘Fast’ waveform activity from mouse spinal cord cultures recorded on commercial 
MEAs. (A) Three representative ‘fast’ waveforms recorded at 10, 27 and 44 DIV. Left trace shows all 
the waveforms sorted from one active channel for that day; 10 DIV = 64 spikes, 27 DIV = 238, 44 
DIV = 30 waveforms. The trace on the right is the average of all the spikes. (B) Visualisation of the 
’fast’ waveform half-widths (double headed arrow) at 10, 27 and 44 DIV. Asterisks indicate statistical 





































Figure 4.6: ‘Slow’ waveform activity from mouse spinal cord cultures recorded on commercial 
MEAs. (A) Three representative ’slow’ waveforms recorded at 10, 27 and 44 DIV. Left trace shows 
all the spikes sorted from one active channel for that day; 10 DIV = 12, 27 DIV = 8, 44 DIV = 12 
waveforms. The trace on the right is the average of all the waveforms. (B) Visualisation of the ’slow’ 
waveform half-widths (double headed arrow) at 10, 27 and 44 DIV. Asterisks indicate statistical 

































Figure 4.7: Number of channels with ‘fast’ and ‘slow’ waveform activity. (A) ‘Fast’ and ‘slow’ 
waveforms were observed throughout the whole culture period of the mouse spinal cord cultures up 
to 8 weeks in vitro. Each channel represents one MEA electrode with a total of 59 electrodes per MEA. 
(B) Percentage of channels with ‘fast’ (left) and ‘slow’ (right) waveform activity. 
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4.3.5 Spike Frequency 
 
The spike frequency, over the period of 7 WIV, of active channels with ‘fast’ spike 
activity was calculated (Figure 4.8A). An increase in spike frequency between 1 and 2 
WIV was observed, however, no statistical significance could be found as there was only 
1 active channel with ‘fast’ spike activity during 1 WIV. This was also the case for 6 
WIV. The mean spike frequency was above 1 Hz for 2 to 5 and 7 WIV. To analyse the 
data for statistical significance the Kolmogorov-Smirnov test was used as the data were 
non-parametric and each week was separately statistically analysed compared to other 
weeks. The decrease in spike frequency from 2 WIV (n = 42) and 4 WIV (n = 63) was 
found to be statistically different (p = 0.0074). No statistically significant differences 
were found when comparing the spike frequency of the remaining data points as p > 0.05.  
 
When compared to the spike frequencies of the ‘fast’ waveforms, that of the ‘slow’ 
waveforms was at least five times less, as it was below 0.2 Hz throughout 8 WIV (Figure 
4.8B). To analyse the data for statistical significance, the Kruskal-Wallis test was used as 
the data were non-parametric and contained multiple samples. The increase in spike 
frequency of the slower spikes between 1 WIV and 4 WIV was found to being statistically 
significant (p = 0.0015). There was a significant increase in spike frequency between 2 
WIV and 4 WIV (p = 0.0009) as well as a significant increase was found between 3 WIV 
and 4 WIV (p = 0.0057). Also, the decrease in spike frequency observed from 4 WIV to 

































Figure 4.8: Spike frequency of mouse spinal cord cultures recorded on commercial MEAs. The 
frequency of (A) ‘fast’ and (B) ‘slow’ spikes obtained over an eight-week period in culture. The data 
indicates that active channels comprised of ‘fast’ spikes had a higher spike frequency when compared 
to those with slow spikes. Data are presented as the mean and standard error of the mean used for error 























4.3.6 Bursts of Activity in Mouse Spinal Cord Cultures 
 
Once the spikes were sorted into ‘fast’ and ‘slow’ waveforms it was also observed that 
bursts of activity were present in the traces with ‘fast’ waveforms. Bursts of activity are 
often described as more than 2 spikes firing within a few milliseconds apart. The 
interevent interval measurement was used to observe if a burst of activity was present in 
an active channel.  
 
The results show (Figure 4.9A) the coefficient of variation percentage from 6 DIV up to 
48 DIV (last day where ‘fast’ waveform activity was recorded). The coefficient of 
variation percentage was calculated from the means and standard deviation of the 
interevent interval. When the percentage was above 100% (dashed line), bursts of activity 
were observed. Bursts of activity were observed between 9 and 23 DIV. Prior to 9 DIV 
and from 24 DIV and onwards the ‘fast’ spike waveform activity did not indicate any 
bursting activity. The data shown were from representative active channels and the 
number of waveforms and coefficient of variation percentages at each day are shown in 
Table 4.1. 
 
A representative trace at 17 DIV (Figure 4.9B) shows what a burst in activity looks like 
(top). A closer look at the bottom trace, shows 13 ‘fast’ waveforms all within 100 ms. A 
representative trace at 44 DIV shows no bursting of activity but instead single ‘fast’ 


































Figure 4.9: Coefficient of variation percentage of ‘fast’ waveforms from mouse spinal cord 
cultures between six to forty-eight days in vitro. (A) The coefficient of variation was calculated 
using the mean interevent interval and standard deviation. The interevent interval was obtained from 
electrically active channels that contained ‘fast’ waveforms. Values above 100% (dashed line) indicate 
bursts of activity present.  Representative data shown for each day in vitro. The n values (number of 
spikes) varied from 6 (11 DIV) to 387 (21 DIV). The n values for each day can be seen in Table 4.1. 
Representative traces showing (B) bursts of activity at 17 DIV compared to (C) single spike activity 
at 44 DIV.   
 
  



































Table 4.1: Coefficient of variation percentage at different days in vitro. A percentage over 
100 indicates bursts of activity.  
  
Days in vitro Coefficient of variation (%) Number of ‘fast’ 
waveforms 
6 70 50 
8 69.63 115 
9 522.2 78 
10 378 171 
11 146.9 6 
12 68.33 8 
13 236 26 
14 216.1 35 
15 217.4 363 
16 361.7 65 
17 520.9 34 
21 181.2 387 
22 183.1 148 
23 147.7 364 
24 75.3 58 
27 88.69 76 
29 62.64 103 
41 56.83 29 
44 74.76 30 
48 95.86 90 
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4.3.7 Conduction Velocity Between Electrodes 
 
‘Fast’ waveform activity was observed at similar time points within traces of different 
channels. In real-time, this difference was impossible to be distinguished (Figure 4.10A; 
two top traces). A closer look at the two bottom traces (Figure 4.10A) shows that the two 
waveforms still look fairly similar. This meant that it was necessary to automatically 
detect the time of peaks by using a peak value calculation with Clampfit software. 
Calculating the difference between closely correlated events on two adjacent electrodes, 
which were separated by a known distance, enabled me to calculate the nominal 
conduction velocity (NCV). NCV increased from 6 DIV up until 24 DIV, with a big jump 
from 6 to 10 DIV (Figure 4.10B and Table 4.2). No further NCVs were calculated after 
24 DIV as similar ‘fast’ waveforms were not detected in two separate channels or there 
was no more than one channel active. The slowest mean NCV was measured at 6 DIV 
(0.03 m/s) and the fastest was measured at 24 DIV (15.00 m/s). The data was statistically 
analysed using the Kruskal-Wallis test (with a Dunn’s multiple comparisons test) as the 
data were non-parametric and contained multiple samples. There was a significant 
increase in NCV from 6 DIV (0.03 ± 0.0005 ms) to 23 DIV (13.12 ± 1.67 ms) (p = 
0.0206). The increase in NCV observed between 6 DIV (0.03 ± 0.0005 ms) and 24 DIV 
(15.00 ± 1.95 ms) was also statistically significant (p = 0.0023). The increase in NCV 
measured at 24 DIV (15.00 ± 1.95 ms) when compared to that at 10 DIV (6.38 ± 0.99 ms) 
was found to be of significance (p = 0.0116). The NCV data are presented as the mean ± 
standard error of the mean. 
 
The conduction velocity of ‘slow’ waveforms was also analysed (Figure 4.11 and Table 
4.3). Unlike with ‘fast’ waveforms, when taking a closer look at two waveforms from two 
separate channels (Figure 4.11A; two bottom traces) the waveform peaks clearly arise at 
different times (vertical dashed lines apart from each other). This indicates that the NCV 
was slower than that of ‘fast’ waveforms. Indeed, this was the case as the fastest NCV 
recorded was 0.043 m/s at 6 DIV. Unlike with ‘fast’ waveforms, the NCV did not show 
an increase with time. It remained at around the same levels between 6 DIV and 44 DIV, 
ranging from 0.029 m/s (10 DIV) to 0.043 m/s (6 DIV). When comparing the fastest NCV 
recorded from ‘fast’ waveforms (24 DIV) to that recorded on the same day from active 
channels with ‘slow’ waveforms it was over 400 times higher. No statistically significant 
differences were found for any day when compared to each other as p > 0.05 after carrying 




































Figure 4.10: Nominal conduction velocity measured from ‘fast’ waveforms from mouse spinal 
cord cultures on commercial MEAs. (A) Representative traces of two channels at 24 DIV with ‘fast’ 
waveform activity. A closer look at the two spikes waveforms are shown in the bottom traces. (B) The 
conduction velocity was calculated from ‘fast’ waveforms that were present in two separate channels 
(distance apart ranged from 200 to 1000 μm). The n values (number of pairs of waveforms compared) 
were as follows: 6 DIV = 4, 10 DIV = 21, 15 DIV = 9, 16 DIV = 10, 17 DIV = 5, 23 DIV = 17, 24 
DIV = 12. Data are presented as the mean and standard error of the mean used for error bars; asterisks 
indicate statistical significance, * p < 0.05, ** p < 0.01, *** p < 0.001.  




























































Figure 4.11: Nominal conduction velocity measured from ‘slow’ waveforms from mouse spinal 
cord cultures on commercial MEAs. (A) Representative traces of two channels at 27 DIV with 
‘slow’ waveform activity. A closer look at two spikes waveforms are shown in the bottom. (B) The 
conduction velocity was calculated from ‘slow’ waveforms that were present in two separate channels 
(distance apart ranged from 200 to 725 μm). The n values (number of pairs of waveforms compared) 
were as follows: 6 DIV = 2, 10 DIV = 5, 15 DIV = 7, 23 DIV = 20, 24 DIV = 45, 27 DIV = 17, 44 
DIV = 34. Data are presented as the mean and standard error of the mean used for error bars. 
  




























Table 4.2: Mean nominal conduction velocity of ‘fast’ waveforms from mouse spinal cord 


















Table 4.3: Mean nominal conduction velocity of ‘slow’ waveforms from mouse spinal cord 


























4.3.8 Mouse Spinal Cord Cultures on Custom MEAs 
 
Mouse spinal cord cultures were also grown on custom MEAs. The cultures remained 
adhered well on the surface used (SiO2) for up to 21 DIV (Figures 4.12A-C). The cells 
were also cultured in a two well PDMS module with microchannels. Cell growth did not 
change compared to the single well PDMS module. However, the growth of 
processes/axons through the microchannels and into the second compartment was not 
observed. Different attempts to encourage such growth included adding mouse spinal 
cord cells in both wells, as well as adding nerve growth factors in the second well not 
containing cells. Neither of these changed the outcome and no processes extended into 
the second compartment. When microchannel width was varied (two different sizes of 
microchannels were used, 5 or 10 μm in width, 100 μm in length and 25 μm in height)  
the outcome remained the same.  
 
Issues with the earlier versions of custom MEAs (outlined in Chapters 2 and 3) resulted 
in no electrical activity to be recorded. Since updating the custom MEAs to the newer 
version MEAs (V3.2) electrical activity was recorded as cells were successfully cultured 
on them. However, as the interelectrode distances of the custom MEAs was greater than 
that of commercial MEAs, less cell coverage over electrodes was observed which affected 
the electrical activity recorded as it was unlike that obtained from commercial MEAs. 
This resulted in fewer active channels (1 - 4 out of 16) which only showed ‘slow’ 
waveform activity and no ‘fast’ activity (Figure 4.12D). This was not surprising as on 
commercial MEAs where total coverage was achieved ‘fast’ waveform activity was less 



































Figure 4.12: Mouse spinal cord cultures on custom microelectrode arrays. (A) Low power view 
of custom MEA on the left. In the high-power image (right), one electrode (black circle) can be 
observed in relation to the cell bodies (white arrows) and processes (including axons; blue arrowheads) 
of neurons and glia, on an MEA at 15 DIV. Representative images at (B) 17 DIV and (C) 21 DIV. (D) 
Representative traces showing non-active (top) and active (bottom) channels recorded on custom 











Mouse spinal cord cultures have been used for decades to study the central nervous 
systems and have proved particularly useful to study the process of  myelination (Bird 
and James, 1975; Bijland et al., 2019). However, most studies base their findings on static 
changes in neuron-glial interactions using techniques such as electron microscopy and 
immunocytochemistry. Here I have shown that there are detectable changes in electrical 
behaviour with time and that as myelination progresses it became harder to detect ‘fast’ 
waveform activity. This is most likely due to the insulating myelin preventing electrical 
signals associated with spike propagation being detected.  Most notably, by using a non-
biased measurement of electrical waveform delay between electrodes I was able to detect 
an acceleration of nominal conduction velocity (NCV) with time in in vitro myelinating 
cultures for the first time (at such values). The bulk of the data obtained was from 
commercial MEAs but there were some tests carried out on custom MEAs. 
 
The use of MEAs can further supplement the findings of studies that use markers such as 
those used in our recent paper (Bijland et al., 2019) to help us gain a more detailed 
understanding of the process of myelination in the CNS, as well as other CNS functions 
such as spontaneous electrical and synaptic activity. Neuronal electrical activity can be 
used to identify the cell types present in the spinal cord cultures, their metabolic status 
and the general health of the cultures. The use of MEAs have an advantage over single 
cell patch clamp recordings as the throughput is much higher and the cultures can be 
monitored 24 hours a day for as long as the cultures can be kept alive. MEAs allow for 
recordings to be obtained from the whole cell culture and provides a more nuanced 
readout of electrical activity.  
 
Thousands of traces of extracellular electrical activity were obtained throughout the 
whole period of mouse spinal cord cells cultured on MEAs (2 to 52 DIV). A lot of 
information can be extracted from a single active trace which is what I show in this 
chapter. MEAs are shown to be ideal for following the cultures on a day to day basis 
which facilitates in understanding how these mouse spinal cord cultures develop in vitro. 
It was also shown that the MEA cultures react to pharmacological stimuli which means 





4.4.1 Pharmacological Assessment of Mouse Spinal Cord Cultures 
 
Spinal cord cultures for pharmacological experiments were plated onto commercial 
MEAs and 35 mm cultures dishes at 14 DIV and were kept up to 24 DIV. The cultures 
were tested on a day-to-day basis for electrical activity using voltage-clamp on the 35 
mm dishes and MEA recordings on the commercial MEAs. At 24 DIV a series of drugs 
were added to the culture. The results with single cell voltage-clamp showed that the 
cultures were electrically excitable and corelated well with the MEA recordings. Additive 
pharmacology was done in order to gain a better understanding of what types of activity 
were present in the culture as it contained a mixture of neuronal and glial cells. The 
addition of a GABA receptor antagonist, picrotoxin, caused a massive increase in ‘fast’ 
spike frequency. This suggests that inhibitory neurons are present in the culture which 
were previously suppressing any form of spontaneous activity. Following this, TTX was 
added to the culture to see its effect on axonal action potential, as TTX is a voltage-gated 
sodium channel blocker. Indeed, TTX caused the reduction of ‘fast’ waveforms which 
therefore suggested this activity was due to axonal potentials. CNQX, an AMPA receptor 
antagonist, was then subsequently added which blocked some of the ‘slow’ spike like 
activity still present in the presence of TTX. The blocking of these ‘slow’ waveforms 
suggests the presence of glutamatergic neurons and that some of the electrical activity 
present in these cultures arose from the synaptic release of glutamate. The nature of the 
inhibition with GABA and CNQX further suggest that the ‘slow’ waveforms are synaptic, 
generator or dendritic potentials (Kullmann et al., 2005). 
 
These results were validated by the single cell current clamp recordings. They also 
showed an increase in activity with the addition of picrotoxin and the activity was blocked 
with the further addition of TTX and CNQX. The ability to use MEAs to show both a 
pharmacological response in mouse spinal cord cultures means they can be used as an 
additive technique in studying the CNS.  
 
4.4.2 Electrical Activity of Mouse Spinal Cord Cultures 
 
Electrical activity from embryonic day 13 (E13) mouse spinal cord cultures was detected 
on MEAs as early 2 DIV. This was not entirely surprising as mouse spinal cord neural 
networks are known to be electrically active at E12.5 (Yvert, Branchereau and Meyrand, 
2004) therefore the dissociated cells would be expected to become active as soon as the 
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isolation trauma has passed. In our previous work (Bijland et al., 2019), we did not 
investigate electrical activity prior to 20 DIV and after 24 DIV. Here I use MEAs to study 
the cultures for a longer period of time starting at 2 DIV and concluding at 52 DIV which 
enabled me to follow with much greater precision the development of the spinal cord 
cultures. This is particularly useful information as neural activity has been linked to the 
process of myelination (Shimba et al., 2019) and other neuron-glia interactions (Wanke 
et al., 2016). 
 
About 34% of the channels were electrically active in the first week in culture. The 
electrical activity remained at about the same levels at 2 and 3 weeks. During weeks 2 
and 3, it is known that myelin sheaths begin to form (Thomson et al., 2008). From 3 
weeks onwards, the myelin sheaths continue to mature but are more distinct and abundant 
in mouse myelinating cultures which may explain the increase, to about 56% of active 
channels at 4 weeks in vitro. The average number of spontaneous active channels 
remained higher from 4 weeks to 7 weeks when compared to the activity in the first 3 
weeks.  
 
During week 7, the cultures were no longer as healthy as they were in the previous weeks 
as they began to detach and less cells adhered to the surface of the commercial MEAs. 
This was indicative of the drop in the number of active channels as an increased amount 
of cell death was observed during week 8. Therefore, the decision was taken stop at 52 
days which was subsequently a much longer time frame than previous studies, where 
normally axonal degeneration is studied for up to 14 DIV (Mikhailova et al., 2019) and 
up to 31 DIV when studying CNS development and functionality (Bijland et al., 2019). 
Thus, my work here extends the experimental time window for such studies by two to 
three weeks.   
 
One possible reason for the ultimate deterioration of the cultures could have been the 
regular transportation of the cultures from the incubator (37ºC) that was in the tissue 
culture room to our lab (20ºC) and then onto my set-up (37ºC). Regular changes in 
temperature are known to induce a cellular stress response (Neutelings et al., 2013) which 
could explain the culture deterioration by week 8. Therefore, if the setup used for 
recording had a heated/gas enclosure it would mean the MEAs could remain in there 
throughout the whole experimental period. This would avoid any damage caused by 
transportation and exposure to sudden changes in temperature (37°C to 20°C). 
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4.4.3 Classification of Electrical Activity 
 
4.4.3.1 ‘Fast’ and ‘Slow’ Waveforms 
 
When analysing through all the traces, it was clear that the types of waveforms varied 
with time and therefore, I examined this aspect in more detail. Initially the spikes had to 
be sorted into two groups, ‘fast’ and ‘slow’ waveforms. The half-width of neuronal action 
potential varies depending the type of neuron and the recording site, for example the 
waveform half-widths of motor and cortical neurons varies between 0.5 to 2 milliseconds 
(ms) whereas that of dopaminergic neurons of mouse brain slices is not less than about 4 
ms (Bean, 2007). As motor neurons are also present in the mouse spinal cord (Stifani, 
2014), in my analysis, for a spike to be placed in the ‘fast’ group its waveform duration 
had to be less than 3 ms. Any spikes whose waveforms were broader than 3 ms were 
placed in the ‘slow’ group.  
 
The half-width data allowed for differentiating between the different waveforms observed 
at different days. It was found that the ‘fast’ and ‘slow’ waveforms changed with time in 
vitro. The ‘fast’ spikes waveform was narrower pre-myelination (10 DIV), whereas post-
myelination (27 and 44 DIV) the waveform was about three times broader. This could be 
explained by the changes in sodium ion channel distribution on the axons of unmyelinated 
and myelinated axons. Unmyelinated axons have voltage-gated sodium channels evenly 
distributed along them. Nav1.2 (one of the several sodium channel α subunits) channels 
are predominately expressed in unmyelinated axons (Vacher, Mohapatra and Trimmer, 
2008). As the axons become myelinated Nav1.2 channels become replaced by Nav1.6 
channels which are expressed at the nodes of Ranvier (Van Wart and Matthews, 2006). 
This also explains why most ‘fast’ waveforms were predominately present in active 
channels at 3 and 4 WIV (during myelination and myelin maturation) and are later lost 
presumably because of myelin covering the majority of the axons over the recording 
electrodes. 
 
The number of active channels consisting of ‘fast’ waveform activity at  4 WIV was about 
2.5 times greater when compared to ‘fast’ waveform activity containing channels at 2 
WIV (pre- and early myelination). The reduction of ‘fast’ waveform activity after 4 WIV 
could be due to the increase of juxtaparanodal fast potassium currents which suppress re-
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excitation to a certain extent (Vabnick et al., 1999) or insulation of the axons close to the 
electrodes. 
 
Unlike ‘fast’ waveforms, ‘slow’ waveforms became narrower as the number of days in 
culture increased, (mean half-width was 48.5 ms at 10 DIV and 24.9 ms by 44 DIV). 
‘Slow’ waveforms were observed throughout the 8 WIV with not much variation, except 
at 8 WIV when the percentage of channels consisting of ‘slow’ waveforms was reduced 
to 15.3% from 43.0% at 7 WIV. As synaptic activity was demonstrated here both 
pharmacologically and electrophysiologically with whole cell voltage-clamp, these 
slower waveforms were attributed to synaptic potentials. The decrease in half-width of 
‘slow’ waveforms as the DIV increase could be explained by several different factors 
such as the change in distribution of calcium channels on myelinated axons from 
unmyelinated axons (Lai and Jan, 2006). Another factor could be the increase in 
glutamate transporters due the maturation of glial cells (Martinez-Lozada et al., 2014). 
Both of these features shorten and intensify the synaptic potential as synapses mature. 
 
4.4.3.2 Spike Frequency and Bursts of Activity 
 
MEAs also provide the opportunity to study the spike frequency and bursting activity of 
a mixture of cells which is a good proxy of the overall network activity. Knowing the 
firing rate of the cultures as the DIV increase and when bursts of activity arise, helps build 
a picture of axonal and synaptic maturation. My spike frequency results were similar to 
the results of another study which looked at mouse ventral horn (spinal) cultures (Black, 
Atmaramani and Pancrazio, 2017), where it was found that spike frequency of ‘fast’ 
waveforms increased after 1 WIV and remained between 1 to 2 HZ throughout the 
remaining culture period. 
 
I used the interevent interval between spike peaks and their coefficient of variation 
expressed as a percentage to define burst-like activity. A coefficient of percentage above 
100% is a strong indication that bursts of activity were present. Bursts of activity were 
found to be present in cultures after 1 WIV. This coincided with the increase in ‘fast’ 
waveform frequency mentioned earlier. Bursts were present between 9 and 23 DIV. This 
could be explained by the beginning and progression of myelination as well as the 




4.4.4 Assessing Myelination of Mouse Spinal Cord Cultures through 
Electrode-to-Electrode Conduction Velocity 
 
Myelination has been studied for decades using techniques such as electron microscopy 
(Morris, Hudson and Weddell, 1972) and immunocytochemistry (Sternberger et al., 
1978; Thomson et al., 2006). Studies in mice show that it is important to distinguish if 
the myelination is compact or loose, as in the absence of compact myelin neuronal 
cytoskeleton maturation was negatively affected (Brady et al., 1999) and conduction 
velocity (measured in vivo) in the optic nerve of proteolipid protein (PLP)-deficient mice 
which have non compact myelin sheaths was impaired (Gutiérrez et al., 1995). Thus, a 
more accurate evaluation of myelination state would be to measure nominal conduction 
velocity (NCV) in culture which has the advantage of being a repeated measure for the 
same culture for as long as the culture can be kept alive. I examined this idea using custom 
MEAs with integrated microchannels. When this approach failed, I used commercial 
MEAs with electrode-to-electrode connectivity and conduction delays as a proxy for 
axonal conduction. In this case, the electrical activity recorded from mouse myelinating 
cultures on commercial MEAs could be used as an approach to study myelination in vitro.  
 
I found that electrode-to-electrode NCV increased precipitously from 6 DIV to 24 DIV, 
indicating an increase in development and compaction of myelin previously undetected 
with other methods and also correlating with immunocytochemical observations. Bijland 
et al., (2019) showed using positive CNP staining that early myelin sheath formation 
occurred at 12 DIV and continued forming around axons as the days progress. Previous 
studies indicated that myelination began at about 15 DIV, with the majority of 
myelination occurring between 17 to 23 DIV. This was seen through electron microscopy 
images and myelin marker (myelin basic protein, MBP) immunostaining (Thomson et al., 
2006). Therefore, the NCV data shown in this chapter confirms that myelination 
progresses as the number of days in vitro increases. However, an increased NCV was 
observed from as early as 10 DIV, which could indicate that myelination may begin a few 
days earlier than previously reported and/or that maturation of axons and moderate 
increases in NCV occur prior to myelination. The velocity of around 0.03 m/s was found 
at 6 DIV and by 24 DIV this was significantly increased to 15.00 m/s. This is the first 
time such high NCVs have been recorded in vitro and is similar to velocities seen in in 
vivo experiments (Mozafari et al., 2015). Previous in vitro myelin studies show 
conduction velocities ranging between 1 – 2 m/s (Freeman et al., 2015) and 0.44 – 0.59 
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m/s (Sakai et al., 2017). Unlike electron microscopy, using MEAs to assess the progress 
of myelin compaction is more advantageous as the cells do not require to be fixed and 
can be kept alive for as long as required. Also, unlike MEAs, immunocytochemistry is 
unable to distinguish between non-compact and compact myelin. However, I was unable 
to measure possible NCVs higher than 15 m/s due to the sample rate limit from the 
amplifier filters used and this could also explain the lack of faster NCVs in previous 
studies. 
 
It was also important to look at changes in conduction velocity of the ‘slow’ waveforms 
as that would indicate if myelination had also affected the other aspects of cells electrical 
activity. Unsurprisingly, it was found that the conduction velocity measured from ‘slow’ 
waveforms remained fairly constant throughout the culture and ranged between 0.029 to 
0.043 m/s, indicating that NCV changes did not alter in the non-myelinated portions of 
the neurons from as early as 6 DIV up to 44 DIV reinforcing the view that the ‘fast’ 
waveforms were axonal spikes. 
 
Another way to confirm that the NCVs recorded from mouse spinal cord cultures were 
due to the maturation of myelin and not caused by other factors such as straightening of 
axonal branches, increases in axonal diameter or redistribution and optimisation of ion 
channel coverage of the axon surface, would be to measure the effect of carrying out 
demyelination in vitro using cuprizone (cuprizone induces demyelination both in vivo and 
in vitro (Matsushima and Morell, 2001)). A good timepoint for this experiment would be 
at 24 DIV, when a decrease in NCV should be clearly observed. This would further 
increase confidence in the findings in this chapter. This experiment could be repeated 
earlier on, for example at 6 DIV, and observe any changes in NCV in the presence of 
cuprizone. The hypothesis would be that the NCV would not increase after 6 DIV in the 
presence of cuprizone. 
 
Furthermore, remyelination could be assessed by the removal of cuprizone after 
demyelination has occurred. Remyelination has been reported in mice once they are taken 
off a cuprizone diet (Blakemore, 1973). Therefore, it is hypothesised that removing 
cuprizone from the culture should cause remyelination and thus begin to see an increase 
in NCV as the time passes. Once this demyelination/remyelination on MEAs is 
established, novel drugs can be tested on neuronal cultures to study their neuroprotective 
properties as well as their remyelination efficacy. 
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4.4.5 Mouse Spinal Cord Cultures on Custom MEA 
 
Several iterations of custom MEAs (V2.0, V3.0, V3.2, V3.4) were used for the 
experiments in this chapter to enable better measurement of NCV. The main hurdle to 
overcome was to achieve long term culture similar to multi-well plates and glass. The use 
of silicon dioxide (SiO2) for the surface (insulating layer) of the MEA was found to be 
ideal. The custom MEA was designed in a way to allow both stimulation and recording 
from the culture. A PDMS module, bonded onto the surface of the MEA, consisting of 
two wells separated by microchannels allowed for separation of stimulating and recording 
electrodes. The purpose of the microchannels was to restrict the cell bodies in the 
stimulating compartment and for the neuronal processes to grow through the 
microchannels and into the second recording compartment. The issue with the mouse 
spinal cord cultures that arose was that the axons would not grow through the 
microchannels but remained in one compartment together with the cell bodies. At first, 
the issue was that a number of cell bodies would flow through the microchannels before 
adhering onto the surface and that was solved by reducing the width of the microchannels 
to 5 μm from 10 μm. This reduction was found to restrict the cell bodies in one 
compartment; however, the axons still did not grow through the microchannels. 
Therefore, no recordings could be carried out in this culture. 
 
Alongside the microchannel PDMS module, single well PDMS modules without 
microchannels were also used in order to replicate commercial MEAs that had one single 
well where the cells were seeded. This meant that cells would definitely be growing over 
some of the recording electrodes of the custom MEA. Therefore, the quality of the 
electrodes could be assessed. On early custom MEAs, electrical activity was not recorded 
due to inaccurate/faulty electrode exposure  (either the electrodes were not fully exposed, 
or they were fully coated by the insulating layer). Later, by improving the accuracy of the 
deposition of the insulating SiO2 layer functional electrodes were fabricated (see Chapter 
2). Following the adjustments in the deposition of the SiO2 layer, electrical activity was 









Mouse spinal cord cultures, studied electrically using commercial MEAs over a period of 
50 days, were electrically active from as early as 2 DIV. Electrical activity was 
characterised as ‘fast’ and ‘slow’ which meant that the extracellular recordings were from 
different neuronal structures such as the cell body, axons and dendrites. The development 
of myelination was investigated by measuring electrode-to-electrode nominal conduction 
velocity which increased from 6 DIV up until 24 DIV. The velocities measured in this 
chapter are the highest recorded thus far in vitro. Therefore, MEAs ability for long-term 
recording from live neuronal cultures without disturbing the cells makes them a great tool 






















In this thesis, I have successfully combined human and mouse neuronal cultures with 
microelectrode arrays (MEAs) and microfluidic modules. Following an initial 
shortcoming with the custom MEAs produced by Epigem Limited, I was able to fabricate 
them myself at the nanofabrication facility of Heriot-Watt University. This allowed me 
to trial different versions with a fast turnaround from idea to product. The first iterations 
were not up to standard as not all electrodes were functional due to problems with 
electrode and insulator deposition. Also, the cells would not adhere onto them for long 
periods of time and therefore I was unable to record from them. Once these issues were 
overcome, I was able to use custom MEAs to record from human dopaminergic cultures 
and mouse spinal cord cultures.  
 
The purpose of fabricating my own custom MEAs and not only use what is commercially 
available was to produce a low-cost biochip with embedded microchannels that would 
guide axonal growth over recording electrodes and restrict neuronal cell bodies in a 
separate stimulating compartment that could be used to investigate myelination in vitro. 
I showed that the microchannels fabricated functioned as hypothesised by allowing only 
axonal growth of human cerebral cortical neurons (hCCNs) through into the second 
compartment. However, I was not able to record from the biochip as the hCCNs did not 
grow on it long enough for the axons to pass through the microchannels and also obtain 
any recordings from.  
 
Biochips were tested with mouse spinal cord cultures and human dopaminergic cultures 
too but still no growth through the channels was observed. However, myelination in vitro 
was electrically investigated using commercial MEAs and mouse spinal cord cultures. 
Electrode-to-electrode nominal conduction velocity (NCV) was measured which 
increased significantly between 6 days in vitro (DIV) and 24 DIV where it reached a peak 
velocity of 15 m/s. This shows that MEAs can be used to follow myelination in vitro and 
therefore can be done in the biochips I fabricated with human neurons in order to develop 
novel human in vitro multiple sclerosis and other disease models.  
 
I believe that myelination is not assessed electrically as much as other techniques due to 
the multiple difficulties that arise when incorporating different technologies like MEAs, 
microfluidics and human neurons. However, with my biochip (following a few tweaks) 
this hurdle can be overcome.  
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5.1 Microelectrode Arrays and Culture Issues 
 
Following already established techniques such as photolithography and physical vapour 
deposition I fabricated functional custom MEAs on which CNS cells successfully adhered 
onto and were maintained in cultures for 3 to 6 weeks. The different versions I designed 
and fabricated are detailed in Chapter 2 (Table 2.1).  
 
The choice of materials and dimensions were based on the findings from previous studies 
and the cost of materials. In order for the metal to be a suitable substrate for long term 
culture it had to have good electrical conductivity properties and be non-toxic. Possible 
candidates included gold (Au), platinum (Pt) black and titanium (Ti). These metals are 
found in most of the commercially available MEAs from companies such as Multichannel 
Systems (Reutlingen, Germany) and Ayanda Biosystems (Lausanne, Switzerland). Au 
was first considered as it is commonly used, but its high cost meant it was quickly ruled 
out as it was important for the custom MEAs to have a low cost for future possible 
commercialisation and also aligned with the relatively cheap cost of the whole recording 
set up. Similarly to Au, Pt black was also ruled out because of its price but also due to it 
having issues with adhesion and reproducibility. This is because it needs to be redeposited 
after every culture as it is removed during the cleaning process (Eick et al., 2009). 
Therefore, Ti was the ideal candidate due to its low cost, good electrical conductivity and 
lack of toxicity (Kim et al., 2018). 
 
The electrode diameters ranged between 20 to 80 μm for the different versions. The final 
diameter chosen (V3.2, V3.4 and V4.0) was 50 μm which was greater than that of the 
commercial MEAs used (30 μm). MEAs have electrodes of various diameters 
concentrated in a small area in order to increase the spatial resolution of the recorded 
signal, however, the smaller the electrode size the higher the impedance which results in 
a low signal to noise ratio (Cogan, 2008). Therefore, slightly bigger electrodes were 
chosen as to have a lower impedance and thus a better signal to noise ratio than that 
obtained from the commercial MEAs. 
 
I found that culturing and differentiating hNSCs on commercial MEAs was not possible 
as during the differentiation process the cells were no longer adhered onto the surface 
(Chapter 3). After trying different coating solutions as an attempt to improve cell 
adherence on the commercial MEAs and not observing any improvement, I decided to 
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use an alternative insulating layer for the custom MEAs. Therefore, instead of Si3N4, I 
used SiO2. SiO2 is widely used in the field for insulating purposes as it also is 
biocompatible and has better insulating properties (higher resistivity) than Si3N4 
(Bartzsch et al., 2009). Culturing and differentiating hNSCs on SiO2 showed an 
improvement as the density of the cells did not drop as quickly as that of those cultured 
on Si3N4. However, all cells eventually detached after 2 to 3 weeks. 
 
On the other hand, human dopaminergic cultures and mouse spinal cord cultures were 
maintained on the custom MEAs for as long as those cultured on commercial MEAs. 
Therefore, the use of SiO2 for the insulating layer could be considered an improvement 
compared to Si3N4. 
 
5.2 Microchannels for Axon Isolation  
 
In Chapter 2 I described the fabrication process of making microchannels of different 
dimensions using soft lithography. The purpose of these microchannels was to separate 
the neuronal cell bodies from the axons as the cell bodies would be restricted and remain 
in the first compartment while the second would only contain axons. This was achieved 
with microchannels measuring 5 μm in width, 50 μm in length and 25 μm in height. 
hNSCs were seeded into the left-hand side compartment and were differentiated into 
hCCNs. Only axonal growth was observed in the right-hand side compartment as the cell 
bodies were successfully prevented from flowing and adhering in the right-hand side 
compartment by the 5 μm microchannels.  
 
The result achieved was expected as it has been shown by several other studies who used 
a similar concept design (compartments separated by microchannels) to investigate 
axonal growth (Park et al., 2014) and axon/glia interactions (Park et al., 2012). The 
compartment layout for both these studies was different to the one I used as it was 
important for the microchannels to align with the electrode layout of the custom MEAs. 
Another difference was the dimensions of the microchannels. For investigating axonal 
growth, the Park et al., (2014) module consisted of microchannels measuring 20 μm in 
width, 10,000 μm in length and 3 μm in height. The reason for the 200 times greater 
microchannel length was that they were looking at how axonal growth was affected by 
various treatments and therefore wanted to visualise axons growing separately through 
microchannels. My microchannel dimensions were closer to those of the axon/glia study 
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(Park et al., 2012) that had microchannels measuring 20 μm wide, 3 μm high and 400 μm 
long as the end goal was to add glial cells in the axonal compartment to study myelination 
electrically in vitro.  
 
Another design option was to have longer microchannels and have glia growing within 
the channels which was a concept tested by Sakai et al., 2017. They cultured DRG 
neurons whose axons grew through microchannels that contained Schwan cells and could 
stimulate and record from a series of electrodes aligned along microchannel measuring 
50 μm wide, 2000 μm long and 6 μm high (Figure 1.9). The peak conduction velocity 
recorded was 0.59 m/s at 32 DIV which when compared to the velocities measured from 
mouse spinal cord cultures in this thesis was much slower. A direct comparison cannot 
be made due to the different cell types, but the velocities of their myelinated culture was 
only 0.15 m/s greater than the unmyelinated culture. This could be due to the myelination 
being restricted to develop and mature within the microchannels and that is why I did not 
use microchannels longer than 100 μm. Even though still in 2D, the axon/glia interaction 
would occur in an open well and not be restricted by a few microns hindering myelination.  
 
When testing the microchannels with mouse myelinating cultures, even with 50 μm long 
microchannels, I was unable to achieve axonal growth into the second compartment as 
the cells remained and developed in the cell seeding compartment. As the overall aim of 
the microchannels was to isolate axons from cell bodies, the length of the microchannels 
could be further reduced to as low as 5 μm in an attempt for achieving the same results 
as the hCCNs with other cells like those from the mouse spinal cord.  
 
5.3 Characterising Electrically Active Human and Animal Neuronal 
Cultures 
 
5.3.1 Human Neural Cultures  
 
Human dopaminergic neurons and hCCNs were tested electrically using voltage-clamp 
electrophysiology as well as culturing on commercial and custom MEAs to validate the 
MEA measurements. Sodium current densities of both neuronal cultures increased with 
time in culture, following weekly assessments with patch-clamp and as expected the 
addition of TTX blocked the sodium voltage-sensitive currents. Unlike the dopaminergic 
cultures, no excitatory spontaneous postsynaptic currents (ESPCs) were recorded in the 
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hCCNs throughout the 4 weeks tested. ESPCs were observed from week 2 of 
dopaminergic cultures in both TH+ and TH- cells. These results were confirmed as 
dopaminergic cultures positively stained for synaptophysin (presynaptic) and PSD-95 
(postsynaptic) whereas hCCNs did not show any electrical or immunological evidence 
for the presence of synapses. These findings were expected as it is already known that 
hCCNs require a long time (over 4 weeks) in culture before they start firing spontaneous 
action potentials and for functional synapses to be form (Shi et al., 2012). In contrast the 
human dopaminergic neurons showed earlier signs of synapse formation from as early 
week 2 (Yang et al., 2019) which is comparable to the data shown in Chapter 3.  
 
In addition, I showed that culture of human dopaminergic neurons was possible on both 
commercial and custom MEAs which provided further information on the electrical 
behaviour of the cells. The dopaminergic cultures were electrically active from week 4 to 
week 6 which was expected from the findings using voltage-clamp. The main difference 
between these two techniques is that with patch-clamp you can selectively choose which 
cell to analyse and therefore distinguish between TH+ or TH- neurons whereas with 
MEAs the electrical activity is recorded from the whole culture as long as they are 
growing over the electrodes.  
 
My recordings indicated that two distinct waveforms were present in the electrical activity 
traces. These waveforms were classified as ‘fast’ and ‘slow’ depending on their duration. 
‘Fast’ waveform had a duration of less than 3 ms and waveforms with a duration greater 
than 3 ms were classified as ‘slow’. The ‘slow’ waveform activity was more prominent 
(about 70%) than ‘fast’ waveform activity (about 30%) throughout the culture period (4 
to 6 weeks). There was no change in ‘fast’ waveform shape whereas the slow waveforms 
became narrower with time, which can be explained by the synaptic maturation that is 
known to occur in dopaminergic cultures (Shi et al., 2012).  
 
5.3.2 Mouse Neural Cultures  
 
Mouse spinal cord cultures were electrically active from 2 DIV up until 52 DIV on 
commercial MEAs. In Chapter 4, I show that you can follow the development of these 
cells by looking at their waveforms, spike frequency and bursting of activity as well as 
perform additive pharmacology to investigate the origin of the electrical activity 
recorded. The shape of ‘fast’ and ‘slow’ waveforms was altered with as the DIV 
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increased. Broadening of ‘fast’ waveforms was observed with an increase in DIV which 
could be attributed to the change of sodium ion channel distribution along unmyelinated 
and myelinated axons (Vacher, Mohapatra and Trimmer, 2008). Similarly, to human 
dopaminergic cultures, the ‘slow’ waveforms became narrower which could again be due 
to synaptic maturation but in this case could also be caused by the redistribution of 
calcium channels on the axons during the process of myelination (Lai and Jan, 2006).  
 
5.4 Assessing Myelination in vitro using MEAs 
 
An increase in electrode-to-electrode NCV over time was measured from mouse spinal 
cord cultures using commercial MEAs. A large and significant increase in NCV was 
recorded from 6 to 10 DIV as it went from 0.03 m/s to 6.38 m/s. This increase suggests 
that myelination began which is at least 2 days earlier than what previous studies have 
found when staining for CNP (Bijland et al., 2019) or that maturation of axons and 
increasing sodium channel distribution generated faster NCVs. NCVs continued to 
increase up until the last possible recording at 24 DIV which was the peak NCV measured 
at 15.0 m/s. I was unable to calculate NCV past 24 DIV as no ‘fast’ electrical activity was 
recorded from 25 DIV onwards, possibly due to the increase of myelinated axons growing 
over the recording electrodes.  
 
The increase in NCV was expected as it is known that during that time period is when 
myelination occurs in mouse in vitro cultures (Thomson et al., 2006). When compared to 
the study that measured conduction velocity in myelinating rat DRG neurons (Sakai et 
al., 2017) the peak velocity measured here is about 25 times greater. To my knowledge, 
the NCV measurements I present in this thesis are the highest velocity recorded in vitro 
thus far. Future work to enhance these results would be to add demyelinating drugs such 
as amiodarone, dichloroacetate, tumor necrosis factor-α antagonists and measure its effect 
on conduction velocity and possible recovery as demyelination occurred. This would 
allow to study the process of demyelination and remyelination in vitro and an 
investigation of possible neuroprotective agents. 
 
The next step would involve culturing these mouse spinal cord neurons on custom MEAs 
with microchannels (biochip), as on commercial MEAs the cells randomly grow over the 
electrodes in a disorganised manner. Therefore, the source of the electrically activity 
cannot be pinpointed to a certain number of cells and also relies on the spontaneous 
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activity of the cultures. Replacing that with a biochip, would allow for a more organised 
and controlled growth as the cell bodies would remain in a separate compartment to the 
axons and also have the ability to stimulate the cell bodies to evoke an action potential 
that would be recorded from the electrodes in the axonal compartment. Adding a source 
of stimulation means that neuronal cultures that are not spontaneously active such as 




This work has aimed at developing a system integrating MEAs and microchannels that 
can be used as a tool for investigating neurodegenerative diseases like multiple sclerosis. 
To do this, functional custom MEAs were fabricated and were tested using hNSCs, 
hCCNs, human dopaminergic cultures and mouse spinal cord cultures. The fabricated 
microchannels were able to successfully separate hCCN cell bodies and axons in two 
different compartments. Myelination was assessed electrically using commercial MEAs 
and mouse spinal cord cultures by showing that conduction velocity increases with time 
thus indicating an improvement in myelin compaction. This involved the development of 
analysis protocols for electrical events that can be standardised and applied to the 
myelinating cultures and represent a relatively simple and cost-effective approach to 
interrogate the electrical behaviour of the cultures across time.  
 
In conclusion, the findings from this thesis provide proof that MEAs and microfluidics 
are excellent tools for developing in vitro neurological disease models as cells can be 
electrically analysed and manipulated over long periods of time. Combining the two to 
form a biochip adds an extra advantage as cell cultures can now be spatially investigated 
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